Risteys ·

OMOP concept ID	Test name	Measurement unit (harmonized unit)	N people	N records	Missing measurement value	Harmonized value distribution
3006270	fb-folaat	nmol/l (nmol/l)	2578	2993	0.00%
3006270	fb-folaat	— (—)	535	583	100.00%	Distribution not available
3006270	fb-folat	nmol/l (nmol/l)	218	247	0.00%
3006270	fb-folaatti	nmol/l (nmol/l)	39	40	0.00%
3006270	fb-folat	— (—)	10	10	100.00%	Distribution not available
3006270	fb-folaatti(k-pks:n)(ko)	nmol/l (nmol/l)	9	9	0.00%	Distribution not available

LabWAS

N Cases

N Controls

-log₁₀(p)

cases

controls

cases

controls

unit

-log₁₀(p)

N cases

N controls

Speech therapy

370

840

4.51

149.06

1.2

281.86

358.06

nmol/l

9.18

270

712

Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism

754

2380

2.20

81.51

1.2

1.1

356.14

373.76

nmol/l

1.24

612

2029

Anaemias

204

273

4.93

79.33

1.2

1.0

392.01

399.02

nmol/l

0.16

180

262

Other anaemias

415

1477

2.70

75.15

1.3

1.2

327.17

336.81

nmol/l

0.36

328

1171

Aplastic and other anaemias

432

1538

2.65

74.85

1.3

1.2

324.61

338.11

nmol/l

0.59

343

1220

Other and unspecified anaemias

405

1470

2.66

70.97

1.2

325.91

336.16

nmol/l

0.39

319

1164

Diseases of oesophagus, stomach and duodenum

764

2287

2.01

63.45

1.2

1.1

346.93

379.48

nmol/l

3.53

643

1935

Fitting and adjustment of other devices

332

1147

2.64

57.08

1.3

1.2

287.83

334.25

nmol/l

3.55

233

960

Dementia, including avohilmo

387

1063

2.53

57.05

1.3

1.2

312.26

316.54

nmol/l

0.13

302

810

Other antidepressants

713

1861

1.97

54.26

1.2

1.1

378.10

356.95

nmol/l

1.61

610

1573

Organic, including symptomatic, mental disorders

401

1235

2.33

50.27

1.3

1.2

319.14

325.20

nmol/l

0.21

319

960

Dementia

363

1040

2.43

49.18

1.3

1.2

314.10

313.59

nmol/l

0.01

287

781

Dipeptidyl peptidase 4 (DPP-4) inhibitors

411

1480

2.24

48.38

1.2

313.56

349.15

nmol/l

2.28

267

1285

Bacterial infection, other or unspecified

439

1729

2.16

47.91

1.2

320.00

354.19

nmol/l

2.55

337

1445

Nutritional anaemias

405

1784

2.21

47.60

1.3

1.2

353.37

345.68

nmol/l

0.27

334

1447

Bacterial infection, other or unspecified

408

1654

2.16

44.49

1.2

324.13

351.22

nmol/l

1.61

309

1373

Unspecific neurodegenerative disorder

352

1058

2.30

42.26

1.3

1.2

317.69

306.93

nmol/l

0.40

285

777

Recurrent or chronic depression

263

714

2.61

41.87

1.2

1.1

392.30

376.31

nmol/l

0.58

240

636

Type 2 diabetes, wide definition

523

1752

1.92

39.22

1.2

333.36

368.31

nmol/l

2.85

363

1553

Gastro-oesophageal reflux disease

454

1996

1.97

39.15

1.3

1.1

340.16

376.62

nmol/l

3.46

393

1671

Iron deficiency anaemia

341

1555

2.18

39.14

1.2

353.38

348.95

nmol/l

0.14

279

1262

Other and unspecified iron deficiency

281

1210

2.34

38.47

1.2

362.93

346.56

nmol/l

0.64

230

982

Malaise and fatigue

371

1418

2.12

38.30

1.2

1.1

346.85

353.16

nmol/l

0.20

267

1211

Covid-19 suspected case

185

655

2.86

38.05

1.1

397.05

383.83

nmol/l

0.25

605

Unspecified dementia

138

369

3.42

37.32

1.3

1.2

290.13

312.78

nmol/l

0.53

274

Autoimmune diseases

698

2043

1.74

36.62

1.2

1.1

370.42

374.16

nmol/l

0.16

600

1754

Medical observation and evaluation for suspected diseases and conditions

439

1110

2.03

36.51

1.2

1.1

345.89

394.28

nmol/l

4.26

361

938

Other special examinations and investigations of persons without complaint or reported diagnosis

441

1112

2.02

35.88

1.2

1.1

354.02

394.03

nmol/l

3.15

372

939

Autoimmune diseases excluding thyroid diseases

652

2034

1.76

35.63

1.2

1.1

363.40

374.06

nmol/l

0.61

537

1745

Other nutritional deficiencies

427

2092

1.93

35.25

1.2

1.1

389.62

377.57

nmol/l

0.56

339

1854

Use of memantine

255

893

2.39

35.22

1.3

1.2

326.89

306.50

nmol/l

0.74

199

651

Use of other anti-dementia drugs

255

893

2.39

35.22

1.3

1.2

326.89

306.50

nmol/l

0.74

199

651

Care involving use of rehabilitation procedures

425

2034

1.93

34.93

1.1

358.83

372.08

nmol/l

0.54

278

1788

Presence of cardiac and vascular implants and grafts

322

1111

2.17

34.71

1.2

310.94

343.29

nmol/l

1.86

235

888

Autoimmune diseases excluding thyroid diseases, strict definition

626

1978

1.74

33.23

1.2

1.1

360.82

374.68

nmol/l

0.87

516

1701

Used for control exclusion in common control thyroid runs

648

1904

1.73

32.81

1.2

1.1

370.68

374.75

nmol/l

0.17

546

1639

Persons encountering health services for specific procedures and health care

659

2336

1.70

32.74

1.2

1.1

353.50

380.32

nmol/l

2.36

528

2067

Depression or dysthymia

402

1115

2.00

32.74

1.2

1.1

375.20

358.52

nmol/l

0.77

347

941

Symptoms and signs involving cognition, perception, emotional state and behaviour

617

2479

1.70

31.88

1.2

1.1

370.55

368.87

nmol/l

0.07

510

2117

Biguanides

604

2150

1.72

31.53

1.2

349.85

369.33

nmol/l

1.30

434

1921

Diaphragmatic hernia

268

1236

2.19

31.28

1.2

324.56

353.75

nmol/l

1.56

232

990

Endocrine, nutritional and metabolic diseases

463

1250

1.88

31.13

1.2

1.1

382.83

386.51

nmol/l

0.13

405

1154

Other diseases of intestines

640

2172

1.68

30.43

1.2

1.1

361.38

381.89

nmol/l

1.53

546

1870

Combinations of oral blood glucose lowering drugs

200

826

2.44

30.27

1.1

1.2

347.69

351.82

nmol/l

0.09

138

729

Hypothyroidism (congenital or acquired)

155

292

3.02

30.22

1.1

398.69

401.17

nmol/l

0.05

142

280

Use of donepezil

199

784

2.46

30.17

1.3

1.2

334.75

312.20

nmol/l

0.70

162

567

Obesity due to excess calories

300

1465

2.06

30.13

1.2

1.1

374.92

377.60

nmol/l

0.08

229

1305

Other functional intestinal disorders

312

1430

2.04

29.96

1.2

1.1

332.59

360.99

nmol/l

1.54

247

1190

Any dementia, excluding more controls

280

896

2.17

29.68

1.3

1.2

309.13

318.97

nmol/l

0.30

215

690

Psychiatric diseases

591

1729

1.72

29.47

1.2

1.1

366.06

370.77

nmol/l

0.20

503

1480

Undefined dementia

140

449

2.92

29.40

1.3

288.43

300.83

nmol/l

0.26

342

Constipation

566

2312

1.70

29.27

1.2

1.1

365.18

360.61

nmol/l

0.18

446

1974

Selective serotonin reuptake inhibitors

603

1864

1.69

28.96

1.2

1.1

377.69

356.59

nmol/l

1.54

518

1576

Hypothyroidism, levothyroxine purchases

152

292

2.96

28.77

1.1

400.54

401.17

nmol/l

0.01

139

280

Hypothyroidism and >3 levothyroxin purchases

152

292

2.96

28.77

1.1

400.54

401.17

nmol/l

0.01

139

280

Obesity and other hyperalimentation

391

2042

1.85

28.70

1.2

1.1

383.42

377.62

nmol/l

0.21

308

1814

Continuous positive airway pressure

130

366

3.02

28.55

1.2

1.1

346.75

374.05

nmol/l

0.66

102

328

Other (not insulin) diabetes medications

604

2149

1.67

28.52

1.2

351.67

371.53

nmol/l

1.31

438

1926

Hyperlipidaemia, other/unspecified

277

1229

2.09

28.46

1.3

1.2

306.17

337.05

nmol/l

1.57

189

1006

Alzheimer disease, excluding more controls

137

300

3.04

28.37

1.2

325.34

317.84

nmol/l

0.13

113

224

Other degenerative diseases of the nervous system

204

638

2.41

28.13

1.2

321.37

339.97

nmol/l

0.55

167

509

Pain in throat and chest

529

1849

1.72

27.95

1.2

1.1

346.33

376.42

nmol/l

2.46

434

1591

Any mental disorder

665

2038

1.64

27.93

1.2

1.1

355.14

374.01

nmol/l

1.38

560

1756

Use of anticholinesterases

282

1077

2.08

27.81

1.3

1.2

332.95

304.83

nmol/l

1.28

225

792

N06DA Anticholinesterases

282

1077

2.08

27.81

1.3

1.2

332.95

304.83

nmol/l

1.28

225

792

Obesity

386

2035

1.84

27.65

1.2

1.1

384.40

377.87

nmol/l

0.24

303

1810

Any dementia

302

1036

2.04

27.50

1.3

1.2

310.59

310.81

nmol/l

0.01

232

775

Hypothyroidism, strict autoimmune

462

1728

1.77

27.02

1.2

1.1

369.64

370.60

nmol/l

0.03

395

1482

Diverticular disease of intestine

458

1662

1.77

26.69

1.3

1.1

352.94

367.01

nmol/l

0.65

367

1385

Condition for Implicit Sepsis (Organ dysfunction codes)

538

2219

1.68

26.49

1.2

1.1

355.21

373.86

nmol/l

1.17

446

1898

Insulin medication

370

1692

1.85

26.35

1.2

325.10

359.51

nmol/l

2.27

258

1501

Other infectious diseases

273

3.43

25.82

1.2

320.00

361.28

nmol/l

0.93

231

Other gastritis (incl. Duodenitis)

166

682

2.46

25.52

1.2

1.1

322.43

358.57

nmol/l

1.36

150

549

Codes for special purposes

345

1893

1.83

24.49

1.2

342.05

362.69

nmol/l

0.87

203

1644

Dizziness and giddiness

469

2211

1.69

24.31

1.2

1.1

362.83

360.95

nmol/l

0.06

376

1868

Provisional assignment of new diseases of uncertain etiology

344

1891

1.83

24.28

1.2

342.05

362.71

nmol/l

0.87

203

1641

Diabetes, insuline treatment (Kela reimbursement), excluding more controls

560

2074

1.63

24.23

1.2

348.52

372.57

nmol/l

1.71

403

1861

Depression medications

158

299

2.67

24.10

1.1

414.64

400.71

nmol/l

0.34

149

287

Diabetes medication

612

2284

1.59

23.98

1.2

355.48

373.78

nmol/l

1.19

451

2057

Infections, IBD-co-morbidities

211

3.31

23.72

1.2

1.1

334.70

393.82

nmol/l

1.85

198

Type 2 diabetes, definitions combined, including avohilmo

562

2023

1.62

23.63

1.2

359.85

374.51

nmol/l

0.80

432

1813

Diabetes, insulin treatment (Kela reimbursement)

599

2282

1.59

23.39

1.2

349.86

371.63

nmol/l

1.53

427

2024

Obesity, other/unspecified

221

1068

2.08

23.00

1.2

1.1

402.98

384.67

nmol/l

0.64

178

966

Other soft tissue disorders, not elsewhere classified

553

2012

1.62

22.91

1.2

1.1

358.80

376.38

nmol/l

1.12

460

1709

Diseases of the digestive system

313

1697

1.85

22.90

1.2

344.88

343.55

nmol/l

0.04

247

1383

Persons encountering health services in other circumstances, wide

708

2382

1.53

22.88

1.2

1.1

371.09

368.80

nmol/l

0.09

591

2017

Type 2 diabetes, strict (exclude DM1)

560

2052

1.61

22.72

1.2

357.32

373.11

nmol/l

0.88

423

1839

Gastrointestinal diseases

333

888

1.89

22.64

1.1

390.83

389.76

nmol/l

0.03

300

791

Type 2 diabetes

578

2126

1.59

22.60

1.2

1.1

361.91

374.93

nmol/l

0.69

438

1911

Type 2 diabetes, definitions combined

558

2046

1.61

22.58

1.2

358.03

372.98

nmol/l

0.81

421

1834

Persons encountering health services for examination and investigation

393

1112

1.78

22.27

1.2

1.1

347.03

394.03

nmol/l

3.47

334

939

Neurological diseases

486

1469

1.67

21.98

1.2

1.1

368.99

380.39

nmol/l

0.53

430

1264

Inflammatory bowel disease treatment related agents

683

2510

1.53

21.97

1.2

374.33

370.15

nmol/l

0.19

573

2129

Persons encountering health services for other counselling and medical advice, not elsewhere classified

661

2341

1.54

21.93

1.2

1.1

366.82

370.07

nmol/l

0.14

552

1987

Benign neoplasm of colon, rectum, anus and anal canal

399

2040

1.71

21.89

1.3

1.2

323.36

353.82

nmol/l

2.17

312

1678

Parasetamol

433

1285

1.71

21.66

1.2

1.1

372.00

389.73

nmol/l

0.80

378

1111

Persons with potential health hazards related to family and personal history and certain conditions influencing health status

555

2290

1.58

21.60

1.2

1.1

343.81

382.75

nmol/l

3.72

459

1980

Alzheimer’s disease (Late onset), excluding more controls

112

256

2.89

21.46

1.3

1.2

308.36

319.31

nmol/l

0.19

185

Diabetes mellitus

586

2194

1.57

21.34

1.2

1.1

362.59

376.22

nmol/l

0.75

446

1978

General symptoms and signs

623

2012

1.56

21.32

1.2

1.1

371.03

375.66

nmol/l

0.20

522

1762

Diabetes, varying definitions

584

2193

1.57

21.28

1.2

1.1

362.81

375.93

nmol/l

0.71

445

1976

Insulin, intermediate and long-acting

344

1916

1.75

21.18

1.2

321.97

356.78

nmol/l

2.22

241

1615

Benign neoplasm: Colon

340

1859

1.76

20.97

1.3

1.2

319.54

346.71

nmol/l

1.64

270

1509

Autoimmune diseases related-to ILD

503

2717

1.59

20.88

1.2

355.90

373.58

nmol/l

1.08

411

2323

Hypothyreosis and Thyroxine purchase for inclusion criteria

559

2349

1.57

20.85

1.2

372.13

367.78

nmol/l

0.17

471

1995

Non-invasive ventilation

141

522

2.43

20.83

1.2

1.1

338.81

394.05

nmol/l

2.59

118

472

Oral corticosteroids

633

2466

1.53

20.71

1.2

372.85

368.53

nmol/l

0.18

530

2087

Abnormalities of heart beat

236

1192

1.95

20.53

1.2

351.01

354.71

nmol/l

0.09

187

995

Condition for Implicit Sepsis (Organ dysfunction codes)

499

2213

1.60

20.49

1.2

1.1

349.64

368.56

nmol/l

1.13

396

1887

Examination and observation for other reasons

337

1091

1.79

20.40

1.2

1.1

373.32

396.50

nmol/l

1.12

292

924

Complications of medical and surgical care

448

2552

1.62

20.39

1.2

351.68

365.58

nmol/l

0.69

362

2159

Hypothyroidism, other/unspecified

536

2253

1.57

20.22

1.2

370.94

368.30

nmol/l

0.09

455

1918

Hypothyroidism, strict autoimmune, 3 medication purchases required

516

2211

1.58

20.19

1.2

370.55

367.17

nmol/l

0.12

436

1875

ILD medications: prednisolone, methylprednisolone, prednisone

647

2395

1.52

20.19

1.2

1.1

380.86

368.74

nmol/l

0.69

550

2023

Nerve, nerve root and plexus disorders

632

2560

1.52

20.15

1.2

1.1

363.85

368.70

nmol/l

0.23

538

2156

Abnormalities of breathing

516

1898

1.58

19.77

1.2

1.1

365.27

377.63

nmol/l

0.64

438

1639

Episodal and paroxysmal disorders

638

2143

1.52

19.75

1.2

1.1

357.61

372.72

nmol/l

0.99

543

1817

Disorders of the thyroid gland

563

2384

1.54

19.65

1.2

368.82

367.61

nmol/l

0.04

475

2030

Other bacterial diseases

541

2353

1.55

19.43

1.2

1.1

341.60

370.47

nmol/l

2.30

422

2019

Metabolic disorders

552

2182

1.55

19.36

1.2

1.1

355.58

371.39

nmol/l

0.92

444

1888

Presence of other devices

174

825

2.12

18.98

1.4

1.2

297.16

336.26

nmol/l

1.92

167

644

Insulin, combination of fast acting with intermediate-acting or long-acting

374

2062

1.66

18.96

1.2

325.76

355.13

nmol/l

1.81

260

1733

Sensorineural hearing loss

457

1943

1.60

18.96

1.2

308.78

368.01

nmol/l

7.83

353

1614

Implicit Sepsis

471

2192

1.58

18.47

1.2

1.1

348.28

365.28

nmol/l

0.92

367

1856

Disorders of gallbladder, biliary tract and pancreas

583

2440

1.51

18.44

1.2

1.1

354.64

370.05

nmol/l

0.96

477

2070

Other and unspecified polyneuropathies, also in other diseases

141

625

2.28

18.42

1.3

1.2

345.07

341.16

nmol/l

0.08

122

507

ILD medications

658

2415

1.48

18.35

1.2

1.1

376.28

369.53

nmol/l

0.32

564

2041

Complications of surgical and medical care, not elsewhere classified

580

2650

1.50

18.19

1.2

1.1

356.71

368.64

nmol/l

0.65

475

2251

Benign neoplasms

568

2062

1.52

18.14

1.2

1.1

371.54

376.81

nmol/l

0.21

488

1749

Anxiety disorders, excluding more controls

449

1838

1.59

18.13

1.2

1.1

379.85

382.49

nmol/l

0.09

393

1597

Intracranial trauma

306

1236

1.75

17.75

1.2

1.1

349.51

384.00

nmol/l

2.16

251

1073

Implicit Sepsis

436

2083

1.58

17.62

1.2

1.1

341.66

359.92

nmol/l

0.97

334

1750

Chronic gastritis

182

908

2.02

17.53

1.2

323.72

350.94

nmol/l

0.72

149

699

Symptoms and signs involving the urinary system

447

2176

1.57

17.44

1.2

337.56

360.06

nmol/l

1.39

346

1828

Conductive and sensorineural hearing loss

466

2019

1.56

17.42

1.2

313.56

370.06

nmol/l

7.38

366

1681

Symptoms and signs involving the circulatory and respiratory systems

573

1903

1.51

17.42

1.2

1.1

373.78

377.53

nmol/l

0.15

496

1643

Presence of other functional implants

341

1408

1.69

17.40

1.2

326.73

354.69

nmol/l

1.29

255

1157

Hypertensive Heart Disease

156

569

2.16

17.22

1.2

281.21

330.29

nmol/l

2.33

130

469

First line medication for Crohn's disease

637

2346

1.47

17.22

1.2

1.1

377.82

370.67

nmol/l

0.35

543

1983

Sleep disorders (combined)

643

2306

1.47

17.05

1.2

369.55

366.43

nmol/l

0.13

555

1937

Mood disorders, excluding more controls

505

1971

1.53

17.00

1.2

1.1

371.49

378.29

nmol/l

0.29

434

1697

Disorders of thyroid, IBD co-morbidities

262

2.67

16.90

1.1

386.43

405.38

nmol/l

0.39

249

Opioids

557

1923

1.51

16.88

1.2

1.1

384.88

374.96

nmol/l

0.48

485

1636

Headache

370

1832

1.62

16.55

1.2

1.1

384.10

379.45

nmol/l

0.16

316

1609

Soft tissue disorders

586

2037

1.48

16.46

1.2

1.1

359.85

375.30

nmol/l

0.98

502

1727

Neurological diseases, wide definition

148

330

2.26

16.29

1.1

397.77

408.08

nmol/l

0.22

138

315

Polyneuropathies and other disorders of the peripheral nervous system

150

720

2.10

16.12

1.2

349.24

342.60

nmol/l

0.14

129

584

Symptoms and signs involving the digestive system and abdomen

570

1924

1.49

16.10

1.2

1.1

368.28

373.94

nmol/l

0.24

488

1631

Non-selective monoamine reuptake inhibitors

222

1176

1.83

15.91

1.2

360.83

350.21

nmol/l

0.29

181

982

Pain (limb, back, neck, head abdominally)

427

1359

1.58

15.75

1.2

1.1

360.24

374.93

nmol/l

0.64

370

1144

Heart failure, not strict

410

1780

1.57

15.71

1.2

1.1

316.26

369.76

nmol/l

6.11

328

1492

Functional dyspepsia

162

810

2.01

15.57

1.2

1.1

326.82

381.42

nmol/l

3.09

131

681

Pain in limb

451

1976

1.53

15.47

1.2

1.1

361.24

376.10

nmol/l

0.79

369

1677

Sleep apnoea

516

2251

1.49

15.37

1.2

1.1

358.96

370.04

nmol/l

0.55

432

1916

Polycystic ovarian syndrome, consortium definition

408

1546

1.57

15.21

1.2

1.1

365.09

388.99

nmol/l

1.51

364

1344

Other bacterial diseases

557

2424

1.46

15.13

1.2

1.1

342.77

375.55

nmol/l

3.08

452

2085

Any gastric operation

460

1506

1.54

15.11

1.2

1.1

359.09

390.34

nmol/l

2.27

404

1263

GASTRO-related operations

460

1506

1.54

15.11

1.2

1.1

359.09

390.34

nmol/l

2.27

404

1263

Codeine

518

1894

1.49

15.02

1.2

1.1

377.94

374.66

nmol/l

0.13

449

1612

Abdominal and pelvic pain

561

1924

1.47

14.89

1.2

1.1

362.46

373.94

nmol/l

0.61

480

1631

Disorders of lipoprotein metabolism and other lipidaemias

464

1905

1.51

14.86

1.2

348.59

366.83

nmol/l

1.01

368

1630

Sulfonylureas

217

956

1.82

14.78

1.2

336.86

321.27

nmol/l

0.43

146

804

Sleep apnoea, including avohilmo

544

2310

1.46

14.76

1.2

1.1

362.27

371.14

nmol/l

0.43

463

1964

Syncope and collapse

263

1324

1.71

14.69

1.2

340.25

349.78

nmol/l

0.29

198

1121

Other disorders of ear

515

2297

1.47

14.60

1.2

1.1

324.51

375.45

nmol/l

6.70

424

1945

Other disorders of urethra and urinary system

419

1982

1.53

14.58

1.2

348.58

369.57

nmol/l

1.21

352

1666

Oxycodone

235

1221

1.75

14.43

1.3

1.1

338.70

345.99

nmol/l

0.19

184

985

Parkinson's disease, strict definition, excluding more controls

280

2.67

14.40

1.2

311.45

330.98

nmol/l

0.35

215

Complications of procedures, not elsewhere classified

461

2571

1.49

14.36

1.2

1.1

362.91

368.33

nmol/l

0.21

374

2183

Neurotic, stress-related and somatoform disorders

472

2227

1.49

14.25

1.2

1.1

383.42

381.01

nmol/l

0.09

415

1930

Alzheimer disease, including avohilmo

256

1053

1.72

14.21

1.2

311.13

307.65

nmol/l

0.09

199

773

Hypertensive heart and/or renal disease

160

606

1.98

14.03

1.3

1.2

281.92

335.18

nmol/l

2.71

130

504

Parkinson's disease, excluding more controls

297

2.59

14.01

1.2

1.1

305.31

333.21

nmol/l

0.58

229

Bacterial Sepsis

284

1476

1.65

14.00

1.2

311.21

342.46

nmol/l

1.62

205

1196

Surgical and other medical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

348

2205

1.56

13.99

1.2

350.48

359.32

nmol/l

0.32

280

1850

Dyspnoea

508

2584

1.46

13.97

1.2

1.1

348.87

367.55

nmol/l

1.17

414

2187

Other dorsopathies, not elsewhere classified

563

2045

1.44

13.89

1.2

1.1

366.78

377.16

nmol/l

0.49

485

1733

Codeine or tramadol medication

640

2492

1.41

13.89

1.2

374.08

367.79

nmol/l

0.31

548

2097

All kidney diseases

538

2556

1.44

13.86

1.2

1.1

356.63

376.16

nmol/l

1.14

427

2217

Degenerative diseases of the nervous system

245

1052

1.72

13.69

1.2

309.55

312.53

nmol/l

0.07

189

781

Gastroduodenal ulcer

166

874

1.91

13.68

1.3

1.2

308.24

346.06

nmol/l

1.72

138

673

Fall on same level

618

2393

1.41

13.67

1.2

1.1

355.17

382.01

nmol/l

2.21

516

2065

Renal tubulo-interstitial diseases

481

2452

1.46

13.64

1.2

1.1

345.87

368.85

nmol/l

1.30

375

2101

Anxiety disorders

475

2257

1.47

13.59

1.2

1.1

383.18

379.52

nmol/l

0.14

418

1951

Depression

514

2412

1.45

13.51

1.2

1.1

373.79

376.40

nmol/l

0.10

443

2074

Gastric ulcer

116

541

2.16

13.51

1.3

1.2

318.69

347.52

nmol/l

0.87

103

414

Certain infectious and parasitic diseases

545

1890

1.45

13.51

1.2

1.1

369.42

375.35

nmol/l

0.25

459

1653

Implicit bacterial Sepsis

272

1429

1.65

13.44

1.2

312.32

339.11

nmol/l

1.24

202

1152

All chronic kidney diseases

310

1595

1.59

13.24

1.3

1.2

331.31

348.52

nmol/l

0.57

233

1327

Renal failure

281

1532

1.63

13.22

1.3

1.2

312.08

332.73

nmol/l

0.71

208

1214

Concussion

251

1226

1.68

13.07

1.2

1.1

348.94

383.73

nmol/l

1.93

205

1064

Arthropathies

493

1713

1.46

12.91

1.2

1.1

380.75

379.35

nmol/l

0.05

426

1470

Migraine

262

1291

1.65

12.88

1.1

405.54

392.43

nmol/l

0.46

237

1155

Acute gastritis

201

2.92

12.75

1.4

1.1

301.38

376.30

nmol/l

1.91

169

Certain infectious and parasitic diseases

429

1441

1.49

12.54

1.2

1.1

363.74

372.65

nmol/l

0.35

365

1239

Spondylopathies

446

1815

1.47

12.54

1.2

344.74

370.25

nmol/l

1.74

374

1513

Other symptoms and signs involving cognitive functions and awareness

268

1513

1.62

12.42

1.2

357.70

343.19

nmol/l

0.52

219

1232

Tramadol

428

1784

1.48

12.35

1.2

1.1

375.43

370.41

nmol/l

0.18

372

1503

Heart failure,strict

292

1293

1.60

12.35

1.3

1.2

298.22

348.98

nmol/l

3.84

233

1043

Other infectious diseases

239

2.71

12.27

1.2

335.41

365.63

nmol/l

0.46

199

Symptoms, signs and abnormal clinical and laboratory findings, not elsewhere classified

188

513

1.84

12.27

1.1

388.06

391.94

nmol/l

0.09

176

469

Dysphagia

154

824

1.88

12.25

1.2

336.54

344.28

nmol/l

0.18

126

669

Other abnormal uterine and vaginal bleeding

140

511

1.97

12.10

1.2

1.1

344.07

377.39

nmol/l

1.13

125

404

Hernia

508

2403

1.42

12.09

1.2

351.49

372.74

nmol/l

1.42

430

2008

Somatoform disorder

105

494

2.14

12.02

1.2

1.1

387.86

385.60

nmol/l

0.04

441

Benzodiazepine use

555

2745

1.39

11.99

1.2

1.1

365.06

370.03

nmol/l

0.21

471

2324

General examination and investigation of persons without complaint and reported diagnosis

330

1106

1.56

11.90

1.2

1.1

345.56

394.83

nmol/l

3.59

311

935

Dorsopathies

564

2048

1.40

11.89

1.2

1.1

371.18

377.18

nmol/l

0.25

492

1735

Polyarthropathies

361

1562

1.51

11.86

1.2

1.1

346.20

373.09

nmol/l

1.60

290

1325

Chronic kidney disease

199

1140

1.72

11.78

1.3

1.2

316.90

330.77

nmol/l

0.31

151

897

Hypothyroidism, drug reimbursement

218

2.51

11.78

1.1

1.0

358.97

392.88

nmol/l

0.73

208

Pain, not elsewhere classified

159

871

1.83

11.75

1.3

1.1

346.98

369.77

nmol/l

0.67

134

766

Excessive, frequent and irregular menstruation

215

685

1.73

11.58

1.1

366.66

388.14

nmol/l

0.71

193

568

Implicit bacterial Sepsis

246

1347

1.63

11.57

1.2

306.16

336.53

nmol/l

1.39

178

1081

Myalgia

136

713

1.92

11.54

1.2

1.1

368.60

378.36

nmol/l

0.22

114

612

Angina pectoris

315

1360

1.55

11.54

1.2

328.96

350.12

nmol/l

0.92

228

1137

Surgical operation and other surgical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

322

2125

1.52

11.49

1.2

355.00

356.64

nmol/l

0.05

257

1773

Antihypertensive medication - note that there are other indications

295

989

1.58

11.41

1.1

401.33

395.00

nmol/l

0.20

273

907

Other disorders of fluid, electrolyte and acid-base balance

187

1031

1.74

11.40

1.2

335.09

342.03

nmol/l

0.16

143

840

Other external causes of accidental injury

458

1593

1.44

11.30

1.2

1.1

362.93

382.17

nmol/l

0.96

391

1368

Intracranial injury

322

2019

1.51

11.23

1.2

339.24

361.35

nmol/l

1.15

254

1693

Benign neoplasm: Ascending colon

436

2.18

11.21

1.3

1.2

330.67

345.68

nmol/l

0.32

353

Irritable bowel syndrome

155

857

1.82

11.15

1.2

1.1

353.07

379.64

nmol/l

0.93

134

749

Cardiovascular diseases

290

990

1.58

11.08

1.1

408.23

412.83

nmol/l

0.14

267

927

Adjustment and management of implanted device

122

626

1.96

11.08

1.1

1.2

352.10

329.87

nmol/l

0.47

508

Cholelithiasis, broad definition with cholecystitis

486

2331

1.41

11.02

1.2

347.49

366.73

nmol/l

1.21

395

1971

Other neurological diseases

402

2188

1.45

10.96

1.2

326.38

355.90

nmol/l

2.10

324

1798

Other heart diseases, wide

466

2012

1.42

10.95

1.2

1.1

387.67

382.01

nmol/l

0.23

405

1761

Diabetic neuropathy

400

2.21

10.91

1.2

351.78

327.05

nmol/l

0.47

278

Shoulder lesions

414

1735

1.45

10.86

1.2

1.1

345.77

368.56

nmol/l

1.46

358

1451

Bleeding

447

2245

1.42

10.80

1.2

344.93

359.37

nmol/l

0.71

357

1874

Alzheimer disease

219

972

1.66

10.79

1.2

319.77

309.29

nmol/l

0.28

169

717

Hypertension, essential

392

1517

1.47

10.79

1.2

1.1

374.23

382.28

nmol/l

0.31

330

1365

Diseases of arteries, arterioles and capillaries (FINNGEN)

123

432

1.98

10.73

1.2

1.1

341.15

383.59

nmol/l

1.36

387

Migraine, single triptan purchase ok & required. ICD-code if available is included

370

1707

1.47

10.73

1.1

424.31

384.83

nmol/l

3.36

342

1516

Triptan medication for migraine, single purchase ok

370

1707

1.47

10.73

1.1

424.31

384.83

nmol/l

3.36

342

1516

Accidents

454

1593

1.43

10.72

1.2

1.1

364.79

382.17

nmol/l

0.83

388

1368

Menorrhagia

194

623

1.74

10.70

1.2

1.1

352.32

384.85

nmol/l

1.29

174

508

Noninfective enteritis and colitis

249

1578

1.58

10.70

1.2

359.72

366.80

nmol/l

0.23

215

1343

Other joint disorders

460

1709

1.42

10.65

1.2

1.1

376.25

379.84

nmol/l

0.13

410

1467

Cardiac arrhythmias

295

1246

1.54

10.62

1.2

1.1

409.25

393.76

nmol/l

0.65

267

1149

Mood [affective] disorders

539

2550

1.37

10.54

1.2

375.38

374.02

nmol/l

0.05

465

2174

Hypokalaemia

395

2.20

10.54

1.1

351.04

351.90

nmol/l

0.01

330

Other diseases of the digestive system

198

1193

1.67

10.53

1.2

330.77

340.88

nmol/l

0.27

151

956

Injuries to the head

594

2706

1.35

10.46

1.2

1.1

352.38

374.17

nmol/l

1.74

485

2318

Migraine without aura and triptan purchases

416

2.15

10.42

1.1

459.52

396.67

nmol/l

2.00

387

Follow-up examination after treatment for conditions other than malignant neoplasms

231

944

1.62

10.40

1.2

1.1

347.19

396.99

nmol/l

3.01

197

796

Mood disorders

539

2553

1.37

10.37

1.2

374.88

373.88

nmol/l

0.04

465

2176

Oxicams

150

462

1.85

10.32

1.2

397.35

340.57

nmol/l

1.95

117

351

Diseases of the eye and adnexa

420

1464

1.44

10.30

1.2

1.1

380.66

391.55

nmol/l

0.49

373

1292

Polyuria

137

749

1.84

10.28

1.3

1.2

340.69

345.38

nmol/l

0.09

106

606

Coxarthrosis

282

1212

1.54

10.17

1.2

1.1

348.88

360.51

nmol/l

0.40

225

994

Migraine without aura

106

534

1.99

10.16

1.1

443.47

399.81

nmol/l

1.33

502

Other CVD (FINNGEN)

217

2.45

10.16

1.2

1.1

342.43

359.09

nmol/l

0.23

184

Misadventures to patients during surgical and medical care

461

2.08

10.12

1.2

1.1

378.28

367.35

nmol/l

0.19

393

Soft tissue disorders related to use, overuse and pressure

149

842

1.78

10.02

1.3

1.1

376.63

361.98

nmol/l

0.35

128

701

Cholelithiasis

463

2299

1.39

9.97

1.2

348.67

365.53

nmol/l

0.96

378

1943

Other intervertebral disc disorders

449

1929

1.40

9.97

1.2

1.1

352.12

374.67

nmol/l

1.50

390

1625

Other arrhythmias

330

1691

1.48

9.95

1.2

1.1

360.22

372.78

nmol/l

0.50

276

1459

Dorsalgia

523

2045

1.37

9.91

1.2

1.1

362.99

377.18

nmol/l

0.74

453

1732

Pure hypercholesterolaemia

389

1774

1.43

9.87

1.2

339.13

363.08

nmol/l

1.40

311

1509

Rotator cuff syndrome

330

1609

1.48

9.85

1.2

1.1

358.42

365.90

nmol/l

0.27

287

1335

Coxarthrosis [arthrosis of hip](FG)

309

1460

1.49

9.77

1.2

1.1

344.38

363.87

nmol/l

0.86

247

1196

All-cause Heart Failure

317

1514

1.48

9.67

1.3

1.2

301.06

338.01

nmol/l

1.97

252

1196

Coeliac disease

339

2.23

9.59

1.3

1.1

324.28

379.32

nmol/l

1.79

303

Use of hypnotics and sedatives

567

2427

1.34

9.54

1.2

378.37

368.00

nmol/l

0.55

481

2061

Alzheimer’s disease, strict definition

177

872

1.68

9.47

1.3

1.2

324.87

309.26

nmol/l

0.44

145

636

Finngen Rheumatological endpoints

502

2092

1.37

9.44

1.2

1.1

357.73

382.21

nmol/l

1.73

430

1794

Senile cataract

321

1334

1.48

9.43

1.3

1.1

332.95

367.53

nmol/l

2.06

249

1131

Rheumatoid arthritis

184

1003

1.65

9.37

1.2

1.1

342.02

366.23

nmol/l

0.83

149

826

Hypertension

391

1552

1.42

9.34

1.2

1.1

385.47

382.50

nmol/l

0.10

333

1398

Heart failure, strict

319

1537

1.47

9.29

1.3

1.2

300.26

338.54

nmol/l

2.11

254

1215

Cerebrovascular diseases

393

1961

1.41

9.27

1.2

319.03

353.18

nmol/l

2.16

312

1604

Oedema, not elsewhere classified

181

1089

1.65

9.23

1.3

1.2

329.43

356.27

nmol/l

0.92

139

923

Falls/tendency to fall

562

2098

1.34

9.23

1.2

1.1

355.18

386.05

nmol/l

2.52

484

1819

Other diseases of urinary system

535

2233

1.35

9.23

1.1

361.96

373.00

nmol/l

0.51

449

1896

Non-rheumatic valve diseases

240

1117

1.56

9.21

1.2

1.1

322.48

351.24

nmol/l

1.39

203

923

Hypertensive diseases

390

1552

1.42

9.21

1.2

1.1

385.71

382.50

nmol/l

0.11

332

1398

Caries of dentine

130

704

1.81

9.20

1.2

1.1

346.28

370.74

nmol/l

0.63

601

Coxibs

165

502

1.74

9.12

1.2

1.1

379.36

348.57

nmol/l

0.95

137

390

Irregular menses

241

1237

1.54

9.08

1.1

378.04

400.20

nmol/l

0.99

224

1122

Fever of other and unknown origin

282

1693

1.49

9.08

1.2

1.1

338.17

363.84

nmol/l

1.24

227

1467

Unspecified urinary incontinence

284

2.31

9.05

1.3

1.1

325.51

366.44

nmol/l

0.92

241

Any reimbursement code in KELA

277

913

1.52

9.05

1.1

392.71

406.63

nmol/l

0.50

251

850

Factors influencing health status and contact with health services

152

430

1.78

9.02

1.2

1.1

367.83

390.14

nmol/l

0.48

131

377

All anxiety disorders

295

1585

1.47

8.97

1.2

1.1

379.99

390.96

nmol/l

0.43

267

1417

Heart failure and coronary heart disease

236

1081

1.55

8.96

1.3

1.2

291.27

334.41

nmol/l

2.32

180

865

Diseases of the ear and mastoid process

606

2310

1.32

8.81

1.2

1.1

345.02

385.67

nmol/l

4.90

515

1989

Low back pain

390

2006

1.40

8.80

1.2

1.1

371.54

378.30

nmol/l

0.27

337

1704

ILD medications: immunosuppressive drugs

315

2035

1.44

8.73

1.2

1.1

356.25

371.87

nmol/l

0.68

273

1736

Insulin, fast-acting

195

1229

1.59

8.72

1.2

325.13

360.28

nmol/l

1.58

135

1036

Valvular heart disease excluding rheumatic fever

238

1121

1.54

8.72

1.2

1.1

322.87

351.81

nmol/l

1.40

202

926

Heart failure and antihypertensive medication

118

415

1.87

8.69

1.2

1.1

311.57

363.07

nmol/l

2.05

362

Anxiety (asthma-related co-morbidities)

290

1530

1.47

8.67

1.2

1.1

380.06

393.20

nmol/l

0.54

262

1370

External causes of morbidity and mortality

361

1271

1.43

8.52

1.1

369.27

382.26

nmol/l

0.48

316

1104

Pneumonia, organism unspecified

464

2409

1.35

8.51

1.2

1.1

342.84

375.85

nmol/l

2.33

383

2062

Disorders of other endocrine glands

235

1530

1.52

8.46

1.1

1.2

350.14

363.72

nmol/l

0.47

192

1293

Diseases of the musculoskeletal system and connective tissue

273

912

1.50

8.45

1.2

1.1

385.11

387.99

nmol/l

0.08

247

786

Genitourinary diseases

282

949

1.49

8.42

1.2

1.1

379.92

387.13

nmol/l

0.21

247

800

Benign neoplasm: Caecum

346

2.13

8.37

1.3

1.2

335.68

349.98

nmol/l

0.24

282

Alzheimer’s disease (Late onset)

163

832

1.66

8.35

1.3

1.2

314.71

306.84

nmol/l

0.19

133

602

Respiratory diseases principally affecting the interstitium, IBD co-morbidites

137

2.60

8.34

1.1

322.45

374.69

nmol/l

0.87

126

Conduction disorders

166

819

1.65

8.34

1.3

1.2

318.77

338.54

nmol/l

0.61

136

655

Paralytic ileus and intestinal obstruction

147

874

1.69

8.33

1.2

340.90

352.07

nmol/l

0.27

111

707

Postmenopausal atrophic vaginitis

146

464

1.74

8.31

1.2

1.1

382.85

379.20

nmol/l

0.06

124

363

Familial hypercholesterolemia

497

1.92

8.28

1.3

1.2

303.32

336.88

nmol/l

0.80

395

Asthma, unspecified (mode), excluding more controls

269

1365

1.48

8.26

1.2

1.1

359.42

383.60

nmol/l

1.11

218

1190

Deforming dorsopathies

149

892

1.68

8.25

1.2

1.1

336.88

372.12

nmol/l

1.53

138

751

Traumatic subdural haemorrhage

365

2.06

8.23

1.3

1.2

310.95

331.88

nmol/l

0.39

284

Obesity related asthma

179

1124

1.60

8.19

1.2

1.1

373.59

369.19

nmol/l

0.10

149

963

Other retinal disorders

338

1871

1.41

8.16

1.3

1.2

320.91

348.38

nmol/l

1.56

258

1528

Disorders of lens

332

1459

1.42

8.13

1.2

1.1

341.93

370.99

nmol/l

1.63

261

1250

Other heart diseases

222

943

1.54

8.12

1.2

1.1

399.00

405.93

nmol/l

0.20

193

879

Cardiovascular diseases (excluding rheumatic etc)

293

1157

1.46

8.06

1.1

406.63

408.82

nmol/l

0.06

264

1085

Coxarthrosis, primary

321

1923

1.42

8.04

1.2

337.21

341.97

nmol/l

0.16

253

1557

Disturbances of skin sensation

145

868

1.68

8.04

1.2

1.1

334.06

384.80

nmol/l

2.39

128

770

Benign neoplasm of other and ill-defined parts of digestive system

109

602

1.82

8.04

1.2

359.07

346.08

nmol/l

0.18

501

Neoplasms

382

1458

1.39

7.96

1.2

1.1

375.77

387.70

nmol/l

0.46

341

1274

Inflammatory bowel disease

160

986

1.63

7.93

1.2

1.1

348.63

382.26

nmol/l

1.38

137

860

Chronic pancreatitis

347

2.09

7.92

1.2

378.03

364.11

nmol/l

0.21

294

Other bacterial intestinal infections

135

797

1.70

7.90

1.2

335.55

353.22

nmol/l

0.46

109

668

Acute tubulo-interstitial nephritis

327

2014

1.40

7.82

1.2

350.18

358.77

nmol/l

0.30

256

1706

Nonorganic sleeping disorders, excluding more controls

514

1.88

7.81

1.1

380.52

386.84

nmol/l

0.11

466

Pneumonia (excl. viral and due to other infectious organisms not elsewhere classified)

495

2560

1.32

7.75

1.2

1.1

339.98

377.91

nmol/l

3.21

410

2195

Acute pancreatitis

110

617

1.79

7.72

1.2

328.59

352.26

nmol/l

0.61

507

Cholecystectomy

382

2423

1.36

7.64

1.2

340.64

362.27

nmol/l

1.25

314

2030

Pneumonias (Asthma/COPD co-morbidities)

503

2573

1.31

7.61

1.2

1.1

344.00

377.76

nmol/l

2.66

418

2210

All pneumoniae

505

2575

1.31

7.56

1.2

1.1

342.32

378.55

nmol/l

3.03

418

2213

GI-bleeding

186

1202

1.55

7.56

1.2

331.59

339.86

nmol/l

0.20

140

962

Vocal cord dysfunction

279

2.13

7.54

1.1

402.93

386.93

nmol/l

0.25

257

Noninflammatory disorders of female genital tract

212

689

1.55

7.54

1.1

379.11

388.30

nmol/l

0.25

199

571

Chronic diseases of tonsils and adenoids

376

1734

1.37

7.53

1.1

417.03

377.98

nmol/l

3.25

342

1510

Other arthrosis

272

1304

1.45

7.49

1.2

1.1

391.49

369.97

nmol/l

0.90

225

1088

Other headache syndromes

206

1363

1.51

7.48

1.2

1.1

410.79

378.88

nmol/l

1.41

183

1181

Myocardial infarction, without ST-elevation

228

1402

1.49

7.47

1.3

1.2

302.40

328.34

nmol/l

1.08

169

1094

Vitamin B12 deficiency anaemia

370

2.02

7.40

1.3

1.2

344.02

330.20

nmol/l

0.16

299

Temporomandibular joint disorders, including avohilmo

208

1364

1.51

7.39

1.1

428.39

387.30

nmol/l

2.55

185

1228

Liquid cancers, helper endpoint

209

1211

1.51

7.35

1.2

342.34

342.94

nmol/l

0.01

167

981

Influenza and pneumonia

524

2564

1.30

7.32

1.2

1.1

346.64

379.54

nmol/l

2.66

435

2208

Septicaemia

222

1401

1.49

7.31

1.2

318.02

345.17

nmol/l

1.25

178

1148

Transient ischemic attack

281

1600

1.43

7.29

1.3

1.2

304.12

341.59

nmol/l

2.58

228

1271

Symptoms and signs involving the skin and subcutaneous tissue

358

2580

1.36

7.24

1.2

1.1

336.38

370.98

nmol/l

2.72

301

2185

Arthrosis

367

1468

1.37

7.23

1.2

1.1

356.29

369.67

nmol/l

0.58

312

1236

Nausea and vomiting

144

868

1.63

7.21

1.2

333.91

351.42

nmol/l

0.44

103

704

Other septicaemia

201

1286

1.51

7.13

1.2

317.88

343.52

nmol/l

1.05

162

1043

Barrett oesophagus

106

2.96

7.13

1.2

1.1

336.62

364.40

nmol/l

0.27

Iron deficiency anaemia secondary to blood loss (chronic)

105

596

1.77

7.13

1.2

306.13

337.34

nmol/l

0.86

483

Colectomy operation

101

567

1.79

7.12

1.2

331.13

346.29

nmol/l

0.28

464

Status post-ami

154

731

1.61

7.07

1.2

294.84

329.47

nmol/l

1.29

118

591

Other diseases of pancreas

219

2.30

7.01

1.1

348.62

363.48

nmol/l

0.18

186

Other mental disorders due to brain damage and dysfunction and to physical disease

371

1.98

7.00

1.3

1.2

328.94

340.15

nmol/l

0.15

299

Other systemic involvement of connective tissue (FG)

147

905

1.61

6.99

1.2

350.47

362.19

nmol/l

0.26

117

740

Other reaction to severe stress, and adjustment disorders

168

1083

1.56

6.94

1.1

386.21

393.39

nmol/l

0.17

145

983

COPD/asthma/ILD related pneumonia or pneumonia derived septicaemia

460

2121

1.32

6.92

1.2

1.1

346.73

376.37

nmol/l

1.93

381

1821

460

2121

1.32

6.92

1.2

1.1

346.73

376.37

nmol/l

1.93

381

1821

Insulin, fast-acting or short human

195

1299

1.51

6.91

1.2

325.13

358.57

nmol/l

1.47

135

1088

Diseases of arteries, arterioles and capillaries

350

1901

1.36

6.91

1.2

330.72

344.45

nmol/l

0.57

252

1564

Asthma, unspecified (mode)

278

1483

1.41

6.88

1.2

1.1

361.07

377.15

nmol/l

0.63

225

1284

Implicit fungal Sepsis

3.14

6.88

1.2

320.22

387.48

nmol/l

0.56

Cough

203

1290

1.49

6.88

1.2

1.1

369.82

362.76

nmol/l

0.19

161

1082

Dental caries

138

818

1.63

6.86

1.2

1.1

346.36

368.41

nmol/l

0.58

102

696

Other or unspecified ileus, impaction or obstruction

103

588

1.76

6.85

1.2

335.73

345.88

nmol/l

0.20

471

Glaucoma

297

1840

1.39

6.83

1.2

339.04

338.99

nmol/l

0.00

240

1473

Cerebrovascular diseases (FINNGEN)

149

655

1.61

6.82

1.2

1.1

368.31

399.42

nmol/l

1.06

129

603

AV-block

109

556

1.73

6.66

1.2

336.20

318.28

nmol/l

0.38

431

Other diseases of oesophagus

263

2.14

6.65

1.2

1.1

296.71

371.85

nmol/l

1.67

212

Thiazolidinediones

325

2.01

6.55

1.2

307.17

347.02

nmol/l

0.66

280

Unspecified haematuria

218

1240

1.46

6.54

1.2

348.20

349.11

nmol/l

0.02

157

1011

Use of pramipexole

125

763

1.65

6.54

1.2

335.57

342.05

nmol/l

0.14

108

622

Symptoms and signs concerning food and fluid intake

312

2.03

6.49

1.3

1.2

335.17

346.73

nmol/l

0.17

274

Primary hyperparathyroidism

340

1.99

6.49

1.1

1.2

298.83

367.83

nmol/l

2.30

288

Hypertensive diseases (excluding secondary)

239

960

1.45

6.48

1.1

412.19

405.54

nmol/l

0.19

212

892

Explicit Sepsis

232

1512

1.44

6.47

1.2

318.96

347.07

nmol/l

1.33

185

1236

Dentofacial anomalies [including malocclusion]

318

1874

1.37

6.47

1.1

419.76

385.18

nmol/l

2.56

280

1674

Fungal Sepsis

2.95

6.44

1.2

320.22

382.18

nmol/l

0.52

Spinal stenosis

266

1440

1.41

6.40

1.2

334.00

356.00

nmol/l

1.01

228

1165

Peripheral artery disease

244

1367

1.43

6.37

1.3

1.2

319.81

325.01

nmol/l

0.13

172

1081

Other specific joint derangements/joint disorders

342

1637

1.35

6.34

1.2

1.1

366.58

382.89

nmol/l

0.74

308

1412

Other bacterial intestinal infections

106

625

1.70

6.34

1.2

321.52

345.62

nmol/l

0.62

515

Atrial fibrillation and flutter with reimbursement

117

441

1.69

6.33

1.3

1.1

409.15

388.22

nmol/l

0.51

394

Asthma (only as main-diagnosis), excluding more controls

340

1435

1.36

6.31

1.2

1.1

376.38

385.99

nmol/l

0.38

291

1255

Post-traumatic stress disorder

211

2.24

6.25

1.1

442.53

421.72

nmol/l

0.28

203

Endometriosis

167

634

1.55

6.24

1.2

1.1

379.28

385.41

nmol/l

0.14

156

525

Alzheimer’s disease (Atypical or mixed), excluding more controls

170

2.26

6.23

1.1

1.2

283.79

303.41

nmol/l

0.21

123

Weight loss

304

2.02

6.23

1.3

1.2

347.92

361.84

nmol/l

0.20

259

Carpal tunnel syndrome

310

2015

1.36

6.22

1.2

359.85

367.82

nmol/l

0.29

267

1694

Unspecified misadventure during surgical and medical care

150

2.49

6.20

1.1

1.2

333.48

381.91

nmol/l

0.75

132

Intestinal stricture

169

1121

1.51

6.20

1.2

345.64

341.56

nmol/l

0.09

129

906

Disturbance of activity and attention

239

2.14

6.19

1.1

429.98

410.62

nmol/l

0.28

231

Generalized anxiety disorder

409

1.87

6.18

1.2

1.1

391.52

407.91

nmol/l

0.28

387

Other blood glucose lowering drugs, excl. Insulins

497

1.78

6.14

1.2

342.85

345.07

nmol/l

0.03

428

Hyperkinetic disorders

246

2.12

6.14

1.1

427.02

413.93

nmol/l

0.18

239

Intestinal infectious diseases

591

2696

1.25

6.12

1.2

1.1

362.85

369.59

nmol/l

0.33

483

2294

Candidiasis

145

933

1.56

6.11

1.2

1.1

356.46

365.58

nmol/l

0.21

124

808

Visual disturbances and blindness

259

1867

1.39

6.09

1.2

350.02

356.75

nmol/l

0.20

221

1542

Budesonide

427

1.84

6.03

1.2

1.1

358.50

381.27

nmol/l

0.43

378

STROKE

264

1288

1.40

6.03

1.3

1.1

342.34

384.06

nmol/l

2.86

220

1135

Additional codes for the location of defect, injury or illness

152

2.46

6.03

1.1

1.2

320.49

389.82

nmol/l

1.14

134

Cervical disc disorders

182

1233

1.48

6.03

1.2

1.1

337.25

370.11

nmol/l

1.39

154

1018

Acute pancreatitis (for exclusion)

110

665

1.66

6.01

1.2

328.59

349.50

nmol/l

0.52

547

L04AX Other immunosuppressants

263

1906

1.38

5.99

1.2

1.1

355.62

371.97

nmol/l

0.65

232

1637

Diseases of the respiratory system

343

1277

1.35

5.98

1.2

1.1

375.96

373.13

nmol/l

0.08

294

1099

Other and unspecified nerve root and plexus disorders, also in other diseases

583

1.71

5.97

1.2

1.1

332.46

383.04

nmol/l

1.97

502

Second line medication for Crohn's disease

268

1952

1.38

5.92

1.2

1.1

354.94

373.78

nmol/l

0.81

236

1682

Alzheimer’s disease (Early onset), excluding more controls

2.88

5.92

1.1

358.81

333.73

nmol/l

0.23

Rheumatoid arthritis, including avohilmo

198

1369

1.45

5.92

1.2

339.23

356.11

nmol/l

0.55

162

1136

Erysipelas

275

1778

1.37

5.88

1.2

334.27

356.04

nmol/l

0.89

200

1484

Triptan medication for migraine, min. 3 purchases

258

1419

1.39

5.87

1.1

430.33

395.81

nmol/l

2.11

245

1301

Abnormal weight loss

277

2.04

5.86

1.3

1.2

323.98

360.35

nmol/l

0.66

236

Benign neoplasm: Transverse colon

312

1.97

5.82

1.3

1.2

315.93

354.62

nmol/l

0.91

259

Paroxysmal tachycardia

104

520

1.68

5.79

1.2

1.1

357.97

387.97

nmol/l

0.71

473

Unstable angina pectoris

197

1073

1.45

5.75

1.2

318.14

337.12

nmol/l

0.56

139

868

Osteopathies and chondropathies

281

1929

1.36

5.74

1.2

328.44

362.87

nmol/l

1.93

221

1616

Retention of urine

182

1017

1.47

5.74

1.3

1.2

296.91

339.35

nmol/l

1.98

141

817

Bacterial intestinal infections, IBD co-morbidities

108

659

1.65

5.72

1.2

318.44

345.28

nmol/l

0.74

538

Degeneration of macula and posterior pole

252

1449

1.39

5.71

1.3

1.2

301.89

327.41

nmol/l

1.25

200

1130

IBD patients in KELA-register

110

675

1.64

5.69

1.2

1.1

364.46

390.66

nmol/l

0.73

609

Other diseases of anus and rectum

153

1012

1.51

5.66

1.2

1.1

339.28

355.55

nmol/l

0.48

123

828

Benign neoplasm: Sigmoid colon

102

615

1.67

5.66

1.3

1.2

308.68

349.59

nmol/l

1.29

493

Disorder of lipoprotein metabolism, unspecified

408

1.82

5.63

1.2

296.59

335.83

nmol/l

1.02

326

Dementia in Alzheimer disease

108

556

1.65

5.60

1.3

1.2

305.27

310.54

nmol/l

0.08

402

Pain in joint

272

1266

1.37

5.59

1.2

1.1

362.31

379.71

nmol/l

0.69

243

1070

Erysipelas

350

2035

1.32

5.58

1.2

1.1

334.07

367.10

nmol/l

2.14

270

1720

Benign neoplasm: Descending colon

183

2.26

5.58

1.5

1.2

337.22

363.60

nmol/l

0.35

154

Rheumatism, unspecified

395

1.83

5.57

1.2

1.1

342.50

368.12

nmol/l

0.57

343

Other cataract

205

1085

1.43

5.56

1.3

1.1

309.53

353.96

nmol/l

2.56

157

906

Trochanteric bursitis

417

1.81

5.55

1.4

1.1

358.75

357.68

nmol/l

0.02

354

Other/unspecified dorsalgia

190

1309

1.44

5.55

1.3

1.2

342.99

367.15

nmol/l

0.66

150

1090

Sequelae of cerebrovascular disease

198

1193

1.44

5.53

1.3

1.2

283.16

327.10

nmol/l

2.43

148

925

Disorders of choroid and retina

405

2236

1.29

5.52

1.3

1.2

335.07

361.52

nmol/l

1.68

315

1860

Asthma (only as main-diagnosis)

355

1561

1.32

5.51

1.2

1.1

376.33

379.46

nmol/l

0.10

301

1357

Vaginitis/vulvovaginitis/vulvitis/abscess of vulva

484

1.74

5.51

1.2

1.1

370.37

394.89

nmol/l

0.35

438

Unintentional cut, puncture, perforation or haemorrhage during surgical and medical care

223

2.12

5.51

1.2

1.1

399.19

377.69

nmol/l

0.26

195

Inflammatory bowel disease, strict (require KELA)

110

681

1.62

5.51

1.2

1.1

364.46

387.54

nmol/l

0.61

614

Female genital prolapse

150

552

1.54

5.49

1.2

1.1

325.72

377.55

nmol/l

2.15

132

439

Other diseases of upper respiratory tract

563

2358

1.25

5.49

1.2

386.11

358.89

nmol/l

2.22

479

1962

Vitamin deficiency

135

2.47

5.46

1.3

1.1

399.46

388.81

nmol/l

0.09

120

Vitamin deficiency, wide

135

2.47

5.46

1.3

1.1

399.46

388.81

nmol/l

0.09

120

Sulfasalazine

141

928

1.52

5.42

1.2

338.83

365.19

nmol/l

0.86

121

801

Implicit fungal Sepsis

192

2.21

5.41

1.3

1.2

298.52

373.07

nmol/l

1.26

165

Heart failure and bmi 25plus

190

887

1.45

5.41

1.3

1.2

315.07

334.71

nmol/l

0.48

154

714

Seropositive rheumatoid arthritis

134

870

1.54

5.39

1.2

328.35

360.44

nmol/l

1.03

110

711

Tongue abnormality

161

2.32

5.36

1.3

1.2

355.27

383.52

nmol/l

0.31

143

Spondylosis

268

1619

1.35

5.24

1.2

337.64

368.24

nmol/l

1.62

218

1341

Injury, poisoning and certain other consequences of external causes

285

1055

1.36

5.23

1.1

369.88

382.56

nmol/l

0.46

250

924

Glucagon-like peptide-1 (GLP-1) analogues

124

802

1.55

5.18

1.2

1.1

358.09

383.97

nmol/l

0.63

740

Sodium-glucose co-transporter 2 (SGLT2) inhibitors

124

802

1.55

5.18

1.2

1.1

358.09

383.97

nmol/l

0.63

740

Nonorganic sleeping disorders

586

1.64

5.12

1.1

380.52

386.21

nmol/l

0.10

531

Radiculopathy

533

1.68

5.11

1.2

304.08

344.89

nmol/l

1.13

424

Other noninflammatory disorders of uterus, except cervix

112

472

1.60

5.08

1.2

1.1

338.02

373.89

nmol/l

0.89

370

Amputation

335

1.86

5.07

1.2

364.67

324.43

nmol/l

0.70

268

Behavioural syndromes associated with physiological disturbances and physical factors

436

2452

1.26

5.06

1.1

1.2

397.77

372.22

nmol/l

1.95

409

2066

Osteoporosis

150

948

1.48

5.06

1.2

294.41

335.20

nmol/l

1.77

116

757

Asthma, excluding more controls

358

1435

1.30

5.05

1.2

1.1

385.81

385.99

nmol/l

0.01

307

1255

170

1025

1.45

5.03

1.3

1.2

289.43

312.26

nmol/l

0.78

133

760

Candidiasis

438

1.74

5.03

1.3

1.1

355.73

374.57

nmol/l

0.30

385

Exclusions for E4_PCOS_CONSORTIUM

356

1722

1.30

5.02

1.2

1.1

381.60

384.25

nmol/l

0.09

313

1503

Intestinal infectious diseases

463

2812

1.25

5.02

1.2

360.58

369.29

nmol/l

0.40

370

2400

Asthma (mode)

378

1570

1.29

5.02

1.2

1.1

379.74

379.12

nmol/l

0.02

322

1363

Disorders of synovium and tendon

249

1613

1.35

5.00

1.2

1.1

378.13

377.96

nmol/l

0.00

210

1370

Atherosclerosis, excluding cerebral and coronary sclerosis

225

1295

1.38

4.98

1.2

309.31

321.96

nmol/l

0.39

155

1021

Vascular dementia (undefined)

140

2.36

4.96

1.4

1.3

283.42

320.80

nmol/l

0.41

101

Other pulmonary diagnosis

403

1579

1.28

4.95

1.2

1.1

374.61

379.18

nmol/l

0.14

341

1368

Other systemic involvement of connective tissue

149

1013

1.48

4.95

1.2

349.49

352.94

nmol/l

0.07

118

829

Migraine with aura

107

677

1.59

4.94

1.1

376.90

395.39

nmol/l

0.42

621

Dementia due to Parkinsons disease, excluding more controls

3.70

4.94

1.3

1.1

330.75

326.32

nmol/l

—

Systemic connective tissue disorders

181

1277

1.42

4.94

1.2

350.08

357.16

nmol/l

0.17

149

1051

Disorders of eyelid, lacrimal system and orbit

430

2599

1.26

4.91

1.2

362.25

364.53

nmol/l

0.07

360

2187

Major coronary heart disease event excluding revascularizations

291

1464

1.33

4.90

1.2

327.04

352.45

nmol/l

1.14

221

1213

Tinnitus

114

734

1.56

4.89

1.2

1.1

340.68

371.10

nmol/l

0.99

105

624

severe traumatic brain injury, does not include concussion

122

798

1.53

4.88

1.3

1.2

330.51

341.29

nmol/l

0.23

632

Disorders of mineral metabolism

221

2.05

4.86

1.1

366.44

375.13

nmol/l

0.09

194

Stroke, excluding SAH

297

1648

1.32

4.85

1.2

310.73

340.77

nmol/l

1.39

223

1319

Polyarthrosis

106

623

1.59

4.85

1.2

1.1

298.34

347.60

nmol/l

2.22

501

Personality disorders, excluding more controls

104

657

1.59

4.84

1.2

1.1

356.98

409.22

nmol/l

1.87

614

Diarrhoea and gastroenteritis of presumed infectious origin

343

2404

1.29

4.83

1.2

359.76

368.01

nmol/l

0.31

275

2045

Benign neoplasm: Rectum

588

1.62

4.83

1.4

1.2

316.21

344.93

nmol/l

0.69

473

Open wound of head

256

1847

1.34

4.83

1.2

344.84

358.32

nmol/l

0.47

197

1533

Ischaemic Stroke, excluding all haemorrhages

283

1592

1.33

4.82

1.2

305.33

341.11

nmol/l

1.76

215

1263

Emergency coronary revascularization (for ACS)

411

1975

1.27

4.82

1.2

341.47

366.40

nmol/l

1.45

314

1678

Percutaneous Coronary Intervention

372

1781

1.28

4.81

1.2

341.94

370.91

nmol/l

1.68

285

1533

Persons with potential health hazards related to socioeconomic and psychosocial circumstances

125

815

1.52

4.80

1.2

1.1

366.75

400.39

nmol/l

1.15

108

760

Small fibre neuropathy

2.91

4.78

1.1

1.2

336.80

388.16

nmol/l

0.44

Injuries to the knee and lower leg

590

2693

1.22

4.75

1.2

360.59

371.53

nmol/l

0.62

493

2290

Benign neoplasm: Colon, unspecified

130

868

1.50

4.74

1.2

316.26

340.09

nmol/l

0.62

696

Acetic acid derivatives and related substances

145

502

1.50

4.74

1.2

1.1

385.62

348.91

nmol/l

1.13

129

390

Visual disturbances

230

1703

1.35

4.71

1.2

356.23

360.12

nmol/l

0.10

196

1418

Fentanyl

373

1.78

4.68

1.3

1.2

305.13

336.28

nmol/l

0.58

290

Peripheral artery operations in Hilmo

433

1.72

4.66

1.2

1.3

332.29

321.47

nmol/l

0.16

344

Diseases of veins, lymphatic vessels and lymph nodes, not elsewhere classified (FINNGEN)

199

900

1.40

4.66

1.1

372.45

404.48

nmol/l

1.34

172

836

Extrapyramidal and movement disorders

194

1401

1.39

4.65

1.2

337.54

346.37

nmol/l

0.26

157

1141

Spondyloarthritis

602

1.60

4.64

1.2

343.94

371.77

nmol/l

0.60

519

Familial hypercholesterolemia, with ischemic heart disease

310

1.85

4.61

1.2

277.65

313.66

nmol/l

0.67

242

Other anxiety disorders

198

1241

1.39

4.61

1.1

372.43

393.53

nmol/l

0.81

181

1120

Abnormal findings on diagnostic imaging and in function studies, without diagnosis

323

2248

1.29

4.59

1.2

347.66

354.58

nmol/l

0.23

245

1865

Asthma

379

1561

1.27

4.58

1.2

1.1

382.58

379.46

nmol/l

0.10

321

1357

Complications of internal orthopaedic prosthetic devices, implants and grafts

120

795

1.52

4.56

1.3

1.2

332.16

339.66

nmol/l

0.14

617

Abnormal spermatozoa

340

1.80

4.56

1.1

1.2

304.69

330.29

nmol/l

0.45

266

Other symptoms and signs involving the digestive system and abdomen

520

1.64

4.55

1.2

1.1

297.13

361.76

nmol/l

2.70

444

Other disorders of nervous system

180

2.13

4.54

1.2

301.19

379.07

nmol/l

1.38

157

Oesophageal obstruction

2.74

4.52

1.4

1.2

357.88

369.19

nmol/l

0.09

Sleep disorders

414

2394

1.25

4.52

1.1

1.2

398.64

372.31

nmol/l

1.95

388

2021

Ischaemic heart disease, wide definition

358

1740

1.28

4.51

1.2

352.08

363.18

nmol/l

0.41

276

1492

Insomnia

408

2376

1.25

4.51

1.1

1.2

397.01

374.64

nmol/l

1.52

384

2013

Thyrotoxicosis, other and/or unspecified

607

1.59

4.49

1.1

383.27

374.56

nmol/l

0.15

529

Fracture of lower leg, including ankle

263

1981

1.32

4.48

1.2

349.90

369.86

nmol/l

0.86

217

1678

Other sleep disorders

313

1.83

4.47

1.1

413.46

378.73

nmol/l

0.57

266

Total colectomy operation

2.55

4.47

1.0

1.1

329.89

389.24

nmol/l

0.71

Total colectomy

2.55

4.47

1.0

1.1

329.89

389.24

nmol/l

0.71

Disorders of sclera, cornea, iris and ciliary body

256

1942

1.32

4.47

1.2

363.05

366.76

nmol/l

0.10

211

1651

Myocardial infarction, strict

226

1190

1.36

4.47

1.2

309.38

345.48

nmol/l

1.63

168

984

Purpura and other haemorrhagic conditions

424

1.71

4.46

1.3

1.2

326.67

354.89

nmol/l

0.53

361

Benign neoplasm: Stomach

314

1.83

4.44

1.4

1.2

361.52

358.63

nmol/l

0.02

267

Stroke, including SAH

307

1723

1.29

4.44

1.2

313.52

346.93

nmol/l

1.69

231

1392

Other disorders of glucose regulation and pancreatic internal secretion

237

1.95

4.39

1.2

367.06

376.62

nmol/l

0.10

209

COPD differential diagnosis

395

1570

1.26

4.38

1.2

1.1

372.87

379.12

nmol/l

0.20

336

1363

ILD differential diagnosis

395

1570

1.26

4.38

1.2

1.1

372.87

379.12

nmol/l

0.20

336

1363

Coronary revascularization (ANGIO or CABG)

368

1782

1.27

4.35

1.2

343.46

371.00

nmol/l

1.55

283

1534

Other and unspecified injuries of head

197

2.04

4.33

1.2

325.82

360.76

nmol/l

0.67

170

COPD/asthma related infections

517

2121

1.22

4.30

1.2

1.1

366.61

376.37

nmol/l

0.42

434

1821

COPD/asthma/ILD related infections

517

2121

1.22

4.30

1.2

1.1

366.61

376.37

nmol/l

0.42

434

1821

Excluding asthma or asthma-COPD overlap

396

1579

1.26

4.29

1.2

1.1

372.68

379.18

nmol/l

0.21

338

1368

Behavioural and emotional disorders with onset usually occurring in childhood and adolescence

414

1.66

4.26

1.1

436.54

415.64

nmol/l

0.41

397

Internal derangement of knee

169

1206

1.40

4.26

1.3

1.1

339.89

372.40

nmol/l

1.28

149

1021

Exposure to unspecified factor

481

2836

1.22

4.24

1.2

367.69

370.62

nmol/l

0.11

401

2415

Other bullous disorders

2.87

4.24

1.2

339.15

374.93

nmol/l

0.26

Progressive vascular leukoencephalopathy

133

2.28

4.24

1.1

1.2

285.63

289.87

nmol/l

0.04

Female infertility

124

502

1.50

4.24

1.1

403.53

404.54

nmol/l

0.02

118

444

Orthopaedic devices associated with adverse incidents

3.19

4.23

1.6

1.2

322.44

369.34

nmol/l

0.40

Injuries to the hip and thigh

245

1686

1.32

4.20

1.2

336.59

340.32

nmol/l

0.08

193

1346

Reimbursement for rheumatic diseases

269

2065

1.30

4.20

1.2

351.32

365.54

nmol/l

0.55

227

1740

Benign neoplasm: Rectum, anus and anal canal

102

666

1.54

4.18

1.4

1.2

321.83

343.78

nmol/l

0.51

538

Hard cardiovascular diseases

385

1834

1.25

4.18

1.2

1.1

347.83

376.57

nmol/l

1.84

307

1590

Secondary hypertension

171

2.09

4.15

1.2

1.1

342.90

367.02

nmol/l

0.33

150

Crohn disease

373

1.72

4.14

1.2

1.1

330.57

388.08

nmol/l

1.55

341

Gout

133

806

1.46

4.14

1.3

1.2

295.87

338.50

nmol/l

1.61

629

Atrial fibrillation and flutter

132

583

1.47

4.13

1.2

1.1

402.57

402.70

nmol/l

0.00

116

532

Lumbar disc prolapse

298

1784

1.28

4.09

1.2

1.1

371.33

378.88

nmol/l

0.25

259

1504

Disorders of conjunctiva

387

2503

1.24

4.09

1.2

1.1

383.61

375.17

nmol/l

0.36

349

2128

124

796

1.47

4.08

1.3

1.2

279.62

315.02

nmol/l

1.16

580

Allergic contact dermatitis

390

1.70

4.07

1.1

351.26

397.87

nmol/l

1.05

360

Right hemicolectomy

175

2.07

4.06

1.4

1.2

326.93

351.55

nmol/l

0.22

146

Enterocolitis due to Clostridium difficile

376

1.71

4.04

1.2

303.78

346.47

nmol/l

0.91

312

Lower back pain or/and sciatica

515

2786

1.21

4.04

1.2

1.1

367.05

370.51

nmol/l

0.14

442

2358

Vascular dementia

312

1.77

4.03

1.4

1.3

273.17

311.56

nmol/l

0.65

226

Paracetamol or NSAID medication

235

1.68

4.03

1.2

1.1

363.12

349.84

nmol/l

0.22

188

Other noninfective gastroenteritis and colitis

124

850

1.46

4.02

1.2

364.89

356.97

nmol/l

0.18

107

715

Vascular disorders of the intestines

196

2.00

4.02

1.1

1.2

279.42

335.92

nmol/l

1.17

152

Use of levodopa decarboxylase inhibitor

476

1.63

4.01

1.2

335.54

324.60

nmol/l

0.17

368

Lesion of ulnar nerve

400

1.68

3.99

1.2

1.1

386.94

378.55

nmol/l

0.11

346

Mycoses

127

879

1.45

3.94

1.2

354.19

364.64

nmol/l

0.20

102

748

Superficial injury of hip and thigh

533

1.58

3.93

1.3

1.2

340.05

343.37

nmol/l

0.05

437

Diseases of veins, lymphatic vessels and lymph nodes, not elsewhere classified

476

2513

1.21

3.92

1.2

1.1

345.37

370.51

nmol/l

1.62

396

2116

Myocardial infarction

233

1245

1.32

3.90

1.2

321.20

346.58

nmol/l

0.99

179

1032

219

1.93

3.88

1.3

1.2

348.84

325.28

nmol/l

0.26

175

Ovarian cyst

159

653

1.41

3.87

1.1

374.80

390.52

nmol/l

0.40

138

543

Amputation of toe

227

1.91

3.87

1.2

346.84

339.99

nmol/l

0.07

181

Follow-up care involving plastic surgery

113

2.32

3.86

1.1

448.42

384.65

nmol/l

0.98

104

Parkinson's disease, strict definition

489

1.60

3.85

1.2

311.45

322.41

nmol/l

0.18

386

Other/unspecified seropositive rheumatoid arthritis (ICD-10)

132

925

1.43

3.85

1.2

330.26

350.69

nmol/l

0.54

108

764

Diseases of vocal cords and larynx+other diseases of upper respiratory tract, no elsewhere classified

230

1709

1.31

3.84

1.2

380.74

364.47

nmol/l

0.58

199

1457

Unspecified fall

242

1837

1.30

3.84

1.2

335.72

356.23

nmol/l

0.83

197

1507

Primary open-angle glaucoma

170

1203

1.37

3.82

1.3

1.2

327.44

320.68

nmol/l

0.16

133

914

Other/unspecified seropositive rheumatoid arthritis

134

943

1.43

3.82

1.2

328.35

350.88

nmol/l

0.63

110

775

Ulcerative colitis

112

762

1.47

3.81

1.2

353.37

378.75

nmol/l

0.71

666

Dermatitis and eczema

533

2762

1.20

3.79

1.2

369.05

369.71

nmol/l

0.02

444

2349

Other and unspecified disorders of skin and subcutaneous tissue

180

2.01

3.79

1.2

1.1

306.48

375.73

nmol/l

1.22

158

Mandibular retrognathia

146

2.13

3.77

1.0

1.1

428.68

400.19

nmol/l

0.35

139

Exclusions for E4_PCOS_BROAD

507

1.58

3.77

1.1

365.02

376.69

nmol/l

0.18

456

Duodenal ulcer

309

1.76

3.76

1.3

1.2

258.08

346.96

nmol/l

2.67

241

Disorders of lacrimal system

205

1545

1.33

3.76

1.2

376.47

361.79

nmol/l

0.40

177

1287

Developmental endpoint to exclude non autoimmune-cases from E4_HYTHY_AI_STRICT

157

1139

1.38

3.75

1.1

1.2

376.25

365.02

nmol/l

0.29

129

978

Gonarthrosis [arthrosis of knee](FG)

370

1735

1.24

3.73

1.2

1.1

345.41

370.81

nmol/l

1.49

309

1452

Delirium, not induced by alcohol and other psychoactive substances

392

1.66

3.72

1.4

1.2

306.29

330.20

nmol/l

0.43

304

Fenamates

314

1.63

3.71

1.1

385.22

361.79

nmol/l

0.40

241

Gonarthrosis

310

1396

1.27

3.71

1.2

1.1

339.07

366.91

nmol/l

1.58

263

1168

Other ulcerative colitis

148

2.11

3.69

1.2

1.1

340.75

392.18

nmol/l

0.81

136

Thyroiditis, ILD-related definition

341

1.71

3.68

1.1

377.83

381.40

nmol/l

0.05

307

Chronic sinusitis

190

1424

1.34

3.67

1.1

1.2

378.44

367.59

nmol/l

0.35

166

1217

Calcific aortic valvular stenosis, including rheumatic fever

164

1165

1.37

3.66

1.3

1.2

335.91

313.17

nmol/l

0.68

122

884

Asthma, including avohilmo

577

2734

1.19

3.66

1.2

381.58

366.78

nmol/l

0.95

489

2315

Papulosquamous disorders

178

1325

1.35

3.63

1.2

363.11

361.64

nmol/l

0.03

129

1135

Major coronary heart disease event

387

1901

1.23

3.63

1.2

341.12

370.05

nmol/l

1.80

303

1622

Nontoxic single thyroid nodule

204

1.92

3.62

1.2

1.1

314.68

385.24

nmol/l

1.35

184

Episcleritis

136

2.15

3.61

1.3

1.1

374.33

408.01

nmol/l

0.33

126

Prolonged pregnancy

402

0.43

3.61

1.0

1.1

463.65

425.12

nmol/l

0.38

389

Primary coxarthrosis, bilateral

145

1046

1.39

3.61

1.3

1.2

344.32

330.80

nmol/l

0.34

114

812

Seronegative rheumatoid arthritis

374

1.67

3.59

1.2

1.1

362.50

357.99

nmol/l

0.06

311

Neuromuscular dysfunction of bladder

277

1.78

3.58

1.2

336.76

353.85

nmol/l

0.19

235

Diseases of tongue

205

1.92

3.58

1.3

1.1

343.88

354.16

nmol/l

0.10

179

Seropositive rheumatoid arthritis, wide

134

956

1.41

3.56

1.2

328.35

351.02

nmol/l

0.64

110

788

Other and unspecified dermatitis

242

1887

1.28

3.54

1.2

1.1

362.28

367.68

nmol/l

0.15

196

1600

Anterior Iridocyclitis

644

1.50

3.53

1.2

1.1

369.76

367.83

nmol/l

0.03

555

Artrosis, including avohilmo

408

1831

1.22

3.51

1.2

1.1

369.81

368.85

nmol/l

0.03

350

1542

Diseases of male genital organs

206

784

1.33

3.46

1.2

359.28

363.45

nmol/l

0.10

166

649

Other bursopathies

378

1.65

3.46

1.2

1.1

373.06

358.56

nmol/l

0.21

305

Focal brain injury

152

2.05

3.45

1.2

358.39

353.30

nmol/l

0.05

125

Haemorrhoids and perianal venous thrombosis

145

1052

1.38

3.45

1.2

1.1

326.57

356.42

nmol/l

1.05

124

858

Coxarthrosis, primary, with hip surgery

225

1631

1.29

3.45

1.2

349.41

335.67

nmol/l

0.46

178

1296

Operations 2 for CAVS

162

1162

1.36

3.45

1.3

1.2

333.25

314.05

nmol/l

0.54

120

882

Calcific aortic valvular stenosis, diagnosis (helper)

162

1162

1.36

3.45

1.3

1.2

333.25

314.05

nmol/l

0.54

120

882

Calcific aortic valvular stenosis

162

1163

1.35

3.43

1.3

1.2

333.25

314.47

nmol/l

0.52

120

883

Calcific aortic valvular stenosis, operated

162

1163

1.35

3.43

1.3

1.2

333.25

314.47

nmol/l

0.52

120

883

5-aminosalicylic acid

632

1.49

3.43

1.2

1.1

383.22

381.76

nmol/l

0.02

559

Psoriatic and enteropathic arthropathies

334

1.68

3.40

1.1

362.13

384.97

nmol/l

0.36

296

Injuries to the thorax

215

1661

1.30

3.39

1.2

338.99

355.53

nmol/l

0.59

181

1371

Other Crohn's disease

167

1.99

3.39

1.2

1.1

312.04

396.35

nmol/l

1.66

156

Biological medication for rheuma

466

1.57

3.38

1.1

373.63

396.00

nmol/l

0.47

432

Injuries to the elbow and forearm

327

2331

1.23

3.38

1.2

339.78

373.73

nmol/l

2.23

264

1983

Acute and subacute iridocyclitis

602

1.50

3.38

1.2

1.1

366.51

366.44

nmol/l

0.00

520

Tonsillectomy and adenotomy

225

1210

1.30

3.38

1.1

408.42

400.78

nmol/l

0.23

213

1108

Supplementary factors related to causes of morbidity and mortality classified elsewhere

142

1034

1.38

3.37

1.2

1.1

324.71

369.78

nmol/l

1.75

103

883

Type 1 diabetes

106

732

1.45

3.36

1.2

358.27

383.10

nmol/l

0.60

664

Parkinson's disease, including avohilmo

555

1.52

3.35

1.2

311.25

326.00

nmol/l

0.28

432

Fracture of femur

148

983

1.37

3.35

1.2

332.26

322.23

nmol/l

0.17

123

747

Noninfectious colitis NAS

444

1.58

3.34

1.3

1.1

351.26

368.79

nmol/l

0.31

391

Personal history of malignant neoplasm

189

1.92

3.34

1.0

1.1

338.17

388.25

nmol/l

0.85

165

Left hemicolectomy

2.74

3.33

1.5

1.2

343.73

355.32

nmol/l

0.06

Diseases of the skin and subcutaneous tissue

498

2097

1.19

3.32

1.2

1.1

354.15

374.26

nmol/l

1.24

413

1802

Anaemia in chronic diseases classified elsewhere

2.65

3.31

1.1

394.55

356.71

nmol/l

0.21

Diabetic maculopathy, excluding more controls

299

1.71

3.31

1.2

350.19

357.75

nmol/l

0.08

269

Fissure and fistula of anal and rectal regions

106

737

1.44

3.28

1.2

1.1

340.90

376.15

nmol/l

0.99

630

Coronary atherosclerosis

293

1485

1.25

3.25

1.2

361.48

356.61

nmol/l

0.12

239

1253

Parkinson's disease

535

1.52

3.25

1.2

305.31

326.43

nmol/l

0.43

417

Dermatitis

286

2293

1.24

3.25

1.2

1.1

369.00

369.46

nmol/l

0.01

234

1942

Arthropathies in other diseases classified elsewhere

2.40

3.23

1.3

1.2

345.40

377.16

nmol/l

—

Endometriosis of ovary

452

1.56

3.23

1.2

1.1

399.88

392.12

nmol/l

0.11

379

Epilepsy

137

998

1.37

3.20

1.1

1.2

309.36

369.27

nmol/l

3.01

832

Spondylopathies (FG)

410

1.59

3.19

1.2

1.1

378.11

388.65

nmol/l

0.14

366

Type of accident

133

968

1.38

3.19

1.2

1.1

326.27

368.35

nmol/l

1.45

825

Psoriatic arthropathies

266

1.74

3.15

1.2

1.1

372.22

380.69

nmol/l

0.10

235

Anomalies of dental arch relationship, including avohilmo

477

1.52

3.15

1.1

442.25

394.18

nmol/l

1.19

445

Crossbite

120

2.09

3.14

1.1

471.32

394.00

nmol/l

0.87

111

Disorders of calcium metabolism

165

1.95

3.14

1.1

385.00

367.84

nmol/l

0.17

144

Conjunctivitis

333

2279

1.22

3.13

1.2

1.1

383.08

377.51

nmol/l

0.20

309

1962

Thrombocytopenia, unspecified

194

1.87

3.11

1.3

1.2

335.26

364.14

nmol/l

0.35

168

Diarrhoea and gastroenteritis of presumed infectious origin

485

2707

1.18

3.10

1.2

367.39

370.28

nmol/l

0.11

408

2299

Any death

274

1574

1.25

3.09

1.2

329.05

349.07

nmol/l

0.82

219

1304

Malignant neoplasm of colon, including Hilmo

102

714

1.43

3.06

1.3

1.2

327.00

334.44

nmol/l

0.12

552

Synovial cyst of popliteal space [Baker]

217

1.81

3.05

1.3

1.1

374.15

369.05

nmol/l

0.05

182

Other disorders of skin and subcutaneous tissue

327

2387

1.22

3.03

1.2

340.54

358.57

nmol/l

0.86

260

1994

Phobic anxiety disorders

322

1.65

3.02

1.2

1.1

375.17

406.43

nmol/l

0.50

305

Hernia of abdominal wall, postoperative

537

1.49

3.00

1.2

1.1

317.18

361.01

nmol/l

1.23

434

Other (seronegative) rheumatoid arthritis, wide

660

1.44

3.00

1.2

343.76

353.74

nmol/l

0.19

549

Polyp of the female genital tract

139

584

1.37

2.99

1.2

1.1

384.56

383.81

nmol/l

0.01

125

471

Other disorders of lacrimal gland

161

1220

1.32

2.99

1.2

362.81

362.54

nmol/l

0.01

142

1028

Hyperparathyroidism

101

702

1.43

2.98

1.1

1.2

306.97

343.70

nmol/l

1.08

570

UC patients in KELA-register ( KELA 208 prior to 1994, or ICD K51)

530

1.50

2.97

1.2

1.1

387.91

385.55

nmol/l

0.04

481

Ischemic heart diseases

371

1848

1.21

2.96

1.2

347.41

372.08

nmol/l

1.33

290

1595

Inflammatory diseases of female pelvic organs

277

1645

1.24

2.96

1.2

1.1

379.36

385.16

nmol/l

0.17

258

1435

Diseases of liver

153

1154

1.33

2.94

1.1

1.2

353.00

360.87

nmol/l

0.18

121

980

Bronchitis, not specified as acute or chronic

250

1.73

2.91

1.2

390.19

359.31

nmol/l

0.38

219

Benign neoplasm: Rectosigmoid junction

108

2.15

2.91

1.2

382.60

370.08

nmol/l

0.08

Elevated blood glucose level

228

1.76

2.90

1.1

1.2

411.43

370.07

nmol/l

0.66

205

Anankastic personality disorder

2.23

2.90

1.3

1.1

391.52

404.44

nmol/l

0.12

therapeutic use

2.39

2.90

1.6

1.2

320.50

398.55

nmol/l

0.98

Acquired absence of limb

4.17

2.90

1.2

373.00

364.29

nmol/l

—

Panic disorder

397

1.57

2.89

1.1

388.55

401.59

nmol/l

0.23

376

Use of rasagiline

2.46

2.89

1.4

1.2

360.92

389.34

nmol/l

0.27

Other diseases of liver

550

1.48

2.88

1.1

354.97

369.40

nmol/l

0.26

479

Propionic acid derivatives

137

504

1.37

2.88

1.2

1.1

370.16

347.75

nmol/l

0.55

120

392

Diseases of salivary glands

143

1073

1.34

2.86

1.2

346.22

369.68

nmol/l

0.77

121

921

All influenza

116

843

1.38

2.84

1.2

323.08

363.79

nmol/l

1.42

690

Abnormal findings on diagnostic imaging of other body structures

431

1.54

2.84

1.2

1.1

363.68

364.46

nmol/l

0.01

371

Symptoms and signs involving the nervous and musculoskeletal systems

265

2151

1.23

2.83

1.2

371.21

356.15

nmol/l

0.60

219

1794

Chronic iridocyclitis

123

2.05

2.82

1.3

1.1

357.68

388.30

nmol/l

0.35

108

Other general symptoms and signs

115

2.08

2.81

1.1

376.96

403.32

nmol/l

0.31

108

Any mental disorder, or suicide (or attempt), or psychic disorders complicating pregnancy, partum or puerperum or nerve system disorders, excluding more controls

102

724

1.41

2.81

1.1

378.69

402.21

nmol/l

0.59

664

Peripheral arterial reconstruction

603

1.45

2.80

1.2

296.80

316.00

nmol/l

0.39

461

Unspecified jaundice

137

1.98

2.80

1.1

1.2

328.81

376.90

nmol/l

0.46

114

Asthma (diagnoses ohter than nonallergic)

407

2853

1.18

2.80

1.2

367.54

368.36

nmol/l

0.03

343

2418

Covid-19 confirmed case

169

1303

1.30

2.79

1.2

322.46

349.07

nmol/l

0.95

145

1104

Somnolence, stupor and coma

117

2.07

2.77

1.3

1.2

273.53

371.39

nmol/l

1.15

Other disorders of skin and subcutaneous tissue, not elsewhere classified

498

1.49

2.77

1.2

319.21

347.01

nmol/l

0.52

412

Female infertility, cervical, vaginal, other or unspecified origin

106

491

1.41

2.76

1.1

417.41

403.75

nmol/l

0.29

101

434

Superficial injury of head

113

823

1.38

2.75

1.2

353.86

362.33

nmol/l

0.18

687

Myocardial infarction, with ST-elevation

614

1.44

2.74

1.2

320.63

325.96

nmol/l

0.07

474

Heartburn

293

1.64

2.74

1.3

1.1

365.14

376.77

nmol/l

0.16

257

Hallux valgus (acquired)

159

872

1.31

2.73

1.2

1.1

356.21

369.14

nmol/l

0.31

127

728

Pediculosis, acariasis and other infestations

451

1.51

2.73

1.1

373.40

390.86

nmol/l

0.29

416

Iridocyclitis

103

740

1.40

2.73

1.2

1.1

362.49

362.54

nmol/l

0.00

626

Inflammatory diseases of prostate (prostatitis)

348

1.59

2.72

1.3

1.2

341.91

342.97

nmol/l

0.01

276

Gilbert syndrome

6.10

2.71

1.2

312.83

437.70

nmol/l

—

Implicit viral Sepsis

683

1.41

2.69

1.2

320.64

349.12

nmol/l

0.66

553

Hypotension

658

1.42

2.69

1.2

341.54

319.54

nmol/l

0.39

502

560

2503

1.16

2.69

1.2

362.64

368.25

nmol/l

0.25

464

2122

Restless leg syndrome

429

1.52

2.68

1.2

1.1

342.33

364.41

nmol/l

0.41

373

Other diseases of pericardium

112

2.07

2.67

1.2

1.1

319.71

352.14

nmol/l

0.33

Benign leiomyoma with endometriosis

527

1.47

2.67

1.2

1.1

381.58

358.80

nmol/l

0.43

448

Cystitis

404

2030

1.18

2.67

1.2

368.51

371.27

nmol/l

0.08

351

1713

Disorders of parathyroid gland

111

801

1.37

2.67

1.1

1.2

308.43

341.50

nmol/l

1.05

650

Allergic conjunctivitis

248

1963

1.23

2.65

1.2

1.1

401.23

379.94

nmol/l

0.96

238

1710

Superficial injury of thorax

487

1.48

2.65

1.2

335.92

358.53

nmol/l

0.45

411

Impingement syndrome of shoulder

677

1.41

2.65

1.2

1.1

337.37

368.27

nmol/l

0.78

578

Seropositive rheumatoid arthritis, strict definition

479

1.49

2.64

1.2

1.1

300.52

363.55

nmol/l

2.04

409

Viral Sepsis

686

1.40

2.64

1.2

320.64

348.50

nmol/l

0.64

556

Asthma-related infections

271

2178

1.22

2.63

1.2

375.62

360.79

nmol/l

0.58

227

1823

Asthma, hospital admission 2, infections

271

2178

1.22

2.63

1.2

375.62

360.79

nmol/l

0.58

227

1823

Chronic lower respiratory diseases

572

2645

1.15

2.63

1.2

1.1

372.20

370.90

nmol/l

0.05

477

2258

Other eating disorders

113

2.04

2.61

1.3

1.0

432.09

397.19

nmol/l

0.40

106

Dementia in other diseases classified elsewhere

134

1.95

2.60

1.3

1.2

354.25

348.29

nmol/l

0.04

106

Schizophrenia

454

0.53

2.60

1.1

326.06

388.94

nmol/l

1.05

416

Mouth breathing

161

1247

1.29

2.58

1.1

379.41

372.71

nmol/l

0.16

142

1074

Fracture of forearm

251

1876

1.23

2.57

1.2

329.49

371.98

nmol/l

2.63

199

1597

Cardiac arrest

126

1.91

2.57

1.2

1.1

315.45

354.05

nmol/l

0.38

108

Use of eye-antiallergens (taken as indicator of allergic/atopic conjunctivitis)

236

1862

1.23

2.56

1.2

1.1

400.14

381.96

nmol/l

0.75

228

1626

Injuries to the neck

707

1.39

2.56

1.2

1.1

345.30

380.89

nmol/l

0.99

618

Fibroblastic disorders

104

758

1.38

2.55

1.2

321.83

356.12

nmol/l

0.99

607

Psoriasis

123

921

1.34

2.54

1.2

1.1

361.67

367.51

nmol/l

0.11

795

Phlebitis and thrombophlebitis (not including DVT)

108

793

1.37

2.54

1.2

336.84

355.87

nmol/l

0.28

664

Bullous disorders

164

1.84

2.53

1.3

1.2

357.71

380.31

nmol/l

0.25

137

Other enthesopathies

125

940

1.33

2.51

1.1

363.77

380.94

nmol/l

0.42

109

812

Scleritis and episcleritis

165

1.83

2.49

1.3

1.1

367.12

398.62

nmol/l

0.32

151

Osteoporosis with pathological fracture (FG)

255

1.66

2.48

1.2

270.97

352.07

nmol/l

2.07

196

Malignant neoplasm of colon

552

1.44

2.48

1.3

1.2

315.22

336.44

nmol/l

0.36

425

Spinal instabilities

2.21

2.48

1.5

1.1

350.62

402.77

nmol/l

0.43

Fibromyalgia

255

1.65

2.48

1.2

1.1

415.54

405.26

nmol/l

0.12

231

Symptoms and signs involving speech and voice

151

1169

1.29

2.47

1.2

385.99

360.18

nmol/l

0.85

122

981

Other medical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

294

1.61

2.47

1.2

322.24

366.46

nmol/l

0.73

257

Postmenopausal bleeding

123

487

1.35

2.46

1.2

1.1

377.32

372.09

nmol/l

0.09

102

381

Leisure time condition

595

1.42

2.45

1.2

1.1

318.47

362.46

nmol/l

1.10

515

Diplopia

406

1.51

2.45

1.2

1.1

343.44

364.34

nmol/l

0.38

351

Abnormal findings on examination of blood, without diagnosis

213

1578

1.24

2.44

1.2

368.68

344.52

nmol/l

0.86

160

1306

Other CVD

105

773

1.36

2.44

1.2

329.60

332.52

nmol/l

0.04

597

Postprocedural endocrine and metabolic disorders, not elsewhere classified

359

1.54

2.42

1.1

410.83

383.09

nmol/l

0.44

325

Ulcerative colitis (strict definition, require KELA)

481

1.46

2.41

1.2

1.1

377.60

382.58

nmol/l

0.07

435

Other problems related to primary support group, including family circumstances

288

1.59

2.40

1.1

378.58

406.71

nmol/l

0.44

271

Other menopausal disorders

113

469

1.36

2.40

1.1

431.23

386.32

nmol/l

1.44

103

383

Streptococcal septicaemia

250

1.65

2.39

1.2

330.72

344.40

nmol/l

0.15

216

Other/unspecified rheumatoid arthritis

433

1.48

2.39

1.3

1.2

354.59

351.23

nmol/l

0.04

361

Asthma, hospital admissions , main diagnosis only

374

2814

1.17

2.38

1.2

370.84

369.58

nmol/l

0.04

316

2389

Degeneration of the brain due to alcohol

2.44

2.38

1.2

1.1

213.89

359.18

nmol/l

—

Anti-inflammatory and antirheumatic products, non-steroids

133

504

1.33

2.38

1.2

1.1

361.60

347.75

nmol/l

0.32

117

392

Other extrapyramidal and movement disorders in other diseases

109

812

1.35

2.36

1.1

1.2

330.73

349.17

nmol/l

0.47

671

Asthma/COPD (KELA code 203)

446

2641

1.16

2.35

1.2

1.1

378.89

370.70

nmol/l

0.35

376

2254

Lateral epicondylitis

362

1.52

2.34

1.2

1.1

362.82

393.10

nmol/l

0.52

323

Psoriatic arthropathies, ICD10

291

1.59

2.33

1.2

1.1

372.22

379.29

nmol/l

0.08

262

Enthesopathies of lower limb, excluding foot

669

1.38

2.32

1.1

368.46

380.07

nmol/l

0.23

576

Carbimazole or st.post thyroidectomy, condition for graves disease

662

1.38

2.30

1.1

397.76

379.48

nmol/l

0.38

587

Thyrotoxicosis with diffuse goitre

396

1.49

2.30

1.1

419.44

385.21

nmol/l

0.73

355

Meniscus derangement

242

1338

1.22

2.29

1.2

1.1

377.38

370.41

nmol/l

0.19

206

1120

Diseases of inner ear

248

1983

1.21

2.29

1.2

334.57

355.92

nmol/l

0.92

203

1636

Arthropathic psoriasis

324

1.55

2.29

1.2

1.1

373.62

375.11

nmol/l

0.02

296

Subjective visual disturbances

110

825

1.34

2.29

1.3

1.1

365.86

359.38

nmol/l

0.11

705

Malignant melanoma, including Hilmo

622

0.63

2.29

1.1

1.2

358.38

342.62

nmol/l

0.22

495

Other/unspecified synovitis and tenosynovitis

332

1.54

2.29

1.2

1.1

349.04

386.85

nmol/l

0.67

286

Infections of the skin and subcutaneous tissue

245

2005

1.21

2.28

1.2

1.1

338.31

373.15

nmol/l

1.77

197

1723

Palmar fascial fibromatosis [Dupuytren]

479

1.44

2.27

1.2

304.00

337.48

nmol/l

0.84

369

Gonarthrosis,primary

426

2263

1.16

2.27

1.2

342.39

361.67

nmol/l

1.09

355

1868

Sequelae of injuries, of poisoning and of other consequences of external causes

724

1.36

2.25

1.3

1.1

392.14

377.85

nmol/l

0.25

629

Other and unspecified drugs and medicaments

239

1.64

2.25

1.1

351.17

389.88

nmol/l

0.48

214

Degenerative macular diseases

439

1.46

2.25

1.4

1.2

313.92

329.56

nmol/l

0.27

341

Ulcerative proctitis

171

1.76

2.24

1.2

1.1

367.58

405.20

nmol/l

0.41

159

Bell's palsy

350

1.52

2.24

1.2

1.1

381.62

370.27

nmol/l

0.15

300

Speech and linguistic disorders, excluding more controls

140

1.82

2.22

1.2

1.1

358.20

388.83

nmol/l

0.29

133

Cirrhosis, broad definition used in the article https://doi.org/10.1101/594523

440

1.46

2.22

1.2

308.53

360.83

nmol/l

1.25

366

Hypoglycaemia, other or unspecified

194

1.71

2.22

1.2

349.54

382.10

nmol/l

0.33

171

Other specified/unspecified systemic involvement of connective tissue

157

1.79

2.21

1.3

1.1

330.79

396.37

nmol/l

0.94

145

Personality disorders

104

778

1.34

2.21

1.2

1.1

356.98

400.38

nmol/l

1.42

716

Other hammer toe(s) (acquired)

521

1.40

2.20

1.2

369.27

341.36

nmol/l

0.52

412

Dislocation, sprain and strain of joints and ligaments at neck level

417

1.47

2.19

1.1

344.15

390.24

nmol/l

1.18

385

Cervicalgia

677

1.36

2.18

1.2

1.1

361.11

365.54

nmol/l

0.07

559

Dental operations

333

1449

1.18

2.17

1.2

345.34

361.08

nmol/l

0.70

275

1197

Other postsurgical states

158

1.78

2.17

1.2

1.1

347.26

383.81

nmol/l

0.40

139

Implicit viral Sepsis

134

1042

1.29

2.16

1.2

342.21

347.18

nmol/l

0.10

102

846

Artificial joint operation, meniscal resection

425

2391

1.15

2.16

1.2

356.79

363.11

nmol/l

0.25

365

1977

Degeneration of nervous system due to alcohol

2.32

2.15

1.2

1.1

213.89

360.16

nmol/l

—

Other metabolic disorders

394

1.48

2.15

1.1

404.98

383.06

nmol/l

0.33

357

Hypo-osmolality and hyponatraemia

599

1.38

2.15

1.4

1.2

324.79

330.08

nmol/l

0.08

486

Pneumocystosis

2.65

2.15

1.0

1.1

286.83

368.57

nmol/l

—

Ulcerative colitis (strict definition, require KELA, min 2 HDR)

460

1.44

2.15

1.2

1.1

371.18

385.04

nmol/l

0.22

417

Substance abuse, excluding more controls

212

1480

1.22

2.14

1.2

1.1

349.06

374.72

nmol/l

1.08

167

1290

Unspecified kidney failure

354

1.50

2.14

1.3

1.2

245.68

321.40

nmol/l

2.37

280

Haemorrhage from respiratory passages

153

1092

1.27

2.12

1.2

333.72

339.34

nmol/l

0.13

126

884

Drugs, medicaments and biological substances causing adverse effects in therapeutic use

259

1.59

2.11

1.1

345.06

385.98

nmol/l

0.56

231

Protozoal diseases

2.22

2.11

1.1

1.2

281.38

383.72

nmol/l

—

Adenomyosis (Endometriosis of uterus)

363

1.49

2.11

1.3

1.1

343.25

379.96

nmol/l

0.71

291

Pacemaker

164

1257

1.25

2.11

1.2

325.93

320.34

nmol/l

0.12

121

967

Thyroiditis

205

1.67

2.11

1.1

404.29

393.12

nmol/l

0.13

182

Coagulation defects, purpura and other haemorrhagic conditions

657

1.36

2.09

1.2

340.88

358.72

nmol/l

0.34

560

198

1485

1.22

2.06

1.2

324.38

320.25

nmol/l

0.10

155

1146

Secondary and unspecified malignant neoplasm of lymph nodes, including Hilmo

506

1.41

2.06

1.1

1.2

352.95

347.28

nmol/l

0.09

413

Keratitis

149

1183

1.26

2.06

1.2

368.19

365.58

nmol/l

0.05

124

1011

Circumscribed brain atrophy

2.34

2.05

1.3

1.2

252.38

341.30

nmol/l

1.10

Explicit bacterial Sepsis

325

1.51

2.05

1.3

1.2

325.78

351.94

nmol/l

0.39

270

Chronic rhinitis, nasopharyngitis and pharyngitis

124

963

1.29

2.04

1.2

1.1

378.33

362.46

nmol/l

0.39

111

835

Intestinal adhesions without obstruction

246

1.59

2.04

1.2

1.1

304.00

365.35

nmol/l

1.28

210

Diseases of the myoneural junction and muscle

391

1.46

2.03

1.3

1.2

364.16

354.33

nmol/l

0.14

333

Decubitus ulcer and pressure area

192

1.68

2.03

1.1

1.2

334.46

344.93

nmol/l

0.09

155

Speech disturbances, not elsewhere classified

286

1.54

2.02

1.3

1.2

342.75

351.75

nmol/l

0.09

242

Other disorders of conjunctiva

483

1.41

2.02

1.2

411.50

346.70

nmol/l

1.51

400

Chronic ulcer of skin, not elsewhere classified

208

1.64

2.01

1.2

343.17

345.09

nmol/l

0.02

173

Medical abortion

208

1369

0.82

2.01

1.1

383.15

378.79

nmol/l

0.11

181

1186

Other disorders of bladder

368

1.47

2.00

1.3

1.2

369.14

339.50

nmol/l

0.38

294

Malignant neoplasm of bronchus and lung

579

0.67

1.99

1.2

282.16

317.78

nmol/l

0.64

450

Recurrent aphthous stomatitis , including avohilmo

443

1.43

1.98

1.3

1.1

343.30

366.08

nmol/l

0.40

387

Abrasion of teeth

138

1092

1.27

1.98

1.3

1.1

396.40

375.28

nmol/l

0.64

124

952

Elevated erythrocyte sedimentation rate and abnormality of plasma viscosity

264

1.56

1.97

1.0

1.2

298.00

342.41

nmol/l

0.70

224

Disorders of ocular muscles, binocular movement, accommodation and refraction

189

1536

1.22

1.96

1.2

1.1

369.28

380.78

nmol/l

0.34

158

1339

Endometriosis ASRM stages 3,4

100

760

1.32

1.95

1.2

1.1

379.97

375.60

nmol/l

0.07

674

Malignant neoplasm of digestive organs

181

1164

1.23

1.95

1.2

345.91

336.24

nmol/l

0.23

143

934

Pain associated with micturition

362

1.47

1.95

1.2

371.57

366.47

nmol/l

0.05

313

Spirochaetal infections, other/unspecified

123

962

1.28

1.94

1.2

379.23

363.76

nmol/l

0.37

116

820

Other skin changes

632

1.35

1.93

1.2

347.03

343.80

nmol/l

0.05

522

Other diseases of blood and blood-forming organs, wide

710

1.33

1.92

1.2

331.23

356.24

nmol/l

0.54

595

Sequelae of tuberculosis

2.26

1.91

1.2

302.00

330.73

nmol/l

—

Gout, FINNGEN

133

1050

1.27

1.91

1.3

1.2

295.87

329.91

nmol/l

1.19

821

188

1534

1.22

1.90

1.1

1.2

385.75

369.46

nmol/l

0.53

156

1309

Abnormal findings on diagnostic imaging of lung

215

1717

1.20

1.90

1.2

339.93

341.45

nmol/l

0.04

162

1407

Deviated nasal septum

130

1026

1.27

1.90

1.2

1.1

343.99

361.42

nmol/l

0.44

103

863

Injury of muscle and tendon at forearm level

0.00

1.89

0.0

1.2

—

416.52

—

Prolapse and hernia of ovary and fallopian tube

127

1.80

1.89

1.1

1.2

218.94

328.70

nmol/l

2.03

Other spirochaetal diseases

124

976

1.27

1.87

1.2

382.38

364.04

nmol/l

0.46

117

833

Azathioprine

415

1.43

1.87

1.3

1.1

342.46

383.89

nmol/l

0.79

370

Enlarged lymph nodes

474

1.40

1.86

1.1

399.93

363.07

nmol/l

0.69

417

Multiple myeloma and malignant plasma cell neoplasms

129

1.79

1.86

1.3

1.2

346.12

352.89

nmol/l

0.05

107

Polymyalgia rheumatica

509

1.38

1.84

1.2

327.67

327.75

nmol/l

0.00

392

Viral pneumonia

408

1.43

1.84

1.1

333.41

353.97

nmol/l

0.31

343

Bipolar affective disorders

509

1.38

1.84

1.2

1.1

351.41

404.25

nmol/l

1.56

472

Other psoriatic arthropathies

285

1.51

1.84

1.1

375.71

379.43

nmol/l

0.04

257

Primary open-angle glaucoma, strict

127

1003

1.27

1.84

1.2

334.23

323.13

nmol/l

0.24

101

761

Non-ischemic cardiomyopathy

135

864

1.26

1.83

1.3

1.2

281.55

339.55

nmol/l

3.08

117

704

Myeloid leukaemia

2.14

1.82

1.1

1.2

432.44

359.56

nmol/l

—

Cervicocranial syndrome

310

1.49

1.82

1.2

1.1

391.00

377.34

nmol/l

0.16

265

Adhesive capsulitis of shoulder

485

1.38

1.81

1.1

337.51

365.47

nmol/l

0.53

401

Asthma-related pneumonia

171

1399

1.22

1.81

1.2

344.46

346.41

nmol/l

0.04

142

1129

Seborrhoeic dermatitis

270

1.52

1.81

1.1

395.54

375.48

nmol/l

0.23

236

ILD medications: azathioprine

418

1.41

1.81

1.3

1.1

342.46

384.76

nmol/l

0.81

373

Hypertensive Renal Disease

1.96

1.80

1.4

1.1

303.08

346.49

nmol/l

0.32

Glaucoma, exfoliation

427

1.41

1.80

1.4

1.2

320.35

316.40

nmol/l

0.04

324

Hydronephrosis

377

1.44

1.80

1.2

347.69

349.80

nmol/l

0.02

314

Leiomyoma of uterus

290

1405

1.17

1.79

1.2

1.1

375.26

376.88

nmol/l

0.05

253

1209

Asthma, hospital admissions 3, pneumonia

171

1401

1.22

1.79

1.2

344.46

346.55

nmol/l

0.05

142

1131

Asthma-related pneumonia or sepsis

171

1401

1.22

1.79

1.2

344.46

346.55

nmol/l

0.05

142

1131

Lyme disease

121

956

1.27

1.79

1.2

381.16

363.45

nmol/l

0.43

114

815

Other noninflammatory disorders of cervix uteri

124

1.78

1.76

1.4

1.1

326.57

380.61

nmol/l

0.54

100

Mixed hyperlipidaemia

1.90

1.75

1.3

1.1

384.23

359.51

nmol/l

0.19

Hyperplasia of prostate

146

665

1.25

1.75

1.2

338.57

347.56

nmol/l

0.19

109

537

Vasomotor and allergic rhinitis

141

1116

1.24

1.75

1.2

1.1

367.91

381.04

nmol/l

0.33

121

985

COPD, hospital admissions 3, with asthma pneumonia sepsis

913

0.76

1.74

1.2

294.07

326.92

nmol/l

0.79

704

Primary gonarthrosis, bilateral

235

1705

1.18

1.73

1.3

1.2

332.76

352.63

nmol/l

0.77

185

1375

Disorders of adult personality and behaviour

105

819

1.28

1.73

1.2

1.1

356.28

402.80

nmol/l

1.58

753

Type 1 diabetes, wide definition, subgroup 1

592

1.34

1.72

1.2

345.93

389.25

nmol/l

1.13

542

Multiple myeloma, including Hilmo

140

1.72

1.3

1.2

352.28

340.80

nmol/l

0.08

118

Malignant neoplasm of respiratory system and intrathoracic organs

649

0.72

1.71

1.2

286.12

321.34

nmol/l

0.65

515

Other spirochaetal diseases

121

962

1.26

1.71

1.2

381.16

363.26

nmol/l

0.44

114

821

Open wound of ankle and foot

282

1.49

1.71

1.2

1.1

280.65

385.20

nmol/l

3.26

250

Vitamin D deficiency

2.31

1.71

1.1

342.17

429.26

nmol/l

—

Gout, idiopatic and unspecified

112

883

1.27

1.70

1.3

1.2

295.13

330.50

nmol/l

1.12

691

Iron deficiency

2.07

1.70

1.1

1.0

386.64

427.24

nmol/l

0.33

Other diseases of arteries and capillaries

275

1.50

1.68

1.2

376.17

365.29

nmol/l

0.11

236

Chronic laryngitis and laryngotracheitis

416

1.40

1.68

1.2

393.32

353.88

nmol/l

0.83

350

Mycoses

371

2836

1.14

1.68

1.2

1.1

368.96

372.74

nmol/l

0.13

329

2404

Otalgia

203

1.58

1.68

1.2

1.1

395.70

392.17

nmol/l

0.04

181

Schizophrenia or delusion

1003

0.76

1.66

1.1

347.67

382.48

nmol/l

0.78

887

Disorders of psychological development

233

1.52

1.65

1.2

1.1

359.21

399.68

nmol/l

0.54

221

Thyrotoxicosis

110

870

1.27

1.64

1.1

1.2

384.91

367.60

nmol/l

0.38

751

Viral warts

616

1.32

1.63

1.1

369.94

384.16

nmol/l

0.28

544

Disorders of magnesium metabolism

3.62

1.62

1.2

1.1

279.40

343.93

nmol/l

—

Other viral diseases

139

1122

1.23

1.62

1.1

373.09

393.53

nmol/l

0.60

120

1012

Colonic or urogenital fistula

112

890

1.26

1.61

1.2

1.1

342.56

368.42

nmol/l

0.67

755

Glomerular disorders in diseases classified elsewhere

344

1.43

1.61

1.3

1.2

340.26

364.67

nmol/l

0.34

290

Inguinal hernia

247

1411

1.17

1.61

1.2

347.11

364.53

nmol/l

0.65

218

1149

Gout, unspecified

705

1.29

1.61

1.3

1.2

265.28

335.24

nmol/l

2.98

555

Mixed connective tissue disease

174

1.62

1.61

1.2

1.1

356.60

396.15

nmol/l

0.48

161

Dementia due to Parkinson's disease

1.96

1.60

1.3

1.1

330.75

345.30

nmol/l

—

Use of galantamine

320

1.44

1.59

1.3

319.17

288.13

nmol/l

0.45

244

Fall on same level involving ice and snow

245

2104

1.17

1.59

1.2

339.72

368.08

nmol/l

1.46

196

1780

Primary_lymphoid and hematopoietic malignant neoplasms

104

821

1.27

1.59

1.2

361.43

336.38

nmol/l

0.50

664

Convulsions, not elsewhere classified

680

1.29

1.58

1.1

352.35

371.35

nmol/l

0.37

595

Oter anti-inflammatory and antirheumatic agents, non-steroids

101

434

1.29

1.57

1.3

1.2

369.93

334.26

nmol/l

0.86

326

Acute renal failure

769

1.28

1.57

1.2

302.53

336.50

nmol/l

0.92

610

Bacterial pneumonia, not elsewhere classified

173

1270

1.20

1.57

1.2

313.79

348.60

nmol/l

1.51

135

1035

Gonarthrosis, primary, with knee surgery

261

1792

1.16

1.56

1.2

337.96

352.08

nmol/l

0.52

214

1447

Sicca syndrome [Sjögren]

280

1.47

1.56

1.1

350.26

381.98

nmol/l

0.39

244

Ganglion

629

1.31

1.56

1.2

1.1

384.49

389.41

nmol/l

0.08

551

Other disorders of eyelid

204

1645

1.18

1.56

1.2

336.49

340.81

nmol/l

0.10

157

1334

Orchitis and epididymitis

223

1.53

1.56

1.2

336.70

334.59

nmol/l

0.02

175

Specific development disorders of speech and language

117

1.73

1.55

1.2

1.1

313.53

383.24

nmol/l

0.83

107

Flat foot [pes planus] (acquired)

264

1.48

1.55

1.2

1.1

376.32

364.54

nmol/l

0.14

230

Pneumonia due to other infectious organisms, not elsewhere classified

1.89

1.55

1.1

1.2

317.17

386.18

nmol/l

—

Fall involving bed

107

1.79

1.55

1.1

1.2

282.33

362.76

nmol/l

0.95

Specific personality disorders

665

1.30

1.55

1.2

1.1

358.13

400.72

nmol/l

1.22

615

Other specified/unspecified arthritis

106

842

1.26

1.54

1.2

1.1

343.27

365.86

nmol/l

0.54

704

Benign lipomatous neoplasm

123

994

1.24

1.54

1.2

325.59

357.19

nmol/l

0.98

844

Asthma mixed form (mode)

158

0.44

1.54

1.1

379.86

351.10

nmol/l

—

143

Asthma mixed form (mode), excluding more controls

158

0.44

1.54

1.1

379.86

357.72

nmol/l

—

140

Schizophrenia, schizotypal and delusional disorders

1013

0.77

1.54

1.1

348.97

381.83

nmol/l

0.76

894

Cyst of kidney

200

1.56

1.54

1.1

1.2

398.17

373.54

nmol/l

0.19

168

Disorders of vestibular function (Vertigo)

207

1731

1.18

1.53

1.2

341.61

354.51

nmol/l

0.40

168

1427

Myeloproliferative diseases

249

1.49

1.52

1.4

1.2

355.75

360.06

nmol/l

0.04

213

Infections with a predominantly sexual mode of transmission

111

887

1.25

1.52

1.1

431.58

402.56

nmol/l

0.73

102

824

Reactive arthropathies

249

1.49

1.52

1.2

1.1

308.03

368.97

nmol/l

0.90

223

Autoimmune hyperthyroidism

169

1.60

1.52

1.1

365.59

386.94

nmol/l

0.21

155

Raynaud syndrome

241

1.50

1.52

1.1

352.70

398.34

nmol/l

0.77

223

Hernia of abdominal wall

192

1625

1.18

1.51

1.2

338.86

358.02

nmol/l

0.65

161

1358

Stomatitis and related lesions

633

1.30

1.50

1.3

1.1

347.78

373.89

nmol/l

0.60

556

Secondary malignant neoplasm of other and unspecified sites, including Hilmo

840

0.75

1.50

1.1

1.2

323.86

336.26

nmol/l

0.18

679

Cervicobrachial syndrome

695

1.28

1.50

1.1

354.61

379.62

nmol/l

0.57

596

Other noninflammatory disorders of vulva and perineum

242

1.49

1.3

1.1

387.93

387.12

nmol/l

0.01

208

Glucosamine medication

217

1480

1.17

1.48

1.3

1.2

331.75

335.29

nmol/l

0.09

170

1161

Use of levodopa decarbox-comt-inhibitor

1.82

1.47

1.2

300.06

339.92

nmol/l

0.42

Sciatica+with lumbago

213

1675

1.17

1.47

1.2

1.1

363.28

377.98

nmol/l

0.48

180

1420

Ulcerative colitis (strict definition, all Crohn cases excluded)

410

1.37

1.47

1.2

1.1

370.83

388.19

nmol/l

0.27

371

Bacterial pneumoniae

180

1337

1.19

1.47

1.2

313.29

351.08

nmol/l

1.78

139

1092

Malignant neoplasm of head and neck

251

1.48

1.47

1.2

342.44

334.44

nmol/l

0.08

206

Skin changes due to chronic exposure to nonionizing radiation

182

1417

1.19

1.46

1.2

323.95

317.84

nmol/l

0.16

143

1084

Disease of hard tissues of teeth, NOS

208

1277

0.85

1.46

1.2

1.1

357.69

361.59

nmol/l

0.10

188

1072

Psoriasis (vulgaris), strict definition

1.85

1.46

1.2

1.1

350.70

407.94

nmol/l

—

Other factor of the environment

2.52

1.45

1.0

1.1

299.14

430.00

nmol/l

—

Malignant neoplasm, wide definition for exclusion

397

2072

1.12

1.45

1.2

1.1

345.16

377.70

nmol/l

2.49

339

1775

Varicose veins

288

1901

1.14

1.45

1.2

338.92

359.05

nmol/l

0.93

233

1566

Hallux rigidus

403

1.37

1.44

1.3

1.1

345.27

344.57

nmol/l

0.01

328

Benign neoplasm of other and unspecified endocrine glands

412

1.36

1.44

1.2

1.1

331.70

368.92

nmol/l

0.65

360

Malignant neoplasm of breast, ER-negative, including Hilmo

742

1.26

1.43

1.2

331.94

361.36

nmol/l

0.75

618

Other strabismus

654

1.28

1.42

1.2

1.1

387.64

386.26

nmol/l

0.02

584

Other obstetric trauma

155

0.45

1.42

1.0

1.1

478.57

410.42

nmol/l

—

149

Volume depletion

295

1.43

1.41

1.4

1.2

333.33

332.94

nmol/l

0.00

240

Mixed conductive and sensorineural hearing loss

388

1.37

1.41

1.2

327.64

365.53

nmol/l

0.63

313

Malignant neoplasm of bronchus and lung, including Hilmo

676

0.75

1.40

1.2

301.63

320.03

nmol/l

0.32

531

Carcinoma in situ of other and unspecified digestive organs

1.86

1.40

1.0

1.1

248.63

384.03

nmol/l

—

Other disorders of kidney and ureter

406

1.36

1.39

1.2

345.53

356.55

nmol/l

0.13

340

Non-small cell lung cancer, including Hilmo

520

0.70

1.38

1.3

1.2

301.89

321.39

nmol/l

0.26

405

Glomerular diseases

563

1.30

1.38

1.3

1.2

356.78

356.76

nmol/l

0.00

475

Other diseases of biliary tract

280

1.43

1.37

1.2

341.58

356.04

nmol/l

0.16

235

Abnormal results of function studies

239

1.47

1.36

1.4

1.1

335.61

377.86

nmol/l

0.54

215

Infarction of spleen

2.98

1.36

1.0

1.2

224.60

360.42

nmol/l

—

Myeloproliferative diseases (CML excluded)

223

1.49

1.36

1.4

1.2

334.71

359.35

nmol/l

0.29

191

Fracture of rib(s), sternum and thoracic spine

129

1066

1.21

1.35

1.2

337.05

347.55

nmol/l

0.24

112

859

Other and unspecified local infections of skin and subcutaneous tissue

273

1.43

1.35

1.4

1.2

345.41

378.26

nmol/l

0.38

243

Alzheimer’s disease (Early onset)

175

1.55

1.34

1.1

1.2

358.81

326.54

nmol/l

0.33

138

Other and unspecified psoriasis

183

1.54

1.34

1.2

330.95

378.53

nmol/l

0.50

163

Transport accidents

182

1333

1.18

1.34

1.2

1.1

390.89

384.54

nmol/l

0.16

166

1155

Postmenopausal osteoporosis with pathological fracture

232

1.47

1.34

1.2

273.91

336.50

nmol/l

1.13

193

Inflammatory diseases of the central nervous system

232

1.47

1.34

1.4

1.1

366.96

378.58

nmol/l

0.13

209

Actinic keratosis

177

1394

1.18

1.33

1.2

322.59

317.35

nmol/l

0.13

140

1067

Other diseases of lip and oral mucosa

160

1351

1.19

1.33

1.2

358.53

368.83

nmol/l

0.28

136

1150

Injuries to the shoulder and upper arm

366

2636

1.12

1.32

1.2

372.66

362.71

nmol/l

0.39

310

2206

Diseases of external ear

141

1178

1.20

1.32

1.1

1.2

342.78

360.97

nmol/l

0.42

109

985

Viral infections characterized by skin and mucous membrane lesions

371

2839

1.12

1.32

1.2

1.1

374.80

371.15

nmol/l

0.13

327

2407

Other local infections of skin and subcutaneous tissue

291

1.41

1.32

1.4

1.2

337.41

381.27

nmol/l

0.59

260

COPD, hospital admission 2, with asthma infections

102

1075

0.81

1.30

1.2

303.34

332.33

nmol/l

0.77

841

Other disorders of thyroid

2.37

1.29

1.5

1.2

203.13

398.93

nmol/l

—

Fistulae involving female genital tract

2.37

1.29

1.0

1.1

353.38

423.83

nmol/l

—

Disorders resulting from impaired renal tubular function

1.77

1.29

1.3

1.1

223.27

395.77

nmol/l

3.89

Any event in cancer register

412

2182

1.11

1.29

1.1

1.2

349.92

380.26

nmol/l

2.32

353

1873

Event of undetermined intent

153

1.57

1.28

1.2

1.1

332.94

388.84

nmol/l

0.64

141

Amyloidosis

2.10

1.28

1.6

1.1

328.70

318.02

nmol/l

—

Ventral hernia

102

829

1.23

1.27

1.2

311.82

352.85

nmol/l

1.25

675

Other secondary coxarthrosis

1.79

1.27

1.1

1.2

378.67

384.03

nmol/l

—

Diseases of oral cavity, salivary glands and jaws

314

1430

1.13

1.27

1.2

1.1

356.25

355.75

nmol/l

0.01

265

1187

Malignant neoplasm of breast

192

1074

1.17

1.27

1.1

1.2

346.24

385.01

nmol/l

1.85

168

925

Ankylosing spondylitis, ICD10

227

1.46

1.26

1.2

1.1

348.14

375.27

nmol/l

0.34

207

Ulcerative colitis, NAS

405

1.34

1.26

1.2

1.1

362.82

378.02

nmol/l

0.23

364

Malignant neoplasm of breast, HER2-negative, including Hilmo

196

1091

1.16

1.26

1.1

344.47

385.09

nmol/l

2.05

172

940

conjunctival haemorrhage

219

1.47

1.25

1.3

1.2

351.12

366.53

nmol/l

0.15

184

Malignant neoplasm of breast, including Hilmo

196

1091

1.16

1.25

1.1

344.47

385.09

nmol/l

2.05

172

940

Striking against or struck by other objects

120

993

1.21

1.25

1.2

1.1

381.33

383.67

nmol/l

0.04

107

860

Atopic dermatitis

225

1606

1.15

1.25

1.1

386.83

392.73

nmol/l

0.18

206

1441

380

1.34

1.24

1.2

1.1

466.15

385.86

nmol/l

1.47

344

Amiodarone users

295

1.39

1.24

1.2

300.21

332.72

nmol/l

0.44

240

Gout, strict definition

609

1.27

1.23

1.3

1.2

312.39

330.92

nmol/l

0.37

474

Other symptoms and signs involving the nervous and musculoskeletal systems

174

1492

1.17

1.22

1.2

377.63

361.86

nmol/l

0.48

146

1259

Blepharochalasis

124

1033

1.20

1.22

1.1

1.2

343.16

338.80

nmol/l

0.08

839

Mental disorders, not otherwise specified

237

1.44

1.22

1.1

341.89

403.20

nmol/l

0.91

225

Dislocation of lens

2.18

1.22

1.1

309.88

312.00

nmol/l

—

Non-small cell lung cancer

358

0.66

1.21

1.3

1.2

265.06

318.61

nmol/l

0.63

278

Secondary malignant neoplasm of respiratory and digestive organs, including Hilmo

638

1.26

1.20

1.2

302.50

341.30

nmol/l

0.93

516

Colon adenocarcinoma

435

1.31

1.20

1.2

314.09

332.15

nmol/l

0.25

337

Panniculitis, unspecified

2.33

1.19

1.3

1.2

309.00

405.95

nmol/l

—

Persistent mood disorders

612

1.26

1.19

1.2

1.1

368.08

375.62

nmol/l

0.12

533

Myasthenia gravis

2.12

1.18

1.3

1.2

458.50

374.85

nmol/l

—

Localized swelling, mass and lump of skin and subcutaneous tissue

127

1065

1.19

1.18

1.2

324.47

363.56

nmol/l

1.58

112

906

Other acute lower respiratory infections

227

1898

1.14

1.17

1.2

357.96

358.37

nmol/l

0.01

177

1576

Cirrhosis of liver, NAS

141

1.57

1.17

1.4

1.2

273.67

361.70

nmol/l

1.12

121

Hemiplegia

141

1.57

1.17

1.1

1.2

339.20

383.09

nmol/l

0.44

127

Speech and linguistic disorders

174

1.49

1.16

1.2

1.1

358.20

399.21

nmol/l

0.42

162

Poisoning by medicine, drug-induced

0.00

1.16

0.0

1.1

—

416.54

—

Redundant prepuce, phimosis and paraphimosis

485

1.29

1.16

1.1

1.2

314.29

364.57

nmol/l

1.12

401

Non-allergic asthma (mode), excluding more controls

591

1.26

1.15

1.1

372.27

370.65

nmol/l

0.02

502

Allergic asthma (mode), excluding more controls

698

1.24

1.15

1.2

1.1

402.06

391.80

nmol/l

0.19

627

Other diseases of appendix

0.00

1.14

0.0

1.2

—

386.23

—

Otitis externa, unspecified

317

1.36

1.14

1.1

363.93

383.54

nmol/l

0.23

287

Hyperkalaemia

150

1.54

1.14

1.1

1.2

273.56

352.67

nmol/l

1.05

119

Alcohol abuse counselling and surveillance

0.00

1.14

0.0

1.1

—

409.81

—

Cerebral palsy and other paralytic syndromes

343

1.34

1.14

1.1

1.2

343.21

367.93

nmol/l

0.33

302

Hypertrophy of breast in women and men

607

1.25

1.13

1.2

1.1

435.09

396.65

nmol/l

0.93

556

Nephrotic syndrome

1.85

1.13

1.2

442.00

376.00

nmol/l

—

Vascular dementia (subcortical)

103

1.66

1.13

1.6

1.2

277.00

338.02

nmol/l

0.36

Vertebral, anorectal, cardiavascular, thracheoesophagial, renal and limb anomaly

469

0.72

1.12

1.1

415.62

377.36

nmol/l

0.56

417

Lichen ruber planus, wide definition including periferal and oral lichen planus

707

1.23

1.12

1.1

400.92

358.87

nmol/l

0.91

603

Urethral stricture

159

1.51

1.12

1.1

1.2

345.38

338.69

nmol/l

0.05

127

Voice disturbances

108

898

1.20

1.11

1.2

396.81

361.57

nmol/l

1.16

769

Other disorders of bone

609

1.25

1.11

1.2

1.1

348.06

387.08

nmol/l

0.81

539

Other and unspecified diseases of blood and blood-forming organs

1.79

1.11

1.4

1.2

383.69

373.45

nmol/l

0.06

Chronic apical periodontitis

434

2709

0.91

1.11

1.2

1.1

358.87

372.70

nmol/l

0.70

362

2310

Lifestyle-related condition

2.28

1.11

1.0

1.1

299.14

411.80

nmol/l

—

Lichen planus, including avohilmo

610

1.25

1.10

1.1

1.2

394.85

357.02

nmol/l

0.74

519

Cellulitis

718

1.23

1.10

1.2

1.1

321.61

367.08

nmol/l

1.23

611

Deep bite

227

1.39

1.09

1.1

435.89

384.38

nmol/l

0.71

214

Other and unspecified effects of external causes

101

836

1.21

1.09

1.1

358.55

382.96

nmol/l

0.66

744

Coronary artery bypass grafting

113

702

1.20

1.09

1.2

334.83

324.74

nmol/l

0.18

569

Ankylosing spondylitis

243

1.40

1.09

1.2

1.1

348.14

378.06

nmol/l

0.38

213

Lesion of lateral popliteal nerve

120

1.59

1.08

1.1

346.85

395.93

nmol/l

0.37

107

Benign neoplasm: Adrenal gland

210

1.43

1.08

1.1

1.2

299.30

382.70

nmol/l

1.10

183

Urticaria

113

947

1.19

1.08

1.1

384.86

379.00

nmol/l

0.11

850

Other/unspecified reactive arthropathies

177

1.47

1.07

1.3

1.1

278.10

392.75

nmol/l

1.65

162

Diabetic nephropathy, excluding more controls

436

1.27

1.07

1.3

1.2

328.85

359.36

nmol/l

0.54

323

Abnormal findings on antenatal screening of mother

230

0.61

1.06

1.1

371.50

422.03

nmol/l

0.63

225

Injury of nerves and spinal cord at neck level

1.93

1.06

1.0

1.1

391.40

397.23

nmol/l

—

Unspecified acute lower respiratory infection

488

1.27

1.06

1.2

324.68

364.28

nmol/l

0.84

430

Osteomyelitis

186

1.46

1.06

1.1

1.2

389.67

363.82

nmol/l

0.17

157

Anorexia

2.13

1.06

1.1

486.00

431.64

nmol/l

—

Other/unspecified disorders of vestibular function

113

1.60

1.06

1.4

1.1

390.73

370.97

nmol/l

0.11

Colorectal cancer

106

866

1.20

1.05

1.3

1.2

323.55

329.42

nmol/l

0.10

683

Type 1 diabetes, wide definition

649

1.23

1.05

1.2

346.91

385.28

nmol/l

0.97

591

Other peripheral vertigo

288

1.36

1.04

1.3

1.2

329.77

359.79

nmol/l

0.37

245

Injuries to the abdomen, lower back, lumbar spine and pelvis

171

1471

1.15

1.04

1.3

1.2

340.73

352.65

nmol/l

0.32

141

1195

Foreign body entering into or through eye or natural orifice

195

1.44

1.04

1.1

315.48

385.76

nmol/l

0.98

170

Statin medication

293

1476

1.12

1.04

1.2

1.1

381.06

378.34

nmol/l

0.08

257

1302

Bacterial pneumonia (organism specified)

198

1577

1.14

1.04

1.2

310.47

345.38

nmol/l

1.67

151

1272

Abnormal involuntary movements

437

1.28

1.03

1.2

1.1

380.24

362.76

nmol/l

0.27

377

Retained placenta and membranes, without haemorrhage

358

1.32

1.03

1.1

347.54

389.23

nmol/l

0.67

328

Other disorders of white blood cells

146

1.51

1.03

1.1

1.2

340.12

383.34

nmol/l

0.49

131

Other obstetric conditions, not elsewhere classified

117

626

1.19

1.02

1.1

431.15

414.52

nmol/l

0.43

110

603

Gingivitis and periodontal diseases

421

2374

0.91

1.02

1.2

374.83

363.26

nmol/l

0.56

356

2008

Spontaneous abortion

184

1083

1.15

1.02

1.1

380.23

391.91

nmol/l

0.33

173

981

Strabismus

100

832

1.20

1.02

1.2

1.1

382.99

372.01

nmol/l

0.20

719

Malignant neoplasm of pancreas, including Hilmo

281

1.36

1.02

1.2

409.83

339.52

nmol/l

0.85

227

All influenza (not pneumonia)

447

1.28

1.01

1.3

1.1

318.50

366.88

nmol/l

1.15

393

Malignant neoplasm of breast, HER2-negative

186

1064

1.14

1.01

1.1

1.2

344.61

384.57

nmol/l

1.89

163

915

Other viral diseases, not elsewhere classified

785

1.20

1.01

1.1

367.26

390.31

nmol/l

0.51

707

Benign lipomatous neoplasm of other sites/unspecified

273

1.36

1.00

1.2

319.27

355.24

nmol/l

0.53

235

Horner syndrome

2.02

1.00

1.3

1.2

413.57

375.55

nmol/l

—

Presbycusis

532

1.25

1.00

1.3

1.2

296.13

329.61

nmol/l

0.80

399

Arterial embolism and thrombosis

180

1.45

1.00

1.1

1.3

291.29

334.79

nmol/l

0.55

150

Disorders of skin appendages

179

1566

1.14

1.00

1.2

1.1

370.13

378.12

nmol/l

0.19

143

1372

Haemorrhage, not elsewhere classified

1.62

1.00

1.3

1.2

408.64

346.57

nmol/l

0.56

Diabetic retinopathy, excluding more controls

114

537

1.19

0.99

1.2

337.33

370.99

nmol/l

0.85

410

Malignant neoplasm

376

2026

1.10

0.99

1.1

1.2

346.76

375.91

nmol/l

1.98

321

1733

Other complications of surgical and medical care, not elsewhere classified

291

1.34

0.99

1.1

370.45

380.79

nmol/l

0.11

258

Allergic asthma (mode)

712

1.21

0.99

1.2

1.1

402.06

386.85

nmol/l

0.30

641

Open wound of forearm

257

1.36

0.98

1.3

1.2

267.13

371.36

nmol/l

2.41

224

Lichen planus

414

1.28

0.98

1.1

1.2

384.85

355.53

nmol/l

0.36

352

Sub-endpoint used in defining T1D endpoints

123

1032

1.17

0.98

1.2

355.49

364.87

nmol/l

0.20

871

Lagophthalmos

0.00

0.98

0.0

1.1

—

351.75

—

Spontaneous rupture of synovium and tendon

232

1.38

0.97

1.2

1.1

376.50

367.77

nmol/l

0.07

195

Immunodeficiency with predominantly antibody defects

1.75

0.96

1.3

1.1

308.08

393.52

nmol/l

0.98

Herpesviral [herpes simplex] infections

767

1.20

0.96

1.2

1.1

419.23

383.53

nmol/l

0.85

680

Alcoholic liver disease

293

1.33

0.95

1.2

315.70

351.21

nmol/l

0.52

251

Later onset COPD

937

0.84

0.95

1.3

1.2

280.86

304.96

nmol/l

0.57

700

Other follicular disorders

199

1.41

0.95

1.2

1.1

324.76

397.66

nmol/l

0.83

188

Malignant neoplasm of breast, HER-negative

682

1.21

0.95

1.2

328.78

357.16

nmol/l

0.61

564

L04AD Calcineurin inhibitors

270

0.67

0.94

1.2

349.69

379.03

nmol/l

0.22

247

Disorder of thyroid, unspecified

1.90

0.94

1.6

1.2

211.57

388.81

nmol/l

—

UC patients in KELA-register (code 208), prior to 1994

109

1.57

0.93

1.1

334.50

409.18

nmol/l

0.73

Other peripheral vascular diseases

217

1.39

0.93

1.1

1.2

297.36

373.23

nmol/l

1.50

199

Pedal cyclist injured in transport accident

688

1.21

0.92

1.2

1.1

397.09

379.59

nmol/l

0.38

598

Nonsuppurative otitis media

563

1.22

0.92

1.1

340.15

401.60

nmol/l

2.07

512

Sequelae of external causes of morbidity and mortality

104

881

1.18

0.92

1.2

369.73

356.09

nmol/l

0.25

730

280

0.68

0.92

1.1

423.00

425.86

nmol/l

0.02

269

Otitis externa

707

1.20

0.92

1.1

1.2

356.39

374.34

nmol/l

0.29

604

Nephropathy related operations

350

0.71

0.92

1.2

351.00

363.20

nmol/l

0.11

298

Ulcer of lower limb, not elsewhere classified

508

1.24

0.91

1.2

382.13

333.81

nmol/l

0.76

408

Acute nasopharyngitis (common cold)

302

1.32

0.91

1.1

353.86

408.61

nmol/l

1.06

279

Other aneurysm

159

1.45

0.91

1.3

1.2

360.13

344.76

nmol/l

0.12

133

Undetermined asthma, excluding more controls

401

1.27

0.91

1.1

356.74

373.42

nmol/l

0.28

343

Immunodeficiencies

118

1.53

0.91

1.3

1.2

354.22

397.86

nmol/l

0.47

109

Pre-eclampsia

608

1.22

0.91

1.2

1.1

384.27

402.56

nmol/l

0.33

564

Disorders of breast

202

1631

1.12

0.90

1.1

387.80

379.70

nmol/l

0.22

184

1417

malignant neoplasm of male genital organs

119

619

1.17

0.90

1.2

349.67

333.03

nmol/l

0.38

498

Persons encountering health services in other circumstances

152

1322

1.14

0.90

1.3

1.1

340.26

372.83

nmol/l

1.33

140

1121

Fracture of shoulder and upper arm

147

1281

1.15

0.90

1.2

379.85

351.38

nmol/l

0.78

118

1041

Infections with a predominantly sexual mode of transmission

135

1090

1.15

0.89

1.1

438.51

401.86

nmol/l

1.22

126

1008

Other medical care

176

1397

1.13

0.89

1.2

339.29

350.00

nmol/l

0.27

139

1199

Persons encountering health services in circumstances related to reproduction

161

1235

0.88

0.89

1.1

437.93

401.36

nmol/l

1.75

156

1111

Atrophic disorders of skin

465

1.25

0.89

1.2

1.1

373.36

368.27

nmol/l

0.07

408

Other specified and unspecified disorders of eye and adnexa

103

0.48

0.89

1.2

495.20

382.77

nmol/l

—

Embedded and impacted teeth

569

1.20

0.89

1.1

383.05

410.15

nmol/l

0.66

539

Adverse effects, not elsewhere classified

592

1.22

0.88

1.2

1.1

354.48

387.65

nmol/l

0.78

530

Benign neoplasm: Skin of other and unspecified parts of face

359

1.28

0.88

1.2

380.48

354.81

nmol/l

0.28

298

Retinal detachments and breaks

147

1285

1.15

0.88

1.2

355.41

345.71

nmol/l

0.23

118

1039

Fracture of lumbar spine and pelvis

100

847

1.18

0.88

1.3

1.2

323.51

331.16

nmol/l

0.14

670

Pain in thoracic spine

457

1.25

0.88

1.2

1.1

316.82

382.99

nmol/l

1.43

395

Non-allergic asthma (mode)

614

1.21

0.87

1.1

372.27

364.19

nmol/l

0.13

523

Hypertrophy of breast

530

1.23

0.87

1.2

1.1

455.37

400.73

nmol/l

1.45

488

Calculus of kidney and ureter

119

1026

1.16

0.86

1.2

341.62

354.57

nmol/l

0.28

842

Basal cell carcinoma, including avohilmo

201

1234

1.12

0.86

1.2

306.59

339.69

nmol/l

1.48

168

1003

Other maternal diseases classifiable elsewhere but complicating pregnancy, childbirth and the puerperium

113

614

1.17

0.85

1.1

428.50

413.79

nmol/l

0.36

106

591

Superficial injury of lower leg

824

1.18

0.85

1.2

1.1

336.66

368.18

nmol/l

0.77

712

Glaucoma secondary to other eye disorders

112

1.52

0.85

1.2

460.25

361.63

nmol/l

0.86

Conjunctivitis (acute, non atopic)

100

849

1.17

0.84

1.3

1.1

330.48

379.07

nmol/l

1.89

742

Nontoxic multinodular goitre

632

1.20

0.84

1.2

351.20

351.10

nmol/l

0.00

529

Fall on and from stairs and steps

106

908

1.17

0.84

1.2

337.02

363.69

nmol/l

0.72

762

Disorders of refraction and accommodation

785

1.18

0.84

1.1

375.34

390.62

nmol/l

0.32

703

Appendectomy

258

2237

1.10

0.84

1.2

1.1

363.83

383.42

nmol/l

0.88

223

1941

Malignant neoplasm of bladder, including Hilmo

431

1.25

0.83

1.3

1.2

288.69

312.50

nmol/l

0.37

329

Other superficial mycoses

283

1.31

0.83

1.1

458.44

399.11

nmol/l

1.11

264

Trigger finger

407

1.25

0.83

1.3

1.1

354.26

376.09

nmol/l

0.31

356

malignant neoplasm of female genital organs

553

0.79

0.82

1.1

1.2

369.39

343.67

nmol/l

0.30

443

Missing teeth due to accident, extraction or parodontitis

243

2072

1.11

0.82

1.2

368.34

354.39

nmol/l

0.49

202

1709

Other shoulder lesions

266

1.32

0.82

1.2

1.1

366.48

382.59

nmol/l

0.19

238

Plantar fascial fibromatosis

266

1.32

0.82

1.1

369.97

379.50

nmol/l

0.09

232

Dislocation, sprain and strain of joints and ligaments at wrist and hand level

101

864

1.17

0.82

1.1

397.90

396.08

nmol/l

0.03

768

Neovascular glaucoma

113

1.51

0.82

1.2

460.25

365.34

nmol/l

0.82

Reactive arthropathies, FINNGEN

197

1.37

0.82

1.3

1.1

289.86

382.43

nmol/l

1.24

177

Effects of foreign body entering through natural orifice

726

1.19

0.82

1.2

1.1

333.66

377.07

nmol/l

1.09

633

Cholecystitis

498

1.23

0.82

1.2

339.97

338.81

nmol/l

0.01

401

Other disorders of patella

480

1.23

0.81

1.3

1.1

366.42

399.31

nmol/l

0.54

438

Benign neoplasm: Cerebral meninges

293

1.30

0.81

1.1

1.2

344.35

370.71

nmol/l

0.33

246

Wet age-related macular degeneration

687

1.19

0.81

1.3

1.2

304.92

313.31

nmol/l

0.15

503

Other and unspecified glaucoma

232

1.34

0.81

1.1

1.2

387.96

333.12

nmol/l

0.60

189

Cutaneous abscess, furuncle and carbuncle

810

1.17

0.81

1.2

1.1

344.04

379.33

nmol/l

0.77

706

Contact with sharp object, undetermined intent

1.71

0.80

1.1

404.00

418.71

nmol/l

—

Outcome of delivery

324

0.78

0.80

1.1

403.34

420.69

nmol/l

0.26

306

Visual field defects

259

1.32

0.79

1.1

1.2

306.48

353.21

nmol/l

0.72

224

Abnormal blood-pressure reading, without diagnosis

114

1.50

0.79

1.0

1.2

361.73

382.32

nmol/l

0.12

Arteriovenous malformation of cerebral vessels

0.00

0.79

0.0

1.1

—

398.95

—

Psoriasis vulgaris

573

1.21

0.79

1.2

345.48

369.05

nmol/l

0.39

495

Excessive attrition of teeth

208

1874

1.11

0.79

1.2

1.1

401.84

381.47

nmol/l

0.81

182

1649

Need for other prophylactic measures

151

0.59

0.78

1.0

1.1

388.64

397.83

nmol/l

—

136

Chondropathies

456

1.23

0.78

1.2

1.1

323.49

382.52

nmol/l

1.21

412

DVT of lower extremities

666

1.19

0.77

1.2

281.43

341.28

nmol/l

1.90

536

Agranulocytosis

331

1.27

0.77

1.2

339.97

375.49

nmol/l

0.43

286

Urticaria and erythema

137

1206

1.14

0.77

1.1

1.2

377.07

373.55

nmol/l

0.07

109

1056

Other predominantly sexually transmitted diseases, not elsewhere classified

484

1.22

0.77

1.1

413.70

403.00

nmol/l

0.13

456

Other/unspecified enthesopathies, not elsewhere classified

261

1.31

0.76

1.1

1.2

351.68

366.01

nmol/l

0.16

219

Primary angle-closure glaucoma

124

1.46

0.75

1.2

331.08

323.59

nmol/l

—

102

Atypical virus infections of central nervous system

2.10

0.75

1.4

1.1

185.60

415.58

nmol/l

—

Fracture at wrist and hand level

121

1057

1.14

0.74

1.1

376.37

382.06

nmol/l

0.11

919

Venous thromboembolism

233

2047

1.10

0.74

1.2

312.23

349.53

nmol/l

1.57

184

1666

Pre-eclampsia or eclampsia

651

1.18

0.74

1.2

1.1

382.69

400.58

nmol/l

0.32

604

MS-disease / Multiple Sclerosis

210

1.34

0.73

1.0

1.1

387.65

397.84

nmol/l

0.08

199

Clear cell adenocarcinoma of kidney

133

1.43

0.73

1.1

1.2

338.23

368.82

nmol/l

0.28

110

Maternal care for known or suspected disproportion

133

1.43

0.73

1.2

1.1

451.47

426.55

nmol/l

0.21

127

Demyelinating diseases of the central nervous system

245

1.31

0.73

1.0

1.1

377.38

397.44

nmol/l

0.19

231

Chronic periodontitis, including avohilmo

364

2629

0.93

0.73

1.2

1.1

377.39

365.52

nmol/l

0.52

280

2247

Ulcerative rectosigmoiditis

219

1.33

0.73

1.1

341.12

394.45

nmol/l

0.78

199

Acute myeloid leukaemia and myelodysplastic syndromes

1.63

0.72

1.1

1.3

292.80

331.61

nmol/l

—

Solid cancers, helper endpoint

367

2009

1.08

0.71

1.1

1.2

347.72

375.88

nmol/l

1.84

315

1717

Benign neoplasm of mouth and pharynx

326

1.26

0.71

1.2

327.56

365.81

nmol/l

0.77

287

Thyroiditis, unspecified

1.76

0.71

1.3

1.2

392.43

388.44

nmol/l

—

Superficial injury of wrist and hand

608

1.19

0.71

1.2

1.1

359.28

395.50

nmol/l

0.75

538

Malignant neoplasm of prostate

114

595

1.15

0.70

1.2

338.00

327.76

nmol/l

0.22

477

Other predominantly sexually transmitted diseases, not elsewhere classified

572

1.19

0.70

1.1

430.31

402.89

nmol/l

0.45

540

Benign lipomatous neoplasm of skin and subcutaneous tissue of trunk

417

1.22

0.70

1.1

342.73

374.58

nmol/l

0.50

368

Lichen sclerosus et atrophicus

318

1.26

0.70

1.2

1.1

384.38

365.25

nmol/l

0.24

273

Beningn neoplasm: Meninges, unspecified

1.72

0.70

1.0

1.2

368.14

364.66

nmol/l

—

Erythema intertrigo

1.56

0.70

1.2

495.78

414.10

nmol/l

—

Any mental disorder, or suicide (or attempt), or psychic disorders complicating pregnancy, partum or puerperium or nerve system disorders

102

888

1.15

0.69

1.1

378.69

398.30

nmol/l

0.48

816

Pre-eclampsia or poor fetal growth

106

922

1.15

0.69

1.2

1.1

392.09

404.23

nmol/l

0.27

856

Injury of nerves at wrist and hand level

1.51

0.69

1.2

1.1

321.51

400.21

nmol/l

0.94

Fibrosis and cirrhosis of liver

204

1.33

0.68

1.4

1.2

254.67

362.09

nmol/l

1.82

181

Undetermined asthma

418

1.22

0.68

1.1

356.74

368.82

nmol/l

0.19

358

Divergent concomitant strabismus

204

1.33

0.68

1.0

1.1

361.25

394.41

nmol/l

0.34

189

1.65

0.68

1.1

365.90

445.62

nmol/l

—

Tularaemia

1.86

0.68

1.4

1.1

373.40

373.67

nmol/l

—

Benign paroxysmal vertigo

116

1021

1.14

0.68

1.3

1.2

347.12

351.50

nmol/l

0.09

840

Periodontitis

366

2627

0.93

0.68

1.2

1.1

377.40

365.60

nmol/l

0.52

282

2246

Other benign neoplasms of connective and other soft tissue

284

1.27

0.68

1.1

362.53

372.34

nmol/l

0.11

255

Pregnancy with abortive outcome

244

1391

0.91

0.67

1.1

1.2

363.73

378.92

nmol/l

0.54

214

1205

Other symptoms and signs involving the urinary system

311

1.26

0.67

1.1

1.2

399.14

350.65

nmol/l

0.62

258

Urolithiasis

126

1116

1.13

0.67

1.2

338.71

351.41

nmol/l

0.30

915

Benign neoplasm of meninges

320

1.25

0.67

1.1

348.06

368.85

nmol/l

0.25

270

Foreign body on external eye

374

1.23

0.67

1.1

350.91

389.81

nmol/l

0.56

331

Hydrocele

338

1.24

0.67

1.2

290.69

340.31

nmol/l

0.77

257

Dialysis, with operation codes

363

0.77

0.67

1.2

316.27

363.40

nmol/l

0.58

307

Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, including Hilmo

205

1.32

0.67

1.2

336.20

343.99

nmol/l

0.06

166

Perichondritis of external ear

1.63

0.67

1.1

1.2

350.00

374.74

nmol/l

—

Injury of unspecified body region

205

1.32

0.67

1.1

361.24

372.87

nmol/l

0.09

182

Certolizumab pegol

1.63

0.67

1.0

1.1

367.71

404.82

nmol/l

—

Other malignant neoplasms of skin (=non-melanoma skin cancer)

197

1225

1.10

0.66

1.2

303.06

340.06

nmol/l

1.70

161

994

Exposure to other specified factors

299

2540

1.08

0.66

1.2

1.1

364.35

376.48

nmol/l

0.51

263

2181

Corns and callosities

191

0.68

0.66

1.3

1.1

260.00

390.42

nmol/l

2.94

171

Necrosis of pulp, including avohilmo

217

1978

1.09

0.65

1.2

1.1

363.60

385.56

nmol/l

0.91

175

1757

Abnormal findings on diagnostic imaging of central nervous system

128

1.41

0.65

1.1

1.2

385.00

395.51

nmol/l

0.09

114

Umbilical hernia

847

1.15

0.65

1.2

373.69

369.88

nmol/l

0.07

714

Acute peritonitis

180

1.34

0.65

1.3

1.2

333.79

372.14

nmol/l

0.49

152

Squamous cell neoplasms and carcinomas of the skin

331

1.24

0.64

1.1

1.3

281.43

314.98

nmol/l

0.44

252

Basal cell carcinoma

190

1194

1.10

0.64

1.2

307.69

337.83

nmol/l

1.23

157

965

Diabetic retinopathy

159

891

1.11

0.64

1.2

336.54

346.74

nmol/l

0.22

112

648

DVT of lower extremities and pulmonary embolism

178

1608

1.10

0.63

1.2

316.10

345.42

nmol/l

0.79

136

1293

Carcinoma in situ of skin

287

1.26

0.63

1.2

352.52

327.96

nmol/l

0.24

230

Allergic rhinitis

103

895

1.14

0.63

1.2

1.1

379.79

398.46

nmol/l

0.41

825

Alzheimer’s disease (Atypical or mixed)

429

1.21

0.63

1.1

1.3

280.81

308.84

nmol/l

0.37

319

Pre-existing hypertension complicating pregnancy, childbirth and the puerperium

225

1.29

0.63

1.1

399.14

414.30

nmol/l

0.19

215

Sequelae of injuries of neck and trunk

1.55

0.62

1.3

1.1

347.73

400.03

nmol/l

0.31

Ingrowing nail

130

1.39

0.61

1.2

1.1

424.77

402.41

nmol/l

0.14

120

Other disorders of penis

226

1.28

0.61

1.2

280.95

353.42

nmol/l

1.03

182

Pneumonitis due to solids and liquids

280

1.25

0.60

1.4

1.2

342.34

327.81

nmol/l

0.16

227

Degenerative myopia

0.00

0.60

0.0

1.1

—

341.37

—

Valvular operations

453

1.19

0.60

1.3

1.2

344.83

334.02

nmol/l

0.16

363

Alcohol abuse, main dg, excluding more controls

380

1.21

0.60

1.2

1.1

373.85

389.65

nmol/l

0.22

341

Examination and encounter for administrative purposes

105

1.43

0.60

1.1

326.30

384.63

nmol/l

—

Other disorders of the genitourinary system

426

1.20

0.60

1.3

1.2

319.02

351.66

nmol/l

0.69

361

Carcinoma in situ of skin of other and unspecified parts of face

311

0.77

0.59

1.1

1.2

389.36

301.73

nmol/l

0.88

243

Gender identity disorders

0.00

0.59

0.0

1.1

—

439.50

—

Appendicitis, broad definition

295

2483

1.07

0.59

1.2

1.1

373.03

379.09

nmol/l

0.20

254

2142

Other diseases of the respiratory system

742

1.15

0.59

1.2

330.80

330.66

nmol/l

0.00

581

Other respiratory disorders and diseases

742

1.15

0.59

1.2

330.80

330.66

nmol/l

0.00

581

Acute bronchitis

170

1516

1.10

0.59

1.2

364.34

352.47

nmol/l

0.29

131

1240

Alcohol use disorder, ICD-based

151

1366

1.11

0.59

1.2

337.82

373.27

nmol/l

1.40

118

1165

Contusion of toe(s) without damage to nail

1.57

0.58

1.1

350.50

433.75

nmol/l

—

Other arthritis (FG)

117

1044

1.12

0.58

1.2

1.1

341.75

370.30

nmol/l

0.81

871

Dislocation, sprain and strain of joints and ligaments of knee

221

1876

1.09

0.58

1.1

386.61

388.09

nmol/l

0.04

197

1671

Other disorders of veins

162

1464

1.10

0.58

1.2

343.79

365.56

nmol/l

0.68

128

1236

Other specified/unspecified necrotizing vasculopathies

1.72

0.58

1.0

1.2

279.33

369.30

nmol/l

—

Burns and corrosions

382

1.21

0.57

1.2

1.1

364.55

381.41

nmol/l

0.24

345

Tularaemia

1.49

0.57

1.4

1.2

413.75

390.11

nmol/l

—

Malignant neoplasm of oral cavity, including Hilmo

115

1.39

0.56

1.3

1.2

303.20

374.82

nmol/l

0.55

102

Viral and other specified intestinal infections

589

0.84

0.56

1.0

1.1

376.03

381.69

nmol/l

0.06

532

Other disorders starting during childhood or adolecense, excluding more controls

1.55

0.56

1.2

1.1

464.20

418.32

nmol/l

—

Glaucoma suspect

145

1315

1.10

0.55

1.2

348.41

341.13

nmol/l

0.17

123

1050

Retinal vascular occlusion

421

1.19

0.55

1.2

326.26

330.07

nmol/l

0.05

330

Other pleural conditions

339

1.21

0.54

1.0

1.2

335.68

332.21

nmol/l

0.03

266

Hypersomnia

1.59

0.54

1.0

1.2

551.00

395.61

nmol/l

—

218

1821

1.08

0.54

1.2

360.35

366.43

nmol/l

0.16

168

1555

Disorders of muscles

285

1.23

0.54

1.2

1.1

280.87

370.82

nmol/l

1.97

249

Retinal breaks without detachment

487

1.17

0.54

1.3

1.1

384.30

359.22

nmol/l

0.42

412

Complications of labour and delivery

200

1208

0.92

0.53

1.1

404.44

390.81

nmol/l

0.43

187

1087

COPD, early/later onset

158

1458

0.91

0.53

1.2

322.11

331.39

nmol/l

0.22

117

1165

Acute appendicitis

274

2390

1.07

0.53

1.2

1.1

374.94

380.63

nmol/l

0.18

235

2074

Non-small cell lung cancer, adenocarcinoma

193

0.72

0.53

1.2

261.67

333.10

nmol/l

—

159

Injuries to the wrist and hand

419

2743

1.06

0.53

1.2

1.1

368.65

372.39

nmol/l

0.13

353

2349

Abnormal findings in secretions and smears from cervix uteri vagina vulva

161

1331

0.91

0.53

1.1

397.66

397.78

nmol/l

0.00

151

1209

Other fall from one level to another

674

1.14

0.53

1.2

322.56

372.24

nmol/l

1.52

580

Other viral diseases

870

1.12

0.52

1.1

375.05

392.97

nmol/l

0.37

782

Alcohol use disorder, Swedish definition

206

1745

1.08

0.52

1.2

356.07

366.98

nmol/l

0.33

163

1484

Benign mammary dysplasia

470

1.17

0.52

1.2

1.1

332.40

351.91

nmol/l

0.26

404

Other and unspecified disorders of vitreous body

158

1424

1.09

0.52

1.2

408.44

348.72

nmol/l

2.87

138

1186

Viral infections characterized by skin and mucous membrane lesions

158

1443

1.09

0.52

1.2

342.66

367.76

nmol/l

0.92

133

1227

Open wound of lower leg

498

1.17

0.52

1.2

1.1

328.01

365.83

nmol/l

0.65

424

Urethritis and urethral syndrome

1.41

0.51

1.4

1.1

368.44

394.76

nmol/l

—

Injuries to unspecified part of trunk, limb or body region

296

1.22

0.51

1.1

359.76

368.51

nmol/l

0.08

258

Cardiodefibrillation

140

1271

1.10

0.51

1.2

318.78

334.68

nmol/l

0.41

106

998

Alcohol withdrawal state with delirium

179

1.29

0.51

1.0

1.2

343.71

361.94

nmol/l

0.12

158

Other and unspecified injuries of lower leg

197

1.27

0.51

1.1

360.10

397.86

nmol/l

0.39

181

Corneal ulcer

574

1.15

0.50

1.3

1.1

385.33

375.80

nmol/l

0.14

503

Malignant neoplasm of oesophagus

1.39

0.50

1.1

1.2

316.33

357.68

nmol/l

—

Stenosis and insufficiency of lacrimal passages

306

1.21

0.50

1.1

1.2

368.54

354.92

nmol/l

0.17

263

Peroneal tendinitis

1.47

0.50

1.0

1.1

392.67

426.61

nmol/l

—

Certain disorders involving the immune mechanism

584

1.15

0.50

1.2

365.53

369.44

nmol/l

0.06

506

Distal bite

1.38

0.50

1.1

448.89

418.12

nmol/l

—

Viral pneumonia (unknown virus, not influenza)

171

1.29

0.49

1.0

1.1

369.75

392.77

nmol/l

0.20

153

Other and unspecified rosacea

252

1.23

0.49

1.3

1.1

329.79

388.58

nmol/l

1.27

228

Open wound of wrist and hand

155

1388

1.09

0.49

1.2

1.1

361.26

378.50

nmol/l

0.50

136

1199

Retinal vascular disorders

436

1.17

0.49

1.2

326.26

330.39

nmol/l

0.05

338

Malignant neoplasm of bladder

234

1.24

0.49

1.2

1.3

295.50

317.72

nmol/l

0.22

177

Other and unspecified visual disturbances

298

1.21

0.49

1.1

379.45

373.46

nmol/l

0.06

260

Congenital malformations, deformations and chromosomal abnormalities

240

2063

1.07

0.49

1.1

396.39

382.51

nmol/l

0.50

212

1814

Periapical abscess

162

1489

1.09

0.49

1.2

1.1

342.73

377.40

nmol/l

1.43

129

1294

Use of antiglaucoma preparations and miotics

280

1.22

0.48

1.3

1.2

414.78

319.25

nmol/l

1.98

220

Acute and transient psychotic disorders

323

0.80

0.48

1.2

1.1

318.75

386.76

nmol/l

1.14

296

Complications predominantly related to the puerperium

765

1.13

0.48

1.1

384.47

405.68

nmol/l

0.43

713

Diseases of peritoneum

326

1.20

0.48

1.2

340.12

360.51

nmol/l

0.29

280

Dislocation, sprain and strain of joints and ligaments of shoulder girdle

106

956

1.11

0.47

1.2

1.1

342.54

364.90

nmol/l

0.55

803

Other chronic obstructive pulmonary disease, including avohilmo

190

1693

0.93

0.47

1.2

337.92

337.98

nmol/l

0.00

141

1367

Pulmonary heart disease, diseases of pulmonary circulation

132

1204

1.10

0.47

1.3

1.2

333.67

337.97

nmol/l

0.06

101

962

Diseases of appendix

295

2502

1.06

0.47

1.2

1.1

373.03

378.65

nmol/l

0.18

254

2157

Subarachnoid haemorrhage

365

0.82

0.47

1.4

1.2

343.79

345.22

nmol/l

0.01

299

Later onset COPD, excluding more controls

599

1.12

0.46

1.2

290.58

319.78

nmol/l

0.63

465

Adenocarcinoma, papilloma adenocarcinoma and mucinous carcinomas of rectum

320

0.81

0.45

1.3

1.2

363.87

346.13

nmol/l

0.16

258

Seborrhoeic keratosis

781

0.88

0.45

1.2

370.18

335.91

nmol/l

0.65

629

Non-small cell lung cancer, adenocarcinoma, helper endpoint

187

0.75

0.45

1.2

261.67

341.65

nmol/l

—

151

Suppurative and necrotic conditions of lower respiratory tract

164

0.73

0.45

1.1

1.2

336.17

358.05

nmol/l

0.14

138

Abnormalities of gait and mobility

403

1.17

0.45

1.2

345.00

345.39

nmol/l

0.00

325

Superficial injury of ankle and foot

329

1.19

0.45

1.3

1.1

379.68

392.46

nmol/l

0.14

301

Other disorders of pigmentation

112

1.34

0.44

1.2

1.1

277.56

393.12

nmol/l

—

Malignant neoplasm of kidney, except renal pelvis, including Hilmo

348

1.18

0.44

1.2

318.72

334.47

nmol/l

0.20

275

Congenital malformations, deformations and chromosomal abnormalities

212

1885

1.07

0.44

1.1

396.30

383.27

nmol/l

0.42

187

1662

Injuries to the ankle and foot

266

2225

1.06

0.43

1.2

1.1

363.28

384.85

nmol/l

0.92

223

1954

Bronchitis

469

2820

1.05

0.43

1.2

355.04

370.28

nmol/l

0.86

388

2399

Mental and behavioural disorders due to alcohol, excluding acute intoxication

161

1482

1.08

0.43

1.2

346.43

372.86

nmol/l

0.91

125

1262

Glomerulonephritis

284

1.20

0.43

1.1

1.2

386.23

367.57

nmol/l

0.24

252

Acute upper respiratory infections of multiple and unspecified sites

284

2230

0.94

0.43

1.2

360.88

374.78

nmol/l

0.57

243

1914

Endometriosis diagnosis and infertility diagnosis occurring together

312

1.19

0.43

1.1

417.76

413.72

nmol/l

0.05

295

Benign neoplasm: salivary glands, exclude unknown (D119)

257

1.21

0.43

1.2

370.96

384.03

nmol/l

0.13

224

Sequelae of injuries of upper limb

257

1.21

0.43

1.2

1.1

378.38

391.07

nmol/l

0.10

232

Pregnancy, childbirth and the puerperium

112

643

0.91

0.42

1.2

345.82

361.29

nmol/l

0.34

535

Benign neoplasm of other and unspecified sites

0.65

0.42

1.0

1.2

354.67

381.56

nmol/l

—

Dilated cardiomyopathy

360

0.83

0.42

1.2

355.84

342.57

nmol/l

0.11

289

Maternal care related to the fetus and amniotic cavity and possible delivery problems

143

911

0.92

0.42

1.1

404.92

413.05

nmol/l

0.21

137

848

Other and unspecified tonsillitis

109

834

1.10

0.42

1.1

413.67

415.92

nmol/l

0.04

777

Benign neoplasm of ovary

574

0.87

0.42

1.3

1.1

328.95

357.90

nmol/l

0.52

494

Inflammatory disorders of breast

184

0.76

0.41

1.1

381.36

402.49

nmol/l

0.16

171

Malignant neoplasm of rectum, including Hilmo

424

0.85

0.41

1.3

1.2

352.38

345.03

nmol/l

0.06

337

Other malignant neoplasms of skin (=non-melanoma skin cancer), including Hilmo

203

1286

1.07

0.41

1.2

299.76

344.46

nmol/l

2.52

166

1048

Nontoxic goitre/thyroid nodule

116

1061

1.09

0.41

1.2

337.32

355.48

nmol/l

0.42

891

Other disorders of the musculoskeletal system and connective tissue

491

1.14

0.41

1.3

1.2

347.60

354.48

nmol/l

0.09

418

Peritonsillar abscess

557

1.13

0.41

1.1

372.09

384.60

nmol/l

0.17

502

COPD, hospital admissions 1, only main diagnosis

122

1137

0.92

0.40

1.2

328.30

328.75

nmol/l

0.01

894

Ascites

204

1.23

0.40

1.0

1.1

310.50

363.65

nmol/l

0.80

177

Presbyopia

186

1.24

0.40

1.0

1.1

414.06

389.38

nmol/l

0.21

173

Impacted cerumen

324

1.17

0.40

1.1

1.2

319.81

343.63

nmol/l

0.29

265

Tuberculosis, IBD comorbidity

238

0.80

0.40

1.1

1.3

366.64

339.78

nmol/l

0.19

190

Squamous cell neoplasms and carcinomas of the skin, including Hilmo

491

1.14

0.40

1.1

1.2

316.45

318.13

nmol/l

0.02

374

Thoracic aortic aneurysm

408

1.15

0.40

1.2

354.11

340.83

nmol/l

0.18

330

Idiopathic gout

278

1.19

0.40

1.3

1.2

371.63

324.09

nmol/l

0.66

218

Other disorders of cornea

278

1.19

0.39

1.2

1.1

323.52

374.42

nmol/l

1.00

242

Diseases of middle ear and mastoid

209

1603

1.07

0.39

1.1

367.26

381.52

nmol/l

0.50

170

1408

Lung cancer and mesothelioma

580

0.89

0.39

1.2

304.00

332.45

nmol/l

0.55

465

Major anomalies of jaw size

1.31

0.39

1.0

1.1

479.63

398.36

nmol/l

—

Other diseases of pleura

187

1532

1.07

0.39

1.3

1.2

316.17

334.96

nmol/l

0.62

151

1213

Shoulder region

1.43

0.39

1.2

428.02

392.57

nmol/l

—

Idiopathic pulmonary fibrosis

260

1.19

0.39

1.1

1.2

278.54

333.10

nmol/l

0.77

202

Impacted teeth

430

1.14

0.39

1.2

1.1

365.84

413.18

nmol/l

1.05

414

COPD, hospital admissions

159

1444

0.93

0.39

1.3

1.2

321.43

332.11

nmol/l

0.26

117

1152

Dermatographic urticaria

187

1.23

0.39

1.1

367.00

402.59

nmol/l

0.34

174

Other congenital malformations of the digestive system

1.36

0.38

1.1

339.33

394.72

nmol/l

0.37

Foreign body in respiratory tract

133

1.28

0.38

1.2

1.1

417.27

395.29

nmol/l

0.11

119

Malignant neoplasm of prostate, including Hilmo

113

615

1.09

0.38

1.2

349.00

331.12

nmol/l

0.41

494

Respiratory insufficiency

279

1.18

0.37

1.3

1.2

282.68

339.17

nmol/l

0.99

217

Procedures for purposes other than remedying health state

1.31

0.37

1.0

1.2

400.56

424.00

nmol/l

—

Problems related to lifestyle

271

1.18

0.37

1.2

1.1

332.09

393.96

nmol/l

0.99

252

Pregnancy examination and test

314

0.87

0.37

1.1

431.05

421.69

nmol/l

0.14

297

Adenocarcinoma and papilloma adenocarcinoma of rectum

311

0.83

0.37

1.3

1.2

363.87

347.01

nmol/l

0.15

249

Embedded teeth, including avohilmo

216

1.20

0.36

1.0

1.1

382.27

412.81

nmol/l

0.39

204

Colorectal adenocarcinoma

732

1.10

0.36

1.2

328.90

332.24

nmol/l

0.05

577

Early onset COPD

693

0.89

0.36

1.2

369.78

364.67

nmol/l

0.07

576

Femoral hernia, unilateral

1.27

0.36

1.1

1.2

414.00

360.22

nmol/l

—

Inguinal of femoral hernia, unilateral

1.27

0.36

1.1

1.2

414.00

360.22

nmol/l

—

Inguinal hernia, unilateral

1.27

0.36

1.1

1.2

414.00

360.22

nmol/l

—

Acute appendicitis, with complications

649

1.11

0.36

1.2

400.35

360.59

nmol/l

0.81

552

Other diseases of hard tissues of teeth

283

1389

1.05

0.36

1.3

1.1

351.13

355.95

nmol/l

0.15

244

1161

Focal epilepsy, strict definition

649

1.11

0.36

1.1

1.2

314.35

357.24

nmol/l

1.19

539

0.66

0.36

1.2

345.40

349.47

nmol/l

—

Acute sinusitis

196

1707

1.06

0.36

1.1

381.02

382.41

nmol/l

0.03

169

1499

Maternal care for known or suspected malpresentation of fetus

418

0.88

0.35

1.1

390.78

424.38

nmol/l

0.63

402

Bicipital tendinitis

126

0.71

0.35

1.0

1.2

324.33

385.90

nmol/l

—

108

Atopic dermatitis, strict definition with reimbursement

841

1.09

0.34

1.2

1.1

390.22

412.48

nmol/l

0.49

783

Benign neoplasm: Choroid

163

1.23

0.34

1.3

1.2

384.75

377.80

nmol/l

0.07

142

COPD (mode)

118

858

1.08

0.34

1.2

1.1

323.36

345.00

nmol/l

0.51

704

Memory loss

265

1.17

0.33

1.2

370.80

350.85

nmol/l

0.19

211

Perforation of tympanic membrane

293

1.16

0.33

1.4

1.1

360.44

383.35

nmol/l

0.22

258

Diseases of pulp and periapical tissues and dental caries

336

1645

1.05

0.33

1.2

349.81

358.08

nmol/l

0.30

273

1372

L04AA Selective immunosuppressants

672

1.10

0.33

1.1

345.77

379.32

nmol/l

0.74

593

Schizophrenia or delusion, excluding more controls

826

0.91

0.33

1.1

347.67

383.94

nmol/l

0.82

733

Viral and other specified intestinal infections

835

0.91

0.33

1.0

1.1

383.83

383.77

nmol/l

0.00

753

Other condition

425

1.13

0.33

1.2

1.1

331.39

376.18

nmol/l

0.75

380

Insulin, fast-acting (human)

435

0.87

0.33

1.1

368.73

382.67

nmol/l

0.15

395

Disorders of vitreous body

189

1722

1.06

0.33

1.2

401.64

351.95

nmol/l

2.41

160

1414

Dermatophytosis

397

1.13

0.32

1.2

365.35

356.72

nmol/l

0.09

334

Acute upper respiratory infections

457

2711

1.04

0.32

1.2

370.61

366.92

nmol/l

0.14

391

2287

Nasal polyp

587

1.11

0.32

1.0

1.2

321.10

349.80

nmol/l

0.62

490

Acute appendicitis, no complications

202

1902

1.06

0.32

1.2

1.1

366.23

385.03

nmol/l

0.70

175

1670

Intentional self-poisoning by and exposure to other and unspecified chemicals and noxious substances

454

1.12

0.32

1.2

1.1

341.07

405.97

nmol/l

1.62

422

Pruritus

360

1.14

0.32

1.2

1.1

357.59

382.01

nmol/l

0.32

322

Puerperal sepsis

360

1.14

0.32

1.1

358.87

385.83

nmol/l

0.28

330

Mental and behavioural disorders due to sedatives or hypnotics

165

0.79

0.32

1.2

1.1

363.88

395.30

nmol/l

—

155

Premature rupture of membranes

484

0.90

0.31

1.1

363.34

416.45

nmol/l

1.48

464

Disorders of vitreous body and globe

196

1781

1.06

0.31

1.2

401.04

351.29

nmol/l

2.51

165

1463

Type1 diabetes, definitions combined, early onset

131

0.76

0.31

1.0

1.1

370.50

420.02

nmol/l

—

126

Diabetic maculopathy

429

1.12

0.31

1.2

350.19

344.84

nmol/l

0.06

312

Schizoaffective disorder

197

0.81

0.31

1.0

1.1

270.33

396.84

nmol/l

—

187

COPD related to multimorbidity

143

1286

0.94

0.30

1.3

1.2

312.29

325.62

nmol/l

0.33

104

1013

Disorders of lacrimal system and orbit in diseases classified elsewhere

1.30

0.30

1.0

1.1

374.86

380.83

nmol/l

—

Use of rivastigmine

637

1.10

0.30

1.2

1.3

379.88

307.98

nmol/l

1.52

472

Benign neoplasm: Parotid gland

231

1.17

0.29

1.2

382.86

381.41

nmol/l

0.01

201

Other and unspecified myopathies

278

1.15

0.29

1.2

359.90

343.13

nmol/l

0.18

230

Graves ophthalmopathy, strict

1.25

0.29

1.0

1.1

374.86

398.31

nmol/l

—

Pulmonary embolism

116

1083

1.07

0.29

1.2

340.85

340.09

nmol/l

0.01

861

Toxic effects of substances chiefly nonmedicinal as to source

316

1.14

0.29

1.1

379.61

389.56

nmol/l

0.12

289

Poisoning by drugs, medicaments and biological substances

698

1.09

0.28

1.2

1.1

327.29

398.12

nmol/l

2.55

638

Nonalcoholic fatty liver disease

260

1.15

0.28

1.1

379.04

384.72

nmol/l

0.05

236

Malignant neoplasm of kidney, except renal pelvis

279

1.15

0.28

1.1

1.2

336.53

323.47

nmol/l

0.13

222

Failed induction of labour

167

1.20

0.28

1.3

1.1

407.80

412.96

nmol/l

0.05

161

Poisoning by medicine

622

1.09

0.28

1.2

1.1

323.59

397.57

nmol/l

2.46

569

Oedema, proteinuria and hypertensive disorders in pregnancy, childbirth and the puerperium

161

1323

1.06

0.28

1.2

1.1

387.07

399.90

nmol/l

0.35

141

1216

Hepatocellular carcinoma, including Hilmo

1.30

0.28

1.2

273.33

335.81

nmol/l

—

Disorders of eyelid in diseases classified elsewhere

1.30

0.28

1.5

1.1

279.82

385.14

nmol/l

1.00

Non-follicular lymphoma

289

1.14

0.28

1.1

1.2

326.61

345.71

nmol/l

0.18

238

Other otitis externa (chronic)

186

1.18

0.28

1.0

1.1

427.80

390.67

nmol/l

0.27

166

Labour and delivery complicated by umbilical cord complications

149

1.21

0.27

1.1

351.01

379.79

nmol/l

0.28

141

Non-Hodgkin lymphoma, all, including Hilmo

441

1.11

0.27

1.1

1.2

340.95

342.40

nmol/l

0.01

357

Substance abuse

212

1899

1.05

0.27

1.2

349.06

371.26

nmol/l

0.89

167

1629

Malignant neoplasm of eye, brain and central nervous system

119

0.76

0.27

1.2

260.00

379.72

nmol/l

—

107

Pulmonary heart disease

116

1087

1.07

0.27

1.2

340.85

339.61

nmol/l

0.01

867

Other benign neoplasms of skin

146

1380

1.06

0.26

1.2

360.44

349.45

nmol/l

0.25

123

1135

Hodgkin lymphoma, hilmo

1.20

0.26

1.4

1.1

370.88

404.36

nmol/l

—

Malignant neoplasm of liver and intrahepatic bile ducts

1.28

0.26

1.1

1.2

330.33

338.88

nmol/l

—

Hydrocephalus

246

0.85

0.26

1.3

1.2

347.00

350.15

nmol/l

0.02

202

Tobacco use

132

1.21

0.25

1.2

1.1

263.38

378.69

nmol/l

—

120

Other maternal disorders predominantly related to pregnancy

190

1250

0.95

0.25

1.1

406.90

399.97

nmol/l

0.19

174

1152

Diabetic nephropathy

618

1.09

0.25

1.3

1.2

328.85

335.90

nmol/l

0.10

441

Rubella [German measles]

1.22

0.25

1.1

1.2

454.33

413.40

nmol/l

—

Pregnancy hypertension

144

1221

1.06

0.25

1.2

1.1

391.38

399.76

nmol/l

0.20

131

1123

Benign neoplasm of other and unspecified female genital organs

114

1.23

0.25

1.5

1.1

429.36

394.62

nmol/l

0.22

104

Other hearing loss

110

1011

1.06

0.25

1.3

1.2

290.28

336.75

nmol/l

2.05

789

Malignant neoplasm of rectum

319

0.88

0.25

1.3

1.2

340.69

346.38

nmol/l

0.05

256

Superficial injury of abdomen, lower back and pelvis

502

1.10

0.25

1.2

1.1

358.13

369.60

nmol/l

0.15

441

Other and unspecified urticaria

608

1.09

0.24

1.1

388.56

382.56

nmol/l

0.09

547

Erosion of teeth , including avohilmo

725

1.08

0.24

1.1

422.35

388.15

nmol/l

0.71

645

Focal epilepsy

715

1.08

0.24

1.1

1.2

320.04

361.64

nmol/l

1.15

598

Artificial joint re-operation

208

1.16

0.24

1.3

1.2

296.50

350.63

nmol/l

0.83

174

Malignant neoplasm of pancreas

227

1.15

0.23

1.2

468.86

342.88

nmol/l

1.51

188

Delivery, wide proxy

121

681

0.94

0.23

1.2

367.81

373.84

nmol/l

0.12

108

574

Other and unspecified vascular occlusions

322

1.12

0.23

1.1

1.2

326.67

328.95

nmol/l

0.02

257

Tuberculosis, wide

254

0.87

0.23

1.0

1.3

391.60

337.37

nmol/l

0.44

204

Erectile dysfunction

243

0.86

0.23

1.0

1.3

314.60

320.35

nmol/l

0.04

179

Acute poliomyelitis

1.28

0.23

1.4

1.2

185.60

373.09

nmol/l

—

Cystic kidney disease

0.76

0.22

1.0

1.2

405.71

381.42

nmol/l

—

Vasomotor rhinitis (mode)

200

1.15

0.22

1.2

1.1

367.39

379.64

nmol/l

0.10

179

Other keratitis

314

1.12

0.22

1.2

1.1

431.83

386.19

nmol/l

0.60

283

223

1888

1.04

0.22

1.2

363.80

366.61

nmol/l

0.07

173

1616

Mental and behavioural disorders due to psychoactive substance use

218

1942

1.04

0.22

1.2

1.1

350.71

371.95

nmol/l

0.82

169

1666

Rosacea

343

1.11

0.22

1.2

1.1

320.57

384.09

nmol/l

1.40

307

Toxic effect of contact with venomous animals

107

1.22

0.21

1.0

1.2

400.00

402.11

nmol/l

0.02

Ulcerative colitis (strict) with PSC

0.00

0.21

0.0

1.3

—

441.36

—

Tracheo-bronchomalasia

0.00

0.21

0.0

1.1

—

409.58

—

Cleft lip and cleft lip and palate

0.00

0.21

0.0

1.2

—

476.67

—

Herpesviral [herpes simplex] infections

363

1.10

0.21

1.1

376.42

383.22

nmol/l

0.07

324

Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder

154

1.17

0.21

1.2

376.73

359.51

nmol/l

0.09

124

Acute epiglottitis

1.16

0.21

1.0

1.2

319.40

371.22

nmol/l

—

Other chronic obstructive pulmonary disease

157

1353

0.96

0.21

1.2

323.19

331.99

nmol/l

0.21

116

1081

Retinal detachment with retinal break

429

0.91

0.21

1.2

380.00

349.39

nmol/l

0.36

353

Cardiomyopathy

543

0.92

0.20

1.2

1.1

367.05

347.46

nmol/l

0.24

439

Diagnoses used for exclusion with ILD

896

1.06

0.20

1.3

1.2

351.97

347.04

nmol/l

0.09

728

Atopic dermatitis, strict definition

811

1.06

0.20

1.2

1.1

395.69

405.96

nmol/l

0.18

754

Vitreous haemorrhage

316

1.11

0.20

1.2

1.1

458.59

358.58

nmol/l

1.63

263

Abnormal serum enzyme levels

106

978

1.06

0.20

1.2

386.17

338.25

nmol/l

1.27

796

Acute alcohol intoxication

821

0.94

0.20

1.2

331.89

366.86

nmol/l

0.74

694

Benign lipomatous neoplasm of skin and subcutaneous tissue of other and unspecified sites

0.00

0.20

0.0

1.2

—

422.21

—

Abnormal findings on examination of other body fluids, substances and tissues, without diagnosis

225

1717

1.04

0.20

1.1

375.10

383.95

nmol/l

0.28

199

1513

Diseases of pulp and periapical tissues, including avohilmo

453

2407

0.97

0.20

1.2

1.1

364.85

371.45

nmol/l

0.27

369

2058

Pyothorax

112

0.80

0.20

1.1

1.2

388.89

361.29

nmol/l

—

Chronic suppurative otitis media, including avohilmo

208

0.86

0.20

1.1

377.54

373.77

nmol/l

0.02

183

Chronic tubulo-interstitial nephritis

114

0.79

0.20

1.1

262.33

366.08

nmol/l

—

100

Ménière disease

307

1.11

0.20

1.1

323.16

365.99

nmol/l

0.51

257

Contraceptive management

137

916

1.05

0.20

1.1

445.33

409.96

nmol/l

1.40

130

839

Benign neoplasm of major salivary glands

298

1.11

0.19

1.2

373.76

367.18

nmol/l

0.07

257

Other specified/unspecified deforming dorsopathies

1.16

0.19

1.3

1.1

427.17

467.57

nmol/l

—

Keratoconus

1.15

0.19

1.2

1.1

324.00

411.13

nmol/l

—

Disorders of optic nerve, not elsewhere classified

1.13

0.18

1.3

1.2

488.83

385.49

nmol/l

—

Suppurative and unspecified otitis media

105

979

0.95

0.18

1.0

1.1

368.33

398.18

nmol/l

0.82

886

Gestational [pregnancy-induced] hypertension

773

1.06

0.18

1.1

421.84

407.37

nmol/l

0.28

720

Other and unspecified disorders involving the immune mechanism, not elsewhere classified

1.17

0.18

1.1

391.71

403.08

nmol/l

—

Dental caries, including avohilmo

343

1802

0.97

0.17

1.2

344.55

361.86

nmol/l

0.85

279

1505

Sarcoidosis

406

1.08

0.17

1.2

1.1

360.50

372.91

nmol/l

0.17

357

Other inflammation of eyelid

424

0.92

0.17

1.3

1.1

379.91

363.92

nmol/l

0.20

357

Graves ophthalmopathy

1.13

0.17

1.0

1.1

374.86

393.95

nmol/l

—

L02BX Other hormone antagonists and related agents

163

0.86

0.17

1.1

1.2

475.11

315.73

nmol/l

—

122

Macular pucker

496

0.93

0.17

1.3

1.2

326.51

334.34

nmol/l

0.09

388

Other viral diseases, not elsewhere classified

541

1.07

0.17

1.2

1.1

369.17

386.12

nmol/l

0.23

489

Carcinoma in situ of skin of lower limb, including hip

0.73

0.17

2.0

1.1

401.40

353.77

nmol/l

—

Polycystic kidney disease

0.72

0.17

1.0

1.1

434.20

401.88

nmol/l

—

Focal epilepsy, mode (most common among epilepsy diagnosis)

611

1.06

0.16

1.1

1.2

312.04

358.33

nmol/l

1.18

513

Malignant neoplasm of corpus uteri, including Hilmo

340

0.91

0.16

1.0

1.2

342.04

348.62

nmol/l

0.07

269

Long labour

623

1.06

0.16

1.0

1.1

429.42

401.68

nmol/l

0.55

590

Superficial injury of forearm

263

1.10

0.16

1.1

385.30

403.87

nmol/l

0.17

243

Special screening examination for neoplasms

139

1.15

0.16

1.1

422.10

398.35

nmol/l

—

120

Exposure to other and unspecified animate mechanical forces

1.13

0.16

1.0

1.1

335.50

412.83

nmol/l

—

Other specified cerebrovascular diseases, other cerebrovascular disorders in diseases classified elsewhere

224

0.89

0.15

1.5

1.2

329.73

322.64

nmol/l

0.05

175

Follicular lymphoma, hilmo

111

1.17

0.15

1.1

1.2

339.38

355.38

nmol/l

—

Gonococcal infection

0.76

0.15

1.5

1.1

432.50

410.10

nmol/l

—

Disorders of continuity of bone

264

1.10

0.15

1.3

1.1

348.45

383.65

nmol/l

0.40

240

Acute alcohol intoxication, ICD10

596

0.94

0.15

1.2

1.1

356.53

379.63

nmol/l

0.30

516

Systemic lupus erythematosus, unspecified

1.16

0.15

1.4

1.2

374.08

400.85

nmol/l

—

Fracture of foot, except ankle

759

0.95

0.15

1.3

1.1

362.32

379.60

nmol/l

0.31

672

Preterm labour and delivery

789

0.95

0.15

1.1

402.62

396.48

nmol/l

0.10

728

Intracerebral haemorrhage

449

1.07

0.14

1.1

1.2

352.33

328.21

nmol/l

0.33

350

Burn and corrosion of wrist and hand

0.79

0.14

1.6

1.1

377.00

405.58

nmol/l

—

Congenital deformities of feet

0.79

0.14

1.1

391.29

410.75

nmol/l

—

COPD-related respiratory insufficiency

401

1.07

0.14

1.3

1.2

283.62

325.69

nmol/l

0.60

314

Recurrent dislocation of patella

139

0.86

0.14

1.2

1.1

421.33

407.74

nmol/l

0.08

133

Gestational diabetes (for exclusion)

119

796

1.04

0.14

1.1

424.14

412.44

nmol/l

0.27

106

763

Pleural plaque

324

1.08

0.14

1.4

1.3

277.07

316.37

nmol/l

0.80

235

Malignant neoplasm of brain

0.83

0.13

1.0

1.2

280.00

401.98

nmol/l

—

Nail disorders

218

1.10

0.13

1.2

1.1

481.61

389.30

nmol/l

0.92

198

L02BG Aromatase inhibitors

1029

0.96

0.13

1.1

1.2

342.25

365.24

nmol/l

0.59

867

Dental pulpitis, including avohilmo

331

2193

0.98

0.13

1.1

376.68

387.37

nmol/l

0.44

271

1949

SLE, strict definition

1.17

0.13

1.4

1.2

330.43

403.57

nmol/l

0.67

SLE, ICD10

1.17

0.13

1.4

1.2

330.43

403.57

nmol/l

0.67

Injury of muscle and tendon at shoulder and upper arm level

113

1172

0.96

0.13

1.2

1.1

382.28

350.16

nmol/l

0.98

101

965

267

1.09

0.13

1.2

336.09

332.88

nmol/l

0.03

216

Diabetes mellitus in pregnancy

102

679

0.96

0.13

1.1

416.73

417.72

nmol/l

0.02

653

ILD, hospital admission 2, with pulmonary infections

314

0.92

0.12

1.1

1.2

269.00

340.59

nmol/l

1.28

254

COPD

165

1388

0.97

0.12

1.2

321.06

333.84

nmol/l

0.34

121

1114

Malignant neoplasm of urinary organs

326

1.07

0.12

1.2

339.29

330.10

nmol/l

0.09

257

Infective dermatitis

336

1.07

0.12

1.1

367.42

376.82

nmol/l

0.09

295

Ptosis of eyelid

354

0.93

0.12

1.3

1.2

352.60

351.85

nmol/l

0.01

289

Alcohol dependence

837

1.04

0.11

1.3

1.2

328.66

365.83

nmol/l

1.12

708

Other viral infections characterized by skin and mucous membrane lesions, not elsewhere classified

160

1.11

0.11

1.2

1.1

361.50

404.38

nmol/l

0.42

151

Acute suppurative otitis media

653

0.96

0.11

1.0

1.1

407.84

412.15

nmol/l

0.06

613

Hypertrophic scar

136

0.88

0.11

1.1

323.25

393.50

nmol/l

0.67

129

Other diseases of intestine

416

1.06

0.11

1.0

1.2

343.46

361.71

nmol/l

0.25

346

Sequelae with surgical and medical care as external cause

691

1.04

0.10

1.2

386.98

349.26

nmol/l

0.73

572

Abdominal aortic aneurysm (AAA)

349

0.94

0.10

1.2

1.3

279.40

315.80

nmol/l

0.49

256

Other disorders of eye and adnexa

427

1.05

0.10

1.3

1.1

383.13

374.87

nmol/l

0.09

382

Dermatophytosis

215

2192

0.98

0.10

1.2

1.1

360.24

369.15

nmol/l

0.27

196

1855

Inflammation of lacrimal passages (acute and unspecified)

1.14

0.10

1.6

1.2

765.40

364.08

nmol/l

—

Laparoscopic left hemicolectomy

1.11

0.10

1.0

1.2

430.20

401.22

nmol/l

—

Certain conditions originating in the perinatal period

129

0.89

0.09

1.1

441.15

397.19

nmol/l

0.36

121

Other disorders of optic [2nd] nerve and visual pathways

164

1.10

0.09

1.2

403.17

380.10

nmol/l

0.21

146

Malignant neoplasm of retroperitoneum and peritoneum, including Hilmo

1.06

0.09

1.2

179.80

389.95

nmol/l

—

Malignant neoplasm of other and ill-defined digestive organs, including Hilmo

1.06

0.09

1.0

1.2

306.80

401.05

nmol/l

—

SLE (Finngen)

1.15

0.09

1.4

1.1

351.07

401.16

nmol/l

—

Malignant cancer of tonsil and base of tongue

1.04

0.09

1.6

1.1

235.84

370.90

nmol/l

—

Intussusception

1.04

0.09

1.0

1.1

392.80

403.38

nmol/l

—

Poor fetal growth

350

0.94

0.09

1.1

407.33

419.45

nmol/l

0.16

338

Single spontaneous delivery

144

782

0.97

0.09

1.2

353.94

379.45

nmol/l

0.74

125

678

Benign neoplasm: Vulva

1.11

0.09

1.3

1.2

506.00

372.24

nmol/l

—

IgA nephropathy (IgA glomerulonephritis)

1.09

0.09

1.0

1.1

406.50

405.28

nmol/l

—

Intrahepatic Cholestasis of Pregnancy (ICP) , incl. ICD-8, excluding more controls

243

1.07

0.08

1.1

428.19

401.29

nmol/l

0.26

231

Follicular cysts of skin and subcutaneous tissue

573

0.96

0.08

1.3

1.2

351.57

365.62

nmol/l

0.18

493

Unspecified mental disorder

137

1338

1.02

0.08

1.1

364.28

380.44

nmol/l

0.39

101

1177

Other congenital malformations of circulatory system

0.82

0.08

1.0

1.1

477.00

405.51

nmol/l

—

Effects of other external causes

0.82

0.08

1.0

1.1

273.80

405.87

nmol/l

—

Bursitis of shoulder

0.79

0.08

1.0

1.2

387.40

405.54

nmol/l

—

Sequelae of infectious and parasitic diseases

224

1.07

0.08

1.1

1.2

312.73

365.10

nmol/l

0.46

198

ILD, hospital admissions 3, with pneumonia sepsis

277

0.94

0.08

1.1

1.2

278.14

335.38

nmol/l

0.84

216

Injury of muscle and tendon at lower leg level

440

0.95

0.08

1.1

396.61

372.51

nmol/l

0.38

381

Viral agents as the cause of diseases classified to other chapters

1.08

0.08

1.0

1.2

363.43

394.32

nmol/l

—

Secondary uncertain malignant neoplasm

450

1.04

0.08

1.1

1.2

362.91

337.71

nmol/l

0.39

364

Caries of dentine, including avohilmo

367

1899

0.99

0.07

1.2

339.36

364.72

nmol/l

1.61

297

1599

Gonococcal infection

0.80

0.07

1.5

1.1

432.50

404.99

nmol/l

—

Fracture of skull and facial bones

658

1.03

0.07

1.2

1.1

316.84

376.23

nmol/l

2.03

565

Dislocation, sprain and strain of joints and ligaments of lumbar spine and pelvis

1.07

0.07

1.0

1.1

356.63

400.03

nmol/l

—

Male infertility

1.07

0.07

1.4

1.1

412.13

408.71

nmol/l

—

Paralytic strabismus

194

0.93

0.07

1.2

370.77

374.86

nmol/l

0.03

167

Cluster headache, strict

0.82

0.07

1.0

1.1

486.14

403.47

nmol/l

—

Other juvenile arthritis

1.07

0.07

1.1

413.22

408.95

nmol/l

—

Caries of enamel

329

2344

1.01

0.07

1.1

400.07

378.51

nmol/l

1.17

294

2042

Zoster [herpes zoster]

188

1820

1.02

0.07

1.3

1.2

351.34

350.22

nmol/l

0.03

159

1481

Injury of eye and orbit

393

1.04

0.06

1.2

1.1

405.38

387.54

nmol/l

0.19

353

Mental and behavioural disorders due to alcohol

178

1682

1.02

0.06

1.2

357.59

370.38

nmol/l

0.35

136

1438

Cluster headache, wide

0.87

0.06

1.0

1.1

497.13

402.10

nmol/l

—

Lung diseases due to external agents

478

0.96

0.06

1.4

1.2

324.97

331.38

nmol/l

0.08

377

Medicines for HER+ breast cancer

131

1266

0.98

0.06

1.1

1.2

350.08

369.21

nmol/l

0.53

110

1078

Acute bronchiolitis

0.89

0.06

1.3

1.1

362.89

398.55

nmol/l

—

Juvenile arthritis (FINNGEN)

1.11

0.06

1.2

1.1

433.91

411.59

nmol/l

0.14

Benign neoplasm: Middle ear, nasal cavity and accessory sinuses

104

0.86

0.06

1.1

450.33

380.62

nmol/l

—

All dysplastic lesions of the cervix uteri, vagina or vulva

888

0.98

0.06

1.1

412.98

402.50

nmol/l

0.19

826

Excessive earwax

199

1970

0.99

0.06

1.2

343.80

351.15

nmol/l

0.21

183

1600

Other coagulation defects

207

1.06

0.06

1.2

1.1

377.50

389.85

nmol/l

0.10

188

Care involving dialysis

213

0.94

0.06

1.1

1.2

336.86

356.54

nmol/l

0.16

189

Alcohol abuse, main dg

444

1.04

0.06

1.2

1.1

373.85

376.45

nmol/l

0.03

394

Aortic aneurysm

784

0.98

0.05

1.2

333.55

324.78

nmol/l

0.15

625

Methotrexate

445

1.03

0.05

1.1

1.2

349.36

359.20

nmol/l

0.11

384

Suicide or other Intentional self-harm

723

1.02

0.05

1.2

1.1

352.24

390.79

nmol/l

0.93

657

Maltreatment syndromes

120

0.92

0.05

1.1

397.09

413.45

nmol/l

0.16

113

Cardiomyopathies, Primary/intrinsic

353

0.96

0.04

1.2

364.83

348.49

nmol/l

0.15

286

Other respiratory diseases principally affecting the interstitium

635

1.02

0.04

1.1

1.2

317.47

336.04

nmol/l

0.31

495

Ill-defined and unknown causes of mortality

302

0.96

0.04

1.3

1.2

278.89

322.41

nmol/l

0.49

239

Hypertrophic disorders of skin

150

0.93

0.04

1.1

351.57

399.11

nmol/l

0.41

140

Malignant neoplasm of oesophagus, including Hilmo

101

1.09

0.04

1.3

1.2

312.91

332.26

nmol/l

0.15

Maternal care for other conditions predominantly related to pregnancy

624

1.02

0.03

1.1

410.02

416.43

nmol/l

0.10

598

Kela-code for severe mental illness

118

1196

0.99

0.03

1.1

361.75

378.11

nmol/l

0.36

1046

In situ neoplasms

147

1487

0.99

0.03

1.2

369.52

349.07

nmol/l

0.55

117

1205

Other sexually transmitted chlamydial diseases

230

0.96

0.03

1.0

481.36

412.67

nmol/l

1.29

220

Cardiomyopathy (excluding other)

371

0.97

0.03

1.2

370.23

352.44

nmol/l

0.17

300

Burns and corrosions of external body surface, specified by site

290

1.03

0.03

1.3

1.1

363.36

383.04

nmol/l

0.21

264

Systemic lupus erythematosus

1.09

0.03

1.4

1.2

351.07

408.93

nmol/l

—

Intrahepatic Cholestasis of Pregnancy (ICP) , incl. ICD-8

251

1.04

0.02

1.1

428.19

400.08

nmol/l

0.28

239

Suggestive for eosinophilic asthma

269

0.97

0.02

1.0

1.1

395.37

366.38

nmol/l

0.39

234

False labour

600

0.99

0.02

1.1

389.29

421.78

nmol/l

0.95

573

Brain meningioma

158

0.95

0.02

1.1

1.2

322.20

385.99

nmol/l

—

139

Inguinal hernia, bilateral

311

1.03

0.02

1.2

370.11

334.84

nmol/l

0.49

240

Tuberculosis

212

1.04

0.02

1.1

1.3

396.92

330.26

nmol/l

0.49

169

Early onset COPD, excluding more controls

610

1.02

0.02

1.2

1.1

369.78

363.43

nmol/l

0.09

522

Haemorrhage in early pregnancy

847

0.99

0.02

1.1

390.94

397.69

nmol/l

0.11

784

Nontraumatic intracranial haemmorrhage

740

1.01

0.02

1.2

342.87

339.93

nmol/l

0.04

573

Superficial injury of shoulder and upper arm

348

0.98

0.01

1.2

1.1

398.59

360.67

nmol/l

0.48

305

Congenital malformations of heart and great arteries

308

0.98

0.01

1.1

387.92

385.66

nmol/l

0.02

281

Malignant neoplasm of skin

197

1342

1.01

0.01

1.2

299.80

350.31

nmol/l

3.11

164

1102

Perineal laceration during delivery

411

1.02

0.01

1.0

1.1

395.73

412.49

nmol/l

0.26

393

Extracorporeal dialysis

153

1.05

0.01

1.1

1.2

288.64

369.31

nmol/l

0.86

131

Melanocytic naevi of other and unspecified parts of face

163

1.04

0.01

1.1

391.06

397.60

nmol/l

0.05

147

Sequelae of injuries of lower limb

253

1.03

0.01

1.2

1.1

476.95

382.65

nmol/l

1.17

231

Gestational [pregnancy-induced] oedema and proteinuria without hypertension

257

0.97

0.01

1.1

349.89

392.73

nmol/l

0.45

232

Pleural effusion

543

1.01

0.01

1.3

1.2

335.73

337.06

nmol/l

0.02

422

Zoster [herpes zoster]

667

0.99

0.01

1.4

1.2

320.24

341.33

nmol/l

0.41

539

Delivery

148

782

1.00

0.00

1.1

1.2

359.26

379.45

nmol/l

0.54

129

678

Substance use, excluding alcohol

576

1.01

0.00

1.2

1.1

317.02

394.11

nmol/l

2.88

522

Aneurysms, operations, SAH

560

1.00

0.00

1.3

1.2

386.86

345.36

nmol/l

0.73

464

Inguinal or femoral hernia, bilateral

315

1.02

0.00

1.2

370.11

336.32

nmol/l

0.47

243

L02BA Anti-estrogens

546

1.01

0.00

1.2

1.1

373.32

369.34

nmol/l

0.05

479

Contact with nonpowered hand tool

105

1.05

0.00

1.4

1.2

374.45

401.04

nmol/l

0.13

L02BB Anti-androgens

302

0.99

0.00

1.1

1.3

378.45

305.99

nmol/l

0.97

221

Other sexually transmitted chlamydial diseases

155

1.03

0.00

1.1

1.0

503.56

417.72

nmol/l

1.46

148

Injury of muscle and tendon at wrist and hand level

372

0.99

0.00

1.2

1.1

386.72

387.50

nmol/l

0.01

324

Malignant neoplasm of thyroid gland, including Hilmo

235

1.02

0.00

1.2

357.53

385.75

nmol/l

0.27

211

Secondary and unspecified malignant neoplasm of lymph nodes

265

1.02

0.00

1.1

1.2

386.09

348.09

nmol/l

0.48

224

Brain meningioma, including Hilmo

161

0.99

0.00

1.1

1.2

310.73

384.78

nmol/l

0.71

142

Melanocytic naevi of trunk

355

1.01

0.00

1.2

1.1

394.53

385.67

nmol/l

0.09

315

Pyogenic arthritis

187

1.02

0.00

1.2

1.1

282.10

359.61

nmol/l

—

163

ILD, hospital admissions 1, main diag only

455

1.01

0.00

1.2

272.20

337.18

nmol/l

1.52

362

Interstitial lung disease endpoints

525

0.99

0.00

1.1

1.2

298.24

338.11

nmol/l

0.72

415

Interstitial lung disease

525

0.99

0.00

1.1

1.2

298.24

338.11

nmol/l

0.72

415

Malignant neoplasm of corpus uteri

298

1.01

0.00

1.0

1.2

351.63

350.86

nmol/l

0.01

238

Diabetic retinopathy, strict definition

586

0.99

0.00

1.2

374.12

348.57

nmol/l

0.37

422

Malignant neoplasm of breast, ER-positive, including Hilmo

124

955

1.00

0.00

1.1

1.2

347.50

383.01

nmol/l

1.24

104

815

Pneumonia due to Streptococcus pneumoniae

104

0.96

0.00

1.1

260.00

379.35

nmol/l

—

Other interstitial pulmonary diseases

523

0.99

0.00

1.1

1.2

298.24

338.41

nmol/l

0.73

414

Dislocation, sprain and strain of joints and ligaments at ankle and foot level

115

1145

1.00

0.00

1.2

1.1

379.90

397.09

nmol/l

0.38

1043

Transient global amnesia

251

1.00

0.00

1.0

1.2

361.44

350.14

nmol/l

0.09

205

Chronic periodontitis, complicated

194

1920

1.00

0.00

1.2

359.86

361.56

nmol/l

0.04

144

1625

ILD, hospital admissions

511

1.00

0.00

1.1

1.2

296.57

338.77

nmol/l

0.76

403

Cluster headache, strict, including avohilmo

122

0.98

0.00

1.0

1.1

496.17

397.68

nmol/l

0.79

114

Malignant neoplasm of breast, HER-positive

121

941

1.00

0.00

1.1

1.2

348.43

382.67

nmol/l

1.16

102

802

Melanocytic naevi

971

1.00

0.00

1.1

392.73

371.33

nmol/l

0.46

840

D07AA Corticosteroids, weak (group I)

449

1.00

0.00

1.1

410.33

388.90

nmol/l

0.29

404

Tubulo-interstitial nephritis, not specified as acute or chronic

226

1.02

0.00

1.0

1.2

361.82

353.07

nmol/l

0.05

193

Myocardial infarction, unclassifiable

822

1.00

0.00

1.3

1.2

297.04

314.19

nmol/l

0.35

613

Other ill-defined and unspecified causes of mortality

273

0.99

0.00

1.3

1.2

279.22

325.18

nmol/l

0.48

216

Other and unspecified cicatricial alopecia

0.00

0.0

1.0

—

396.71

—

Malignant neoplasm of other and ill-defined sites

0.00

0.0

1.6

—

338.71

—

Maxillary prognathism

0.00

0.0

1.3

—

468.50

—

Colour vision deficiencies

0.00

0.0

1.3

—

428.50

—

Embolism and thrombosis of abdominal aorta

0.00

0.0

1.5

—

311.18

—

Venous complications and haemorrhoids in pregnancy

1.00

0.00

1.0

455.20

420.68

nmol/l

—

Meningitis, viral

0.00

0.0

1.2

—

452.83

—

Femoral hernia, bilateral

0.00

0.0

1.4

—

305.13

—

Sleepwalking [somnambulism]

0.00

0.0

1.6

—

486.40

—

Chronic drug-induced interstitial lung disorders

0.00

0.0

1.0

—

418.50

—

Other and unspecified disorders of lacrimal system

0.00

-0.00

0.0

1.0

—

425.20

—

Osteochondrosis of ankle, juvenile

0.00

-0.00

0.0

1.0

—

434.67

—

Cystic kidney disease

0.89

-0.00

1.0

1.1

405.71

391.07

nmol/l

—

Palatinal maxillary canine

0.00

-0.00

0.0

1.1

—

402.57

—

Eccrine sweat disorders

0.00

-0.00

0.0

1.0

—

336.40

—

Golimumab

0.99

-0.00

1.1

346.13

419.23

nmol/l

—

Palatinal maxillary operation

0.00

-0.00

0.0

1.1

—

366.00

—

Retrobulbar neuritis in diseases classified elsewhere

0.00

-0.00

0.0

1.0

—

470.50

—

Changes in corneal membranes

0.00

-0.00

0.0

1.0

—

290.33

—

Other disorders involving the immune mechanism, not elsewhere classified

0.96

-0.00

1.1

391.71

402.34

nmol/l

—

Cluster headache, wide,, including avohilmo

130

1.00

-0.00

1.0

1.1

502.15

403.78

nmol/l

0.88

121

Cicatricial pemphigoid

0.00

-0.00

0.0

1.1

—

402.43

—

Precocious puberty

0.00

-0.00

0.0

1.4

—

357.00

—

Sexual assault by bodily force

0.00

-0.00

0.0

1.0

—

416.00

—

Fat embolism (traumatic)

0.00

-0.00

0.0

1.2

—

385.17

—

Aortic arch syndrome [Takayasu]

0.00

-0.00

0.0

1.2

—

280.60

—

Maternal care for (suspected) damage to fetus from alcohol

0.00

-0.00

0.0

1.2

—

506.60

—

Use of peginterferon beta-1a

0.00

-0.00

0.0

1.2

—

493.17

—

Small kidney of unknown cause

0.00

-0.00

0.0

1.4

—

484.80

—

Ectopic testis

0.00

-0.00

0.0

1.2

—

473.60

—

Medullary carcinoma of thyroid gland, including Hilmo

0.00

-0.00

0.0

1.0

—

405.60

—

Complications specific to multiple gestation

0.00

-0.00

0.0

1.1

—

453.88

—

Malignant neoplasm of vagina, including Hilmo

0.00

-0.00

0.0

1.3

—

311.44

—

Phlebitis and thrombophlebitis of superficial vessels of lower extremities, drug-induced

0.00

-0.00

0.0

1.0

—

371.00

—

Malignant neoplasm of vagina

0.00

-0.00

0.0

1.3

—

301.17

—

Other specified disorders of kidney and ureter

0.92

-0.00

1.3

1.1

400.88

374.62

nmol/l

—

Congenital varicose veins

0.00

-0.00

0.0

1.5

—

453.67

—

Cleft lip and palate

0.00

-0.00

0.0

1.3

—

480.75

—

Complications of anaesthesia during pregnancy

0.00

-0.00

0.0

1.2

—

488.60

—

Congenital malformations of ear causing impairment of hearing

0.00

-0.00

0.0

1.4

—

463.00

—

Other congenital malformations of male genital organs

0.00

-0.00

0.0

1.0

—

516.20

—

Esophageal diverticulum (pouch)

0.00

-0.00

0.0

1.0

—

291.00

—

Congenital vesicoureteral reflux

0.00

-0.00

0.0

1.2

—

361.17

—

Ovarian dysfunction, other/unspecified

0.00

-0.00

0.0

1.1

—

462.63

—

ILD-related respiratory insufficiency

100

1.00

-0.00

1.0

1.2

290.70

349.10

nmol/l

—

Cutaneous lupus erythematosus

1.02

-0.00

1.2

384.17

385.57

nmol/l

—

Papilloedema, unspecified

1.02

-0.00

1.0

1.2

396.20

392.93

nmol/l

—

Viral agents as the cause of diseases classified to other chapters

1.02

-0.00

1.0

1.1

339.00

399.43

nmol/l

—

Complications of anaesthesia during labour and delivery

0.00

-0.00

0.0

1.0

—

432.00

—

Dronedarone medication

0.88

-0.00

1.2

1.1

373.83

330.13

nmol/l

—

≡ Risteys

R13

FinnGen R12 + FinRegistry

FinnGen R11 + FinRegistry

FinnGen R10 + FinRegistry

FinnGen R10

FinnGen R9

FinnGen R8

FinnGen R7

FinnGen R6

FinnGen R5

FinnGen R4

FinnGen R3

Folate [Moles/volume] in Blood

Coding

Definition

OMOP mapping QC

Cohort

Year of birth distribution

Age at first measurement

Age at last measurement

Age at start of registry

Duration from first to last measurement

Statistics

Number of measurements over the years

Number of measurements per person

Distribution of lab values

Value range per person

LabWAS